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Subconcussive (SC) impacts have become a growing concern within the neuroscience
community regarding the immediate and long-lasting effects of sports-related injuries. While a
single low-level impact, i.e., a subconcussion, may not cause cerebral perturbations, it has been
increasingly recognized that repeated SC exposure can induce deleterious effects. Therefore,
determining the lower limits of systematic perturbation resulting from multiple SC impacts is of
critical importance in expanding our understanding of cerebral vulnerability and recovery.
Currently, there is a lack of correlation between a mild traumatic brain injury (mTBI) and
repeated SC impacts with respect to injury biomechanics. Moreover, the cumulative threshold for
repetitive low-level impacts is currently undefined. Thus, this research was designed to
determine the pathophysiological differences between a single impact of an mTBI and repeated
SC impacts with a subdivided cumulative kinetic energy of the single mTBI impact.
In order to address this gap in knowledge, the present investigation employed a surgeryfree, closed-head, weight drop injury device capable of producing repeatable, head impacts
within a rat model. General locomotion and anxiety-like behavior were assessed using an Open
Field Test and motor coordination dysfunction was measured using the rotarod assay.

Neuroinflammation was measured using immunohistochemical assessment of astrogliosis
(GFAP) and microgliosis (Iba-1) within the hippocampus. Additionally, immunohistochemical
assessment of neuronal loss (NeuN) was measured within the hippocampus. To investigate the
tolerance and the persistence of cerebral vulnerability following a single mTBI and repeated
subconcussive impacts, measurement outcomes were assessed over two-time points (3- and 7days) post final impact.
Although injury groups were not statistically different from their associated sham groups
with respect to behavioral outcomes; on average, RSC injury rats displayed a significant increase
in anxious-like behavior after 7-days of recovery compared to the single mTBI group. From an
inflammatory perspective, both mTBI and RSC injury groups led to extensive microgliosis in the
gray matter following 3-days post-impact. Overall, this work’s findings do not provide evidence
in support of the notion that repeated subconcussive impacts do result in behavioral disturbances
and neuroinflammation, that do not manifest following a single mTBI of the same energy input.
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CHAPTER I
INTRODUCTION
1.1

Definition of Traumatic Brain Injury
Traumatic brain injury (TBI) is best defined as a neurological event causing a “complex

pathophysiological process affecting the brain, induced by biomechanical forces” (Budson et al.,
2017, pg. 11). Biomechanical forces can include any of the following: the head being struck by
an object, the head striking an object, the brain undergoing rapid acceleration/deceleration
movement without any external trauma applied to the head (i.e., whiplash), an object penetrating
the brain, or a force to the head applied from a blast or explosion. When there is a mechanical
insult, force, acceleration/deceleration, or rotational stress conveyed on the brain that causes
modified brain function leading to symptoms and signs, it is recognized as a concussion (Budson
et al., 2017, pg. 6). Symptoms and signs include temporary loss of consciousness, headaches,
dizziness, fatigue, irritability, memory loss, inability to concentrate, and emotional lability such
as depression and anxiety (Arciniegas et al., 1999; Kibby and Long, 1996; Levin et al., 1987). It
is important to note, the mechanical force needed to impart some of these symptoms is not as
great as the forces needed to cause a loss of consciousness. Thus, while loss of consciousness is a
clinical hallmark of concussion, it is not required to make the diagnosis. For most patients, rest
over time helps alleviate symptoms of a brain injury within an hour or days. However, others
may have symptoms lasting much longer.
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Diagnosis of TBI is made clinically and relies on several clinical criteria (Blyth &
Bazarian, 2010), one of which is the Glasgow Coma Scale (GCS). The Glasgow Coma Scale is a
neurological scale based on motor responsiveness, verbal performance, and eye-opening analysis
to appropriate stimuli to assess the level of impaired consciousness among individuals (Teasdale
et al., 2014) and is a widely used and accepted prognosis indicator for head injuries.
Traditionally, the GCS classifies head injuries according to their injury severity, mild (GCS 1415), moderate (GCS 9-13), or severe (GCS 3-8) (Mena et al., 2011). However, the Canadian
Computed Tomography (CT) Head Rule Study, Advanced Trauma Life Support (ATLS) reports
a modification to the GCS classifications so that a GCS score of 13 falls under a mild TBI
category (GCS 13-15) (Kortbeek et al., 2008; Smits et al., 2005; Stiell et al., 2005). Other criteria
used to identify the severity of head injury includes structural imaging of the head, duration of
unconsciousness, post-traumatic amnesia, and any alteration of mental state (see Table 1.1)
(Blyth & Bazarian, 2010).
Table 1.1

Clinical criteria for classifying the severity of injury for traumatic brain injury.

Criteria
Structural imaging of the
head
Duration of
unconsciousness
Post-traumatic amnesia

Mild TBI

Moderate TBI

Normal

Normal or abnormal

0-30 min

> 30 minutes and <
24 hrs

A moment up to 24
hrs
0-1 day

Severe TBI
Normal or
abnormal
> 24 hrs

> 24 hrs Severity based on other criteria

Alteration of mental state
> 1 and < 7 days
> 7 days
Glasgow Coma Scale
score (within first 24
13-15
9-12
<9
hours)
Notes: This table was adapted from Blyth, B. J., & Bazarian, J. J. (2010), Traumatic alterations
in consciousness: traumatic brain injury, Emergency Medicine Clinics, 28(3), 571-594.
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Mild TBI (mTBI), interchanged with concussion throughout this dissertation, is clinically
characterized as an individual with normal structural imaging i.e., no hemorrhaging or bleeding
or skull fracture (Blyth & Bazarian, 2010). However, in conjunction, individuals may have a loss
of consciousness up to 30 minutes or any period of altered amnesia within 24 hours post-injury
and have a GCS score of 14-15 (Blyth & Bazarian, 2010). Moderate TBI is defined as loss of
consciousness of 30 minutes to 24 hours, amnesia lasting more than 24 hours, normal to
abnormal structural imaging, or a period of 1-7 days of amnesia with a lower GCS score of 9-12
(Blyth & Bazarian, 2010). Finally, a severe TBI is classified to patients who show normal to
abnormal structural imaging, a loss of consciousness greater than 24 hours, any period of altered
amnesia greater than 24 hours post-injury, or any alteration of mental state greater than 7-days
and have a GCS score of 3-8 (Blyth & Bazarian, 2010). The vast majority of head traumas are
categorized as mild, up to 90% of all cases, and occur during sports-related activities (Gardner &
Zafonte, 2016; Leo & McCrea, 2016; Langlois, Rutland-Brown, and Wald 2006, Centers for
Disease Control and Prevention (CDC) 2003).
1.2

Incidence, prevalence, and cost estimates of TBI
According to the Centers for Disease and Control (CDC), each year the number of new

cases of TBI in the United States is over 2.8 million (Peterson, et. al, 2019). These incidence
rates include approximately 2.5 million TBI-related emergency room visits, around 288,000 TBIrelated hospitalizations, and over 57,000 deaths related to TBI. Mounting evidence suggests that
the number of incidences is much larger than that reported because many cases are unreported or
undiagnosed due to the mild nature of the initial injury (Faul et al., 2010). According to the
National Center for Injury Prevention and Control, an estimated 5.3 million individuals are living
with a disability due to a traumatic brain jury in the United States (Centers for Disease Control
3

and Prevention, 2003). This represents a prevalence of about 2% of the U.S. population
(Peterson, et. al, 2019). These disabilities can range from symptoms that have a minimal effect
on everyday life to those that cause physical, emotional, and mental alterations that may interfere
with daily activities. Not only can there be acute and chronic outcomes following a TBI, but
there is also the economic burden that patients pose to their families, careers, and society.
According to van Dijck et al. (2019), estimations of the in-hospital cost for patients with severe
TBI were between $2,130 to $401,808. Variations in cost were primarily due to the
heterogeneity in patient and treatment characteristics including the length of stay and surgical
(van Dijck et al., 2019). Although in-hospital costs are an important part of the overall costs for
patients, this study did not include other major contributors to the total cost post-injury including
post-discharge rehabilitation, disability, or long-term care costs (van Dijck et al., 2019).
1.3

Anatomy of the Human Head
The brain and spinal cord form what is known as the central nervous system (CNS). The

CNS is responsible for integrating sensory information and responding accordingly. The brain is
responsible for coordinating sensory and motor systems, both voluntary and involuntary, of the
body as well as facilitating our ability to perceive and interact with the environment. Although
the brain only represents 2% of the body weight, it also consumes 15% of the cardiac output,
20% of total body oxygen, and 20% of the body’s energy supply at rest (Maldonado &
Alsayouri, 2020). The functional complexity of the brain is intricate in itself due to the large
magnitude of neuronal (up to 86 billion) and non-neuronal (up to 86 billion) cells which results
in a substantial metabolic demand (Azevedo et al., 2009). The brain’s structural complexity is
multi-layered and includes various gross anatomical components, cellular organization, and
morphology.
4

1.3.1

Gross Components
The human head is a complex anatomical structure comprised of hard (bone) and soft

tissues. It contains important parts of the body’s sensory nervous system such as the nose, ears,
eyes, and brain. The brain is the most essential organ that integrates and coordinates all
information and activity of all the body parts. To protect this vital and delicate organ, a multilayered structure encompasses the brain comprised of scalp, skull, and meninges (see Figure
1.1).

Figure 1.1

Illustration of the structural layers of the human head (“Medical Gallery of
Blausen Medical 2014,” 2014).

Notes: Illustration was obtained and adapted courtesy of © Blausen Medical
(https://en.wikiversity.org); Illustrator: N/A.
The skull or cranium is separated from the scalp by the periosteum, as seen in Figure 1.1,
a fibrous layer that is connected to the skull at the skull sutures (Ellis & Mahadevan, 2014). The
5

skull is comprised of three layers, the cortical outer layer, the cancellous, or diploe, the inner
layer, and the cortical inner layer. Inside the cranial cavity, enclosing the brain, is the meninges
(consisting of three distinct membrane layers) (Weller, 2005). These membranes, the dura mater,
arachnoid mater, and pia mater, envelop the brain and spinal cord (Weller, 2005). The outermost
layer, the dura mater, is a thick fibrous tissue that lines the inner layer of the skull. It deviates
from the contours of the skull by forming the double fold, known as the falx cerebri, as seen in
Figure 1.1 (Abrahams, 2016). The middle membrane, the arachnoid mater, is an impermeable
membrane comprised of web-like, fibrous tissue (Abrahams, 2016; Weller, 2005). This second
layer is separated from the dura mater by a small gap called the subdural space, as seen in Figure
1.1. The pia mater, the innermost meninx layer, adheres to the brain following its unique
contours. The space between the arachnoid and pia (subarachnoid space) is filled with
cerebrospinal fluid (CSF) (Weller, 2005). This fluid is a clear and colorless body fluid, that
circulates and surrounds the brain, ventricles (lateral, third, and fourth ventricles), and spinal
cord (Kegel, 2018), as seen in Figure 1.2. Not only is this fluid an essential component for
nutrient delivery, waste clearance, and pressure regulation of the brain, but it also cushions the brain
against mechanical impacts (Linninger et al., 2016).

6

Figure 1.2

Illustration of the ventricular system (shown in blue) (“Medical gallery of Blausen
Medical 2014,” 2014).

Notes: Illustration was obtained courtesy of © Blausen Medical (https://en.wikiversity.org);
Illustrator: N/A.
The brain can be separated into two parts, the cerebrum and cerebellum. The cerebrum is
the largest component of the brain and is characterized by two symmetrical hemispheres
separated by the falx cerebri. Within these convoluted hemispheres are four lobes – the frontal,
parietal, temporal, and occipital lobe (Figure 1.3). The cerebrum consists of an outer cerebral
cortex, composed of gray matter, and an underlying white matter, as seen in Figure 1.1. Although
macroscopically different in color characteristics, microscopically the two differ in functionality
based on the cellular structures present (Maldonado & Alsayouri, 2020). The gray matter
primarily consists of neuronal cell bodies, dendrites, unmyelinated axons, glial cells, synapsis,
and capillaries (Bayly et al., 2014; Maldonado & Alsayouri, 2020). Alternatively, the subcortical
(beneath the cortex) area is mostly white matter, where its major component is myelinated axons
(Bayly et al., 2014; Maldonado & Alsayouri, 2020). The cerebellum is a much smaller structure
lies between the cerebrum and the spinal cord (Figure 1.3).
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Figure 1.3

Illustration of external and internal cortical structures.

Notes: Central internal structures of the cortical and spinal cord (sagittal view; bottom left) and
external cortical structure (lateral view; top right). The illustration was obtained courtesy of ©
WebMD, LLC (www.webmd.com); Illustrator: N/A.
1.3.2

Cellular Components
Brain tissue is comprised of two major cellular populations – neuron and glial cells. Both

the gray and white matter are comprised of glial cells. Neurons are the basic and functional units
of the nervous system, that convey information both electrically and chemically. Within the
neuron itself, information is passed along through the movement of an electrical charge (i.e., an
impulse or action potential) (“The Principles of Nerve Cell Communication,” 1997). The neuron
has three main components – the dendrites, cell body, and axon (Figure 1.4). Dendrites are short,
thin fibers that extend from the cell in branched tendrils to receive electrical impulses from other
surrounding neurons (“The Principles of Nerve Cell Communication,” 1997). The cell body is
the enlarged portion of the neuron that contains the nucleus and carries out most of the neuron’s
basic cellular functioning. The axon is a thin, long extension that is responsible for signal
transmission. For the axon to maintain its signal strength as action potentials travel down
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towards the axon terminals to reach the synapse, a segmented insulation casing called myelin
surrounds the axonal membrane. (Figure 1.4) (Maldonado & Alsayouri, 2020).

Figure 1.4

Illustration of a neuron and synapse.

The image was obtained and modified from “Overview of neuron structure and function” by
Khan Academy, (www.khanacademy.org); Illustrator: N/A.
The segments of myelin are separated by unmyelinated regions called the Nodes of
Ranvier. Nodes of Ranvier are highly enriched in ion channels, allowing them to participate in
the exchange of ions required to regenerate the action potential. This results in faster conduction
of the action potential along the axon (Nelson & Jenkins, 2017). Both the axonal and dendritic
processes allow neuron cells to create a dense network of communication across the nervous
system.
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At rest, a neuron maintains a polarized membrane potential utilizing specialized ionic
pumps. The main function of these pumps is to keep the outside of the cell positively charged
relative to the inside of the cell (Fox, 2009, pg.171-173). Neurons propagate information to one
another via electrochemical impulses, called action potentials (Fox, 2009, pg.170-172). Upon
sufficient stimulation of ions, the cellular membrane begins depolarizing and an action potential
is fired (Fox, 2009, pg.72-173). When an action potential is triggered, the membrane
depolarization spreads down the length of the axon to the axon terminal (Fox, 2009, pg.172-173).
Here, the action potential then triggers the presynaptic neuron to release a cluster of chemical
regulators called neurotransmitters from the axon endings into a space called the synaptic gap, or
cleft (Fox, 2009, pg.177-180). Neurotransmitters then begin to diffuse rapidly across the synaptic
cleft to bind to receptor sites of the postsynaptic neuron (see Figure 1.4) (Fox, 2009, p.178-182).
Glial cells, consisting of oligodendrocytes, astrocytes, and microglia, constitute a large
fraction of the brain. Glial cells are anything but a small cellular fraction, as they constitute
between 33 and 66% of the total brain volume, depending on the mammalian species (Azevedo
et al., 2009; Herculano-Houzel, 2014). Primarily, glial cells provide support for the neurons.
Structurally, glial cells are smaller than neurons and lack axons and dendrites (Purves et al.,
2001). Oligodendrocytes are responsible for forming myelin sheaths around adjacent neuronal
axons in the CNS. Again, these myelin sheaths enwrap axons to allow fast conduction of action
potentials. One single oligodendrocyte is capable of ensheathing as many as 40-50 axons
(Popovich et al., 2009). Oligodendrocytes are most abundant in the white matter region of the
cerebral tissue; however, some are found in gray matter (Hofmann et al., 2017).
Astrocytes are the most abundant cell type in the CNS. Astrocytes appear to have a starshaped morphology with a multitude of processes extending from their cell body (Argente10

Arizón et al., 2015). Using their expanded processes called “end-feet,” astrocytes are involved in
the formation and maintenance of some of the blood-brain barrier (BBB) properties (Janzer &
Raff, 1987) and can regulate vasodilatation, thus controlling the flow of blood-borne substances
(Macvicar & Newman, 2015; Zonta et al., 2003). The BBB is a critical protective border that
prevents toxins or pathogens from entering the brain through the bloodstream (Freire-Regatillo et
al., 2017). In addition to their maintenance role of the BBB, astrocytes also play a critical role in
maintaining the homeostasis of ions, transmitters, and blood flow that are critical for neural
circuit functions (Burda et al., 2016). Among neurons, astrocytes participate in the reuptake and
recycling of glutamate and gamma-aminobutyric acid (GABA) neurotransmitters from the
extracellular space after neuronal activity (Mederos et al., 2018). This process of reuptake is
essential to prevent glutamate-derived excitotoxicity during neuronal synaptic transmission
(Danbolt, 2001). In response to all forms of CNS insults, astrocytes become activated, a process
called astrogliosis, where they take on a hypertrophic morphology with their processes
increasing in length and size (Burda et al., 2016).
Microglial cells account for 5–12% of the total cell numbers and are mainly responsible
for immune defense in the brain. (Alekseeva et al., 2019; Hanisch, 2013). Under normal
physiological conditions, microglia have long radial processes and are highly motile as they
constantly survey their microenvironment for harmful agents and injurious processes (Sominsky
et al., 2018). Functionally, microglia are involved in brain development, have phagocytosis
properties, and respond rapidly to any immune challenge, pathogen, or injury in the CNS in order
to maintain normal cellular homeostasis (Alekseeva et al., 2019; Loane & Kumar, 2016;
Sominsky et al., 2018). In non-pathological environments, a major function of microglia in the
intact brain is to monitor and maintain the balance between pro- and anti-inflammatory factors
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(Alekseeva, Kirik, Gilerovich, & Korzhevskii, 2019). In response to trauma, microglia enter into
an inflammatory response mode where their morphology is changed to short and thick
projections and assume an ameboid shape extending their processes towards the site of injury
(Alekseeva et al., 2019; Sominsky et al., 2018). In this microglia phenotype form, microglia are
characterized by a predominance of the phagocytic function (phagocytosis of cell debris) and
reception and secretion of various factors, including cytokines (Alekseeva, Kirik, Gilerovich, &
Korzhevskii, 2019).
1.4

Biomechanics of Traumatic Brain Injury
The biomechanics of head injuries has been investigated in a variety of labs over several

decades (Meaney et al., 2014). When a force or load is applied to a system, it may cause initial
damage or lead to delayed damage, however, the point at which the system, in this case, tissue
damage, reaches its tolerance level, is determined by the type and duration of force or load
(LaPlaca et al., 2007).
The most common cause of head injuries is due to dynamic loadings, or high-speed
impact loadings, which occur in rapid durations (under 1 sec) (LaPlaca et al., 2007). These highspeed impact loadings can be further broken down as direct and indirect loading. As the name
suggests, direct loading occurs when there is physical contact between an external object and the
head. Depending on the rate of impact, magnitude of force, and size of the impact area, direct
loading can cause focal or diffuse axonal injury (DAI) (LaPlaca et al., 2007). Indirect loading
occurs when there is motion of the head without an external object encountering the head. This
type of loading is due to inertial forces alone which leads to diffuse axonal injuries (Su & Bell,
2016).
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Magnetic resonance imaging (MRI) findings showed that the concurrence of both injury
types is commonly seen in patients who have suffered from moderate to severe TBI, however,
DAI is one of the most common across all severities of closed head injury (CHI) (Skandsen et
al., 2010; Su & Bell, 2016). Focal brain damage is visibly seen by the naked eye at the site of
impact and is generally associated with an impact that exerts lacerations of the cerebral tissue
due to compressive and concussive forces with evidence of skull fracture and localized contusion
at the site of impact (coup injury; (Schmidt et al., 2004)). At the coup site, the occurrence of
hematoma, epidural, subdural and intracerebral hemorrhages may transpire along with the
accumulation of neuronal and glial cells (LaPlaca et al., 2007; Ng & Lee, 2019) As the brain
tissue rebounds and strikes the opposite site of the skull, a secondary impact, called contrecoup,
may cause a secondary contusion (Schmidt et al., 2004). In contrast to focal injury, the main
mechanism of DAI is indirect loading of rapid acceleration and deceleration which cause
shearing and stretching injury in the cerebral tissue (Koliatsos et al., 2020). More specifically,
diffuse TBI is immense damage of axons throughout the white matter which involves
degradation of axonal cytoskeleton and impairment of axonal transport (Meaney et al., 2014).
Additionally, as one can assume, the degree of axonal injury and neuronal degeneration
determines the severity of TBI.
Understanding the relationship between loading conditions and cellular responses in the
context of injury biomechanics is a deeply complex problem. As a result, many researchers are
characterizing these loading events from the perspective of injury biomechanics in order to better
understand this intricate relationship (Meaney et al., 2014). Furthermore, because concussion and
mTBI are categorized as predominately, if not purely, diffuse injuries (Zacko et al., 2011), the
following pathophysiology described will mainly focus on a diffuse axonal injury.
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1.5

Pathophysiology of Traumatic Brain Injury
There are two aspects to injury caused by a traumatic brain injury: primary and secondary

injury. The primary stage is characterized by the moment and duration of impact involving the
initial tear, neuronal injury and hemorrhage of the cerebral tissue caused by the mechanical insult
(Mustafa & Al-Shboul, 2013). The secondary stage, also referred to as secondary injury, occurs
at the moment of primary injury and subsequently evolves over hours to days and even months
(Kumar & Brain, 2012). The secondary phase of injury may be characterized by metabolic
dysfunction, neurovascular damage, altered cerebral blood flow, neuronal apoptosis,
excitotoxicity, oxidative stress, and inflammation (Pavlova et al., 2018).
Diffuse axonal injury entails both structural and functional alterations. From a structural
standpoint, DAI is a primary axonal perturbation that is featured by fracture of the stiffest part of
the axon cytoskeletal structure, the microtubules (Blennow et al., 2012; Koliatsos et al., 2020).
Mainly caused by ultra-rapid shearing or tensile deformation, the breakdown of microtubules
causes a halt in vesicular transport along the axon (Blennow et al., 2012; Koliatsos et al., 2020).
Once microtubules are fractured, this leads to microtubular undulations, impairment of axonal
transport with an ensuing accumulation of axonal transport cargos, axonal swelling called axonal
retraction balls, followed by eventual disconnection and axotomy (Blennow et al., 2012;
Koliatsos et al., 2020). Additional primary structural effects include mechanoporation of the
axolemma (the cell membrane of an axon) and neurofilament breakdown (Koliatsos et al., 2020).
Furthermore, if the axon is unable to recover, the damage eventually spreads throughout the cell
causing further functional impairments and may lead to neuronal cell death in addition to
network disconnection (Greve & Zink, 2009; Meythaler et al., 2001).
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Even in instances where the axon’s structure is not directly damaged, the forces imparted
to the cerebral tissue typically result in the stretching and tearing of axons causing axonal
disruption to neurons (Greve & Zink, 2009). As a result, dysregulation of protein channels within
the neuronal plasmalemma then ensues, resulting in uncontrolled ion flux and neurotransmitter
effects (Hovda et al., 2014, pg. 209). Specifically, liberation of potassium (K+) ions with a large
influx of sodium (Na+) and calcium (Ca2+) ions (Hovda et al., 2014, pg. 209). The influx of Na+
and Ca2+ elicits rapid neuronal depolarization thus triggering the release of glutamate (Hovda et
al., 2014, pg. 209). Glutamate then acts on several receptors causing further depolarization and
calcium influx into the neuron which can lead to excitotoxicity (Greve & Zink, 2009).
While excess intracellular calcium can lead to axonal swelling, it also promotes oxygen
radical reactions causing a further unstable environment (Greve & Zink, 2009). Due to the
imbalance of normal ionic concentrations, the neuron must rely on the sodium-potassium pumps
to restore ionic homeostasis (Hovda et al., 2014, pg. 209). However, since sodium-potassium
pumps are not passive and are adenosine triphosphate (ATP)–dependent pumps, this leads to the
rapid, acute depletion of ATP and consequently to an immediate period of hyperglycolysis
(Hovda et al., 2014, pg. 210). Moreover, in an attempt to avert the glutamate-mediated
accumulation of intracellular Ca2+ ions, the mitochondria begin sequestering the Ca2+, which in
turn, causes the mitochondria to become less efficient at converting glucose to ATP, creating an
energy crisis, and producing less ATP to drive the sodium-potassium pumps (Hovda et al., 2014,
pg. 210). Consequently, this energy crisis, in turn, exacerbates the cellular conditions to a state in
which, if not corrected, may lead to cell death (Greve & Zink, 2009).
Thus, as the name may lead readers to believe, there is nothing “mild” about an mTBI at
the cellular level. Similarly, repetitive subconcussive (SC) head impacts can also trigger
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neurochemical and neurometabolic reactions, although to a reduced degree which may lead to
chronic neurological syndromes (Bailes et al., 2013). Consequently, in response to the disruption
of homeostasis and the ensuing metabolic crisis, the immune system response is initiated and
neuroinflammation begins.
1.5.1

Neuroinflammation
Neuroinflammation is an important secondary injury mechanism in TBI that involves a

complex process of cumulative changes within the cerebral tissue. Post-traumatic cerebral
inflammation is characterized by the combination of glial cell activation, such as microglia, and
astrocytes, as well as macrophage and leukocyte recruitment, all modulated by complex pro-and
anti-inflammatory mediators, such as cytokine and chemokines (Simon et al., 2017).
Increased neuronal permeability, caused by the shearing and stretching of axons due to
mechanical tissue deformation, is thought to be the initiation of the inflammatory process
(Wofford et al., 2019). As previously described, following mechanoporation to neuronal
membranes, the excessive extracellular levels of glutamate from leaky neuronal membranes are
claimed to be powerful drivers of inflammation (Wofford et al., 2019). Commonly observed
features of neuronal permeability have been seen in the cortex, sub-cortical white matter, and in
the hippocampus of the brain parenchyma (Wofford et al., 2019). In a healthy environment,
astrocytes aid in the reuptake of glutamate from the synapses and recycle it back to neurons,
however, following cerebral injury, excessive glutamate released from neurons and impaired
astrocytic clearance of glutamate further aid the initiation of the inflammatory process
(Sofroniew & Vinters, 2010; Yi & Hazell, 2006). Additionally, microglia, monocyte, and
macrophage immune cells possess glutamatergic receptors; thus, it is further supported that this
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rise of glutamate within the cerebral tissue, as monitored by microglia and astrocytes, is a key
contributor to the immune response process (Kumar & Brain, 2012).
As pathological sensors of TBI, microglia rapidly enter into a state of activation, called
microgliosis, by taking on an amoeboid shape resembling peripheral macrophages, and scavenge
the CNS producing and releasing cytotoxic molecules (i.e., oxygen-free radicals and
inflammatory cytokines) in order to protect and repair the damaged cells (Kumar & Brain, 2012;
Chiu et al., 2016; Aihara et al., 2009). Simultaneously, microglia play a role in clearing cellular
debris (i.e., broken myelin or cellular membranes) and toxic substances by phagocytosis (Chiu et
al., 2016). However, if the damage is too severe or the impact is ongoing, microglia will remain
in a state of continual defense which leads to persistent inflammation and has been shown to
result in neurodegeneration and functional deficits in preclinical (Fehily & Fitzgerald, 2017) and
clinical studies (Faden et al., 2016).
Like microglia, astrocytes are also involved in neuroinflammation, undergoing a
morphological change known as reactive astrogliosis that involves cellular hypertrophy,
lengthened processes, increased expression of intermediate filaments (vimentin and glial
fibrillary acidic protein (GFAP)), and the production/release of pro-inflammatory
mediators (Sofroniew & Vinters, 2010; Zhang et al., 2010). Following injury, hypertrophic
astrocytes are recruited to surround the lesion site not only to protect damaged cells but also to
restrict inflammation and preserve cellular domains and tissue structure through scar formation
(Sofroniew & Vinters, 2010). Additionally, astrocytes play a vital role in regulating
extracellular glutamate levels, which can reduce glutamate excitotoxicity to neurons and
surrounding cells (Schousboe & Waagepetersen, 2005)
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Furthermore, similarly to microglia, reactive astrocytes can have detrimental and/or
beneficial roles following CNS injury (Yuan & Wu, 2022). While astrocytes have been shown to
provide neurotrophic support and guidance for axonal growth following CNS injury (Chung et
al., 2015; Zhou et al., 2020), prolonged astrogliosis can also inhibit axon regeneration and hinder
functional recovery (Furman et al., 2016; Perez et al., 2017).
Bidirectional communication between glial cells is crucial for functions, homeostasis, and
recovery from injury. Studies have shown that activated microglia directly impact the activation
state of astrocytes via the generation and release of inflammatory mediators, such as cytokines,
that, in turn, act on surrounding glia and neurons (Liu et al., 2011; Jha et al., 2019).
Concurrently, activated astrocytes can secrete both pro- and anti-inflammatory cytokines on
microglia (Jha et al., 2019; Sofroniew & Vinters, 2010). Among various cytokines, pivotal
mediators associated with post-traumatic neuropathological damage include tumor necrosis
factor (TNF) and the interleukin (IL) family of peptides and have been shown to markedly
increase in the acute period following both experimental (Holmin et al., 1997; Jha et al., 2019;
Robinson et al., 2017; Zhao et al., 2014) and clinical (Ziebell & Morganti-Kossmann, 2010)
brain trauma.
However, depending on the type of impact, its intensity, and the time of exposure, this
crosstalk of inflammatory mediators does have the capacity to create a neurotoxic environment
thus augmenting the initial injury (Clark et al., 2019; Kreutzberg, 1996; Liddelow et al., 2017).
In synopsis, neuroinflammation is considered to have both beneficial and detrimental roles.
Significant benefits can be achieved when the inflammation is controlled in a regulated manner
and for an acute period. However, when excessive, it can become a major cause of several
neuropathologies and, thereby, drive neurodegenerative processes (Bao et al., 2012; Block et al.,
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2007; Sheng et al., 2013; Shultz et al., 2013; Webster et al., 2015). Thus, understanding the
initiation of immune cell reactivity in addition to its consequences on neuronal health is essential
for preserving the beneficial effects of acute inflammation while minimizing the destructive
consequences of sustained inflammation (Wofford et al., 2019).
1.6

Repeated Head Trauma
Recurrent traumatic brain injury, especially mTBI, has become a popular interest within

the research realm of neurotrauma due to the concern that repeated mTBI increases the risk of
cognitive impairment later in life or possible neurodegenerative diseases such as Chronic
Traumatic Encephalopathy (CTE) and/or Alzheimer’s Disease (Galgano et al., 2016; Prins et al.,
2013; Safinia et al., 2016; Shurley & Todd, 2016; Witcher et al., 2015). CTE is a tau protein
neurodegenerative disorder that, thus far, can only be diagnosed post-mortem (Baugh et al.,
2012). In the past, mounting clinical and preclinical evidence suggested that the pathology
contributing to CTE was caused by repetitive exposure to concussive impacts (Baugh et al.,
2012; Fujita et al., 2012; Hoogenboom et al., 2019; McAteer et al., 2016; A. L. Petraglia et al.,
2014; Prins et al., 2010; Shitaka et al., 2011a; Smith et al., 2013; Stein et al., 2014; Stern et al.,
2011; Thomsen et al., 2017; VanItallie, 2019). However, recent post-mortem neuropathology has
confirmed CTE in football players with no history of diagnosed or reported concussions (but
played in positions, such as lineman, with the greatest exposure to repetitive hits to the head
(Greenwald et al., 2008)), suggesting that repetitive SC impacts may also lead to the
development of this neurodegenerative disease (Bailes et al., 2013; Dashnaw et al., 2012; Gavett
et al., 2011; A. L. Petraglia et al., 2014; Spiotta et al., 2012; Talavage et al., 2014).
Although SC events do not result in observable symptoms and apparent behavioral
modifications (Miller et al., 2007), exposure to repetitive SC blows to the head may result in
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equivalent, if not greater damage than a single concussive event (Bazarian et al., 2012) and may
have cumulative effects (Breedlove et al., 2012). Even though SC impacts are not medically
diagnosed, clinical data has shown that these repetitive low-load impacts can result in
neuropsychological changes (Bazarian et al., 2012; Killam et al., 2005; McAllister et al., 2012;
Talavage et al., 2014). However, what is not known is the number of head impacts and their
intensity that might lead to similar pathophysiological concussive effects (i.e. a concussion
cumulative threshold) (King et al., 2015). The injury threshold is likely to be different for each
person given the multifactorial nature of head injuries, such as age at exposure of impact, type
and magnitude of exposure, location of impact, recovery periods, individual vulnerability, and
others (Bailes et al., 2013). Though, if a threshold could be determined, players could be
monitored to reduce their potential risk for a serious and irreversible cerebral injury.
The increased incidence of repeated head trauma has generated new topics of discussion
about the existence of cerebral vulnerability, its duration, and its relationship to subsequent
injuries. Evidence suggests that repeated head injuries may lead to a state of enhanced
vulnerability in which a secondary insult may exacerbate the initial damage (Gennarelli, 1993;
Jenkins et al., 1989; Yoshino, Hovda, Kawamata, Katayama, & Becker, 1991; Mayumi L. Prins,
Alexander, Giza, & Hovda, 2013a). Recent studies of TBI have shown that while repeat trauma
can exacerbate structural, functional, metabolic, and behavioral responses, these responses only
occur when the injury is repeated within a certain period post-injury (Bolton & Saatman, 2014;
Fehily et al., 2019; Meehan III et al., 2012; Prins et al., 2013). Using rodent models to model
repeated mTBI, this window of vulnerability to the brain is greatest when the interval between
head injuries, also called an inter-injury interval, is short, between hours to days (Bolton &
Saatman, 2014; Fehily et al., 2019; Meehan III et al., 2012; Mayumi L. Prins et al., 2013a), while
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any risk of enhanced damage due to a secondary insult is averted when the inter-injury interval is
elongated, days to weeks (Meehan III, Zhang, Mannix, & Whalen, 2012; Mayumi L. Prins et al.,
2013a). According to Bolton and Saatman (2014), a longer inter-injury interval allows the brain
to recover and reduces the potential for exacerbation of the secondary injury cascade.
Unfortunately, there is not a universal window of vulnerability for repeated head impacts.
Not only does the inter-injury interval between impacts influence the brain’s window of
vulnerability, but also the severity of the initial injury, subconcussive, mild, or severe, can
influence this variable. As such, investigators are forced to rethink the issue of repeated injury to
frame discussions to consider both of these influencers, inter-injury interval and severity of
injuries, as predictors of increased neuroinflammation and neurodegeneration.
1.7

Motivation for Study
While the term concussion is frequently used synonymously with mTBI, some

distinguish mTBI as a post-mortem head injury diagnosis evident through pathophysiology and
concussion as a pre-mortem diagnosis related to functional disturbance symptoms (for example,
fatigue, headache, dizziness, irritability, memory impairment, etc.) (Anderson et al., 2006).
Regardless of the ambiguity of terminology, there is universal agreement that a concussion can
lead to significant impairment and reduced quality of life (Anderson et al., 2006). As such,
concussion has become a widely studied field in neurotrauma. Increased awareness of this
epidemic has led to research efforts focused on determining the threshold of head impact that
will result in cerebral damage and loss of function (Hsieh et al., 2017; Ma et al., 2019;
McNamara et al., 2020). However, these much lighter forms of head impacts, so-called
subconcussive, are currently understudied and their underlying mechanisms and potentially
detrimental effects are unknown (Rawlings et al., 2020).
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While this low-level impact may not induce symptoms that are immediate or necessarily
delayed in onset, it has been increasingly recognized that repeated SC exposure has long-term
consequences (Bailes et al., 2013). Numerous studies have demonstrated that repetitive
concussive and even SC impacts strongly correlate with the development of the
neurodegenerative disease, CTE (Bailes et al., 2013; Galgano et al., 2016; Prins et al., 2013;
Safinia et al., 2016; Shurley & Todd, 2016; Witcher et al., 2015). As such, many preclinical
studies have been conducted to investigate the sequelae of repetitive mTBI impacts in relation to
the pathological presentation of CTE (Fujita et al., 2012; Hoogenboom et al., 2019; McAteer et
al., 2016; Petraglia et al., 2014; Prins et al., 2010; Shitaka et al., 2011b; Thomsen et al., 2017).
Alternatively, limited preclinical studies have been conducted to investigate the
pathophysiological effects of repetitive SC impacts (Bree, Stratton, et al., 2020; Rawlings et al.,
2020; Sagarkar et al., 2017).
Determining the lower limits of systematic perturbation resulting from repeated SC
impacts is of critical importance in expanding our understanding of cerebral vulnerability and
recovery. However, the impact loads utilized in preclinical SC impact studies implement impact
load magnitudes falling within the range of those used to model mTBI (Bree, Stratton, et al.,
2020; Sagarkar et al., 2017). This choice in methodology largely stems from the absence of welldefined guidelines and mechanical parameters for modeling head injury of graded severities
(Siebold, Obenaus, & Goyal, 2018). Furthermore, because of the undefined cumulative threshold
for the repetitive occurrence of low-level impacts, there is a lack of correlation between an mTBI
and repetitive SC impacts with respect to injury biomechanics. Such data would lay the
foundation for a kinetic and kinematically defined threshold of repeated low-level impact
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tolerance and expand upon the current understanding of cerebral vulnerability resulting from SC
head impacts.
1.8

Objectives
The following investigation aimed to address these gaps in knowledge through the

utilization of an in-house built weight drop injury device using a rat model. In order to
investigate the pathophysiological differences between a single mTBI and repeated
subconcussive (RSC) impacts with subdivided cumulative kinetic energy (KE) equal to the
single mTBI impact, a pilot study was performed in order to determine the appropriate impact
load suitable for an mTBI using the in-house built impact device. Results obtained from the pilot
study were used to inform the appropriate impact load to model an mTBI necessary for use in the
full study design. Both study designs evaluated evidence of behavioral alterations, inflammation,
and cerebral vulnerability using behavioral assays and immunohistochemistry. Measurement
outcomes were assessed at two recovery time points, 3- and 7-days, following the final impact.
The primary objective for this investigation was to develop a rodent model of a single
closed head mTBI and repeated SC impacts with subdivided cumulative kinetic energies equal to
the single mTBI impact utilizing an in-house developed weight drop injury device capable of
producing a wide range of repeatable impact loads, including below those reported in the
literature. This not only establishes the foundation for subsequent analyses but addresses the
absence of knowledge surrounding the comparative effects between a concussive and repeated
SC impact. Based on a thorough review of available literature, no study has utilized impact loads
below a KE of 0.146 J for a closed head impact using a rat model. Kinetic energy (J) is the
measure of energy of a moving object (for this study, the impactor to the rat’s head).
Furthermore, the majority of the few laboratories that have utilized impact loads below the range
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associated with an mTBI have done so in the context of open-scalp or craniectomy techniques.
The present investigation aims to achieve an impact load of similar intensity without surgical
procedures directly addressing this knowledge gap.
This is addressed in the second and third objectives for the investigation which aimed to
investigate indications of system perturbation and/or inflammation and cerebral vulnerability
over two-time points (3- and 7-days) post-impact between impact loads (single mTBI vs.
repeated SC). System perturbation investigation includes behavioral tests of anxiety and general
locomotive activity (Open Field Test), as well as neuromotor deficits (Rotarod). The final and
third aim of this study was to assess and compare evidence of inflammation and cerebral
vulnerability using immunohistochemical assessment of astrogliosis (GFAP), microgliosis (Iba1), neuronal loss (NeuN), as well as inflammatory cytokine proteins (IL-6, TNF-α, and IL-10)
within the hippocampus and motor cortex of the treatment groups (mTBI vs RSC). By bridging
investigative measurements from objectives two and three, this study was able to expand the
current understanding and body of knowledge surrounding the cumulative effects between a
single mTBI and RSC impacts.
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CHAPTER II
LITERATURE REVIEW
2.1

Rodent Models of Traumatic Brain Injury
As mentioned earlier, there is a vast array of injury combinations (whiplash, blunt, and

blast) that can induce a traumatic brain injury (TBI) with various injury severities that may result
in acute and chronic symptoms. It is therefore critical to have a wide range of robust,
reproducible preclinical animal models that capture these variations in injury models and
severities to investigate the underlying pathology and functional deficits associated with TBI.
Animal models are typically designed to produce homogeneous injuries, with demographic
features (age and sex) and injury parameters tightly controlled.
Preclinical rodent models of TBI typically employ one of three popular blunt impact
models, Fluid Percussion Impact (FPI), Controlled Cortical Impact (CCI), or Weight Drop Injury
(WDI), to induce brain injury replicating features and outcomes that are seen clinically (Bondi et
al., 2015). Each can be used to produce mild to severe injury and has been subject to variation
due to investigator customization (Bondi et al., 2015). The FPI model is an open head model
(exposed cortical surface) that requires a craniotomy (a surgical opening into the skull) to expose
the dura mater, a thick membrane of connective tissue that surrounds the cerebral tissue, for
injury (Bolouri & Zetterberg, 2015). A major limitation to this choice of head injury model is its
inability to be modified for closed head impacts due to its mechanism of injury. It has been
suggested that the craniotomy procedure itself has been associated with inflammation that can
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exacerbate TBI symptoms and neuropathology (Cole et al., 2011). As such, investigators that
employ an open head model must consider the procedure as a confounding influencer in their
neuroinflammatory analysis. Alternatively, both the CCI and WDI models can be performed as
open head, closed-skull (open-scalp), and closed head (closed-scalp) models (Bondi et al., 2015;
Bree, Mackenzie, et al., 2020; H. Chen et al., 2017; Clark, Schiding, et al. 1994; Flierl et al.,
2009; Fujita et al., 2012; Igarashi et al., 2007; Jamnia et al., 2017; Osier & Dixon, 2016; Yates et
al., 2017). The fluid percussion device induces an injury through a craniectomy by applying a
brief pressurized pulse through a fluidic medium onto the exposed dura resulting in a brief
compression of the neural tissue (Alder et al., 2011). Alterations of severity intensities can be
achieved by adjusting the pressure pulse through the modification of fluid volume and loading
rate (Kabadi et al., 2010). Alternatively, the CCI model employs a pneumatic piston or electrical
actuator to achieve rapid speeds of the impact rod to induce injury (Dixon et al., 1991). In rodent
models, the CCI’s impactor rod tip diameter ranges from 1-6 mm in size in order to localize the
impact at specified stereotaxis coordinates on the rodent’s cortical surface (Osier & Dixon,
2016). Generally, 3 mm tips are commonly used for mice and 5-6 mm tips for rats (Osier &
Dixon, 2016). Alternatively, the WDI model involves exposing the rodent’s head to a freefalling, guided weight. As the name suggests, the technique uses a specified weight to be
dropped through a tube from a precise distance from the rodent head to impact the cranial surface
(Bolouri & Zetterberg, 2015; Fujita et al., 2012; Hoogenboom et al., 2019).
Because there is no defined threshold for modeling a mild traumatic brain injury (mTBI),
there is wide variation in the literature with respect to appropriate input parameters using a rat
model. The injury severity level induced by the CCI device is often tuned through adjustments of
the following input parameters: depth of impact (displacement of cortical tissue), velocity, and
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dwell time (Osier & Dixon, 2016). The WDI model typically uses a specified weight dropped
from a particular height to induce an mTBI (Bodnar et al., 2019; Hoogenboom et al., 2019;
Marmarou et al., 1994). Both the CCI and WDI models typically accept the absence of skull
fracture and 0% mortality as an affirmation of successful modeling of an mTBI/concussion
(Abd-Elfattah Foda & Marmarou, 1994; Bodnar et al., 2019; Hoogenboom et al., 2019;
Marmarou et al., 1994). Alternatively, an FPI model confirms an mTBI when a righting reflex
time occurs between 2-4 minutes along with a 0-5% mortality rate (Alder et al., 2011). A
description of each model is summarized in Table 2.1 in addition to typical parameters,
limitations, and outcomes commonly used to verify successful modeling of an mTBI.
Table 2.1

Typical Impact Parameters and Limitations for Rodent Head Injury Models of an
mTBI.

Head Injury
Model
(Abbr.)

Parameters
(Range)

Fluid Percussion
Injury (FPI)

Fluid pressure (0.9-2.2
atm)

Limitations
(Injury Type)
Craniotomy required
(open head)
Focal Injury

Controlled
Cortical Impact
(CCI)

Depth (1-3 mm)
Velocity (3-6 ms-1)
Dwell time (50-250 ms)

Weight Drop
Injury (WDI)

Weight mass (450 g)
Drop Height (1.0 m)

Typically open head
(open-skull or open-scalp)

References
(Brooks et al., 2017; Chitturi et al.,
2019; Kabadi et al., 2010; Selwyn et
al., 2016; Shultz et al., 2011; Wright
et al., 2019; Zhang et al., 2018)
(Bondi et al., 2015; Hoogenboom et
al., 2019; Osier & Dixon, 2016)

Focal Injury
Possible rebound impact

(Bodnar et al., 2019; Hoogenboom
et al., 2019; Marmarou et al., 1994)

As each model has multiple variations including whether the animal’s skull or scalp is
open or closed during injury, whether the head is fixed in place (using a stereotaxic instrument)
or allowed to move freely for a rotational impact, or whether the impact is given laterally or
centrally to the animal’s head, this introduces a wide array of heterogeneous methods and
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outcome metrics (Bondi et al., 2015). As such, it is difficult to compare the majority of
preclinical investigations due to the diversity of methodologies.
2.2

Rat Models of Closed-Head Subconcussive Impacts
Based on an extensive literature search, a finite number of studies have been conducted

investigating the cumulative effects of repeated impacts loads below the range used to model an
mTBI. According to the limited reports available, the majority of literature indicates that a single
SC impact is not expected to produce detectable pathology or functional alterations (Bree,
Stratton, et al., 2020; Gavett et al., 2011; McKee et al., 2009; Spiotta et al., 2012; Stern et al.,
2011; Talavage et al., 2014). However, according to an extensive review from Bailes et al.
(2013), a single SC head injury can create an environment of cerebral vulnerability that increases
the determinantal effects of subsequent impacts.
Further, the few studies that explore impact loads labeled as “subconcussive” typically do
so in the context of a repetitive impact model. As previously mentioned, while there are a few
studies employing rodent models of single SC impact loads in the literature, for the sake of
brevity, these studies will not be included in this review. Additionally, attention was focused on
rat models, rather than murine. It should be noted that three additional studies utilizing repeated
low-level impact loads were identified in the literature, however, these employed a murine
animal model (Gangolli et al., 2019; Honig et al., 2020; Namjoshi et al., 2014).
In a 2017 study, Sagarkar et al. used a Wistar rat model to study the effects of a repeated
SC head injury (n=5) with a 48 hr recovery period between impacts using a WDI apparatus.
Rather than labeling the CHI as subconcussive, the authors used the terminology “minimal
traumatic brain injury.” Each head impact generated an impact energy load of 0.588 J and an
impact velocity of 2.425 ms-1 using a cylindrical metal weight of 200 g from a 30 cm height onto
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the exposed skull of the rat (Sagarkar et al., 2017). Thus, the total kinetic energy (KE) transfer to
the skull of each treatment animal for 5 impacts was 2.94 J. The purpose of this study was to
detect possible dysregulation of the amygdaloid brain-derived neurotrophic factor (BDNF)
expression as a consequence of injury-induced DNA methylation at 48 hrs and 30 days after
repetitive minimal TBIs (Sagarkar et al., 2017). Amygdaloid BDNF has been widely accepted as
a contributor to abnormalities caused in synaptic plasticity and dendritic maintenance making it a
useful target for detecting low-level disturbances (Bennett & Lagopoulos, 2014). Using a LightDark Box exploration test, investigators measured anxiety in conjunction with genomic testing
related to their objective (Sagarkar et al., 2017). Results indicated that, after a single impact,
minimal TBI animals showed a significant increase in anxiety at 48 hrs and 30 days post-injury
compared to sham animals. Furthermore, significantly increased levels of cytosine methylation
(5-mc) were found in minimal TBI-induced rats at 48 hrs and 30 days post-trauma indicating the
persistent effects of trauma on BDNF promoter DNA methylation in comparison to sham levels.
These findings indicate that the accumulation of repeated low-level impacts results in acute and
chronic systemic perturbations (Sagarkar et al., 2017).
Christie et al. used a juvenile rat model to establish a new rapid neurological assessment
protocol (NAP) for reliably and repeatedly inducing a mild awake closed head injury (ACHI)
with 0% mortality or clinical indications of persistent pain using a CCI apparatus (Christie et al.,
2019). The authors aimed to provide a standardized set of procedures allowing the ACHI and
NAP protocol to be used reliably and repeatedly in various laboratories (Christie et al., 2019). To
immobilize the awake animals during impact, a restraining cone was utilized. A 3D-printed
helmet was affixed to the rodent’s head to better distribute the force of impact across the head.
Before impact, the animal was placed on a foam pad where the impactor tip was positioned on
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the target site of the helmet. A CCI (7 mm diameter tip, 10 mm depth, 6.0 ms-1 speed, 10 ms
dwell) was then delivered to the helmet surface generating a KE of 0.146 J. Depending on group
assignments, rats received 8 ACHI procedures over 1, 2, or 4 days. Immediately after impact,
NAP scores were obtained for both sham and treatment groups following the first, second,
fourth, and eighth ACHI procedure. The NAP consisted of a set of rapid assessment regimes
focused on different tasks (state of consciousness, startle reflex, limb extension, flat beam walk,
rotating beam walk) that are sensitive to mTBI measurements (Christie et al., 2019). Results
revealed no significant indications of pain exhibited by animals. These findings indicated that
according to the neurological assessment protocol, repeated impacts at this low-level load results
in negligible pain (Christie et al., 2019). Furthermore, to the best of our knowledge, the impact
load investigated in this study (~ 0.15 J) is the lowest explorative impact load for a rat model
using a closed head injury (CHI) encountered in the literature.
In a 2020 study, Bree, Stratton, et al. utilized a Sprague-Dawley rat model to investigate
the development of posttraumatic headache-like (PTH) pain and anxiogenic behavior following
three different CHI paradigms, employed in separate cohorts of rats. Using a WDI model, the
first paradigm involved a single, moderate to severe impact, using a 450 g weight from a height
of 80 cm to induce an impact velocity of approximately 3.959 ms-1 inducing an impact KE load
of 3.528 J. The second paradigm involved a single 150 g weight drop from the same height to
induce an impact velocity of 1.176 ms-1 and an energy of 1.176 J. Lastly, the third paradigm
involved three successive 150 g weight drop events, conducted 72 hrs apart, imparting a
cumulative KE of 3.528 J (Bree, Stratton, et al., 2020). The authors labeled the impact load of
1.176 J as subconcussive. However, according to a different laboratory, using a WDI system on a
rat model, investigators label a similar energy load (1.103 J) as an mTBI impact (Singh et al.,
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2016). As such, the appropriate labeling of this impact load is in question. Bree, Stratton, et al.
(2020) employed two behavioral assays, an Open Field Test (locomotion and anxiety-like
behavior) and von Frey Test (tactile pain hypersensitivity). No neuroinflammatory analysis was
investigated in this study. According to group assignments, the open field test (OFT) was
conducted at 3-, 7-, and 14-days post-injury and the Von Frey testing was similarly conducted
with additional investigations at 4- and 6-weeks post-injury. As expected, rats subjected to a
single, moderate to severe CHI displayed an acute decrease in locomotion and increased anxietylike behavior together with headache-like pain that resolved by 6 weeks post-injury. Animals
subjected to a single SC head impact did not lead to any changes in locomotion or indicate
evidence of anxiety or PTH pain behavior compared to shams. However, repeating these SC
impacts in rats did give rise to persistently decreased locomotion in the OFT, which likely
suggests brain injury. In addition, rats receiving repetitive 150 g weight drop injuries displayed
persistent PTH pain behavior resembling that encountered in animals subjected to the single 450
g weight drop injury. These findings indicated that the repeated low-level impacts with
subdivided cumulative kinetic energies of the single, moderate to severe injury resulted in similar
behavioral responses compared to shams (Bree, Stratton, et al., 2020).
2.3

Assessments of Behavioral Deficits Following Traumatic Brain Injury
Individuals sustaining an mTBI often complain of several physical, cognitive, and

emotional/behavioral symptoms generally referred to as post-concussion syndrome (PCS) (Ryan
& Warden, 2003). Commonly self-reported symptoms can include headache, nausea, dizziness,
irritability, balance or motor disturbances, decreased concentration, memory problems,
depression, anxiety, deficits of executive function, and sleep disturbances (Iverson & Lange,
2011; Ryan & Warden, 2003). The majority of these symptoms are often reported between days
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and weeks but can also prolong from months to years following injury (Ryan & Warden, 2003).
It is understood now that individuals diagnosed with a concussion are not always characterized
by diagnosable objective structural brain alterations in congruence with functional disturbances
(Nauman et al., 2020). Interestingly, though, within the last decade, we have begun to see
evidence of the physical and/or behavioral disturbances commonly observed in a diagnosed
symptomatic concussive setting, in both clinical and preclinical SC injuries which are
characteristically asymptomatic (Bailes et al., 2013; Broglio et al., 2012; Talavage et al., 2014;
Gysland et al., 2012; Breedlove et al., 2014; Bree et al., 2020; Christie et al., 2019; Lavender et
al., 2020; Sagarkar et al., 2017).
As previously mentioned, anxiety and sensorimotor impairments are among the
commonly reported post-concussive symptoms (Armstrong & Morrow, 2019). Subsequently,
rodent models of concussion and subconcussion frequently employ a variety of behavioral assays
aiming to understand the physiological basis for these symptoms (Bodnar et al., 2019; AlmeidaSuhett et al., 2014; Beitchman et al., 2020; Bree, Mackenzie, et al., 2020; Kosari-Nasab et al.,
2019; Meyer et al., 2012; Namjoshi et al., 2017; Sagarkar et al., 2017). Two widely used assays
are the Open Field Test (OFT) and rotarod test (Bodnar et al., 2019; Bondi et al., 2015). The
OFT can be used to assess general locomotor activity as well as anxiety-like behaviors
(Seibenhener & Wooten, 2015). Rodents are placed in an open arena and allowed to freely
explore the arena or field in an uninterrupted room for a set duration (typically, <1 hr)
(Seibenhener & Wooten, 2015). To evaluate locomotive activity, the animal’s total distance
traveled and time spent mobile/immobile are typically measured (Seibenhener & Wooten, 2015).
Rodents are naturally curious and explorative creatures. However, in cases where rodents remain
close to the walls of the arena while they explore the arena, commonly referred to as “wall32

hugging” tendency, investigators frequently relate this behavior to anxiety (Seibenhener &
Wooten, 2015). Typically, a non-anxious rodent will cross through the center of the arena during
exploration, while an anxious-like rodent will avoid leaving the wall boundary (Seibenhener &
Wooten, 2015). Thus, common variables to measure for anxious-like behavior during an OFT is
the time spent near the walls of the arena versus the time spent in the center area, thigmotaxis
(the tendency of a subject to remain close to walls), and the number of center area crossings
(Seibenhener & Wooten, 2015).
Similarly, the rotarod test has been utilized in many TBI models as an indicative measure
of motor deficits such as coordination and balance (Bondi et al., 2015; Y. C. Chen et al., 2014;
Hamm et al., 1994; Kim & Han, 2017; Lavender et al., 2020; Mouzon et al., 2012; Onyszchuk et
al., 2007; Thomsen et al., 2017; S. H. Yang et al., 2013). For the rotarod test, rodents are placed
on a rotating spindle for a limited time. Recorded measurements include the time of fall for each
subject, the reason for fall (jump, passive rotation, or actual fall), and all experimental setup
parameters. Typically, rats are trained for this behavior assay prior to surgery and/or injury and
consist of multiple trial runs of both fixed-rate and accelerating protocols, which may vary from
laboratory to laboratory, to establish their baseline performance (Bondi et al., 2015). After
surgery or injury has occurred, measurements of alterations in motor coordination are then
conducted at prescribed time points. Finally, the two outcome variables used to evaluate the
assessment of motor function are the total time (seconds) and/or speed of revolutions
(revolutions per minute, rpm) before the animal loses its balance and falls off the accelerating
rotating rod (Bondi et al., 2015).
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2.4

Assessments of Neuroinflammation and Cytokine Expression Following Traumatic
Brain Injury
Neuroinflammation is a primary consequence of neuronal injury following a traumatic

brain injury (Chiu et al., 2016). It has also been suggested as a potential contributor to the
cumulative neurodegenerative effects of repeated SC injuries (Shultz et al., 2012). Following an
injury to the cerebral tissue, multiple types of dormant glial cells, including microglia and
astrocytes, will undergo a morphological change to become rapidly activated in a process called
“reactive gliosis” (Chiu et al., 2016). During this state of reactive gliosis, activated microglia
begin to initiate and sustain astrocytic activation via the generation and release of inflammatory
mediators such as cytokines and chemokines that, in turn, act on surrounding glia and neurons to
facilitate tissue repair (Chiu et al., 2016). Microglia are considered to protect neurons by
migrating to the site of injury to clear debris (Chiu et al., 2016). Astrocytes play a role in
inflammation signaling, blood-brain barrier maintenance, lesion isolation, debris clearing, and
axonal scar formation (Burda et al., 2016). Detection of glial reactivity is commonly employed in
neurotrauma research and can be accomplished by targeting and measuring the expression of
various biomarkers. Ionized calcium binding adaptor molecule 1 (Iba-1) and glial fibrillary
acidic protein (GFAP) are two popular biomarkers used to identify and measure microgliosis and
astrogliosis (Chiu et al., 2016; Lafrenaye et al., 2020; Z. Yang & Wang, 2015). Cytokine
detection methods include protein analyses methods such as an enzyme-linked immunosorbent
assay (ELISA) as well as multiplex technologies (Chiu et al., 2016).
While neuroinflammatory measures of astrocytic and microglial activity following injury
has been investigated in a large quantity of mTBI/concussive preclinical studies (Bodnar et al.,
2019; Karve et al., 2016; Velayudhan et al., 2021), knowledge of these glial reactivities is limited
for SC impacts employing rodent models (Shultz et al., 2012; Singh et al., 2016). Further, the
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majority of what is known about the temporal expression of cytokines has been explored as a
consequence of mild to severe traumatic brain injury (Kamm et al., 2006; Robinson et al., 2017;
Ziebell & Morganti-Kossmann, 2010) and/or in an open head injury model (Briones et al., 2014;
Holmin et al., 1997; Lagraoui et al., 2012; Lee et al., 2012; Zhao et al., 2014).
Lagaoui et al. employed a murine model to investigate behavioral changes and cytokine
protein responses following a single mTBI using a CCI apparatus (Lagraoui et al., 2012).
Although this study discusses data from a murine model, work from Natalie et al. reveals the
inflammatory response to TBI in mice and rats is highly similar (Natale et al., 2003). A CCI was
performed immediately after a craniotomy using a 3 mm flat tip at an impact velocity of 5 ms-1, a
depth of 2 mm, and a duration of 200 ms, to deliver a KE of 0.086 J (Lagraoui et al., 2012). A
second animal cohort was only subjected to a craniotomy and underwent the same procedures as
the CCI group; they were labeled as “mild brain injury.” Because the impact injury was
performed directly over the motor cortex, post-injury motor function was assessed via rotarod
and balance beam assays. In the rotarod task, CCI mice (labeled as “severe brain injury”) showed
a significant deficit in performance in both the maximum speed attained and latency to fall from
an accelerating rotarod compared to the craniotomy mice (labelled as “mild brain injury”) at 1and 3-days following impact. Although not statistically significant after 3-days post-impact, CCI
mice continued to reveal a consistent deficit compared to craniotomy animals persisting up to 3
weeks post-injury. After one week of recovery, CCI mice returned to the baseline level of
performance in rotarod tasks. In the balance beam task, both CCI and craniotomy mice were
significantly affected during the first-week post-injury. Notably, during the first-week postinjury, motor performance was more severely impaired by CCI than by craniotomy. These data
were significant for the beam crossing time on day 7 and for foot slips on days 3 and 7 after
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injury. By recovery day 10, both animal groups showed a significant improvement in their
performance on the balance beam. In summary, motor function was most pronounced during the
first-week post-TBI, with deficits in function observed in both CCI and craniotomy animals.
In congruence with motor function deficits, Lagaoui et al. (2012) performed histological
analysis of astrogliosis near the site of injury in CCI, craniotomy, and naive animals. Results
showed high astrocyte density and enlarged astrocyte bodies at 3-days post-injury in CCI and
craniotomy animals, relative to naïve controls. Furthermore, a small collection of cytokine
protein levels was assessed at 1-, 3-, and 7-days post-injury, again, comparing tissues of CCI,
craniotomy, and naïve animals (Lagraoui et al., 2012). Cytokines of interest for this study
included the following: chemokine (C-X-C motif) ligand 1 (CXCL1), interleukin (IL)-1 beta (IL1β), IL-6, interleukin-12p70 (IL-12), interferon-gamma (IFNγ), and IL-10. Results showed all
six cytokines significantly increasing following the controlled cortical impact compared to the
naïve controls. Of these six cytokines, peak expression was observed on recovery day 1 for three
cytokines (CXCL1, IL-1β, and IL-6) in the CCI and craniotomy groups, while the other three
cytokines (IL-12p70, IFN-γ, and IL-10) exhibited peak expression on recovery day 3 for CCI
mice and day 7 for craniotomy mice. The only statistically significant difference between CCI
and craniotomy mice was for IL-6 at 1-day post-injury, where CCI mice expressed significantly
higher levels. In general, protein expression data were consistent with the behavior data:
significant behavioral deficits correlated with the peaks of the inflammatory response. These data
suggest that major differences in the extent of brain tissue injury (craniotomy vs. CCI) are
reflected by modest differences in behavioral deficits and inflammatory cytokine production
(Lagraoui et al., 2012).
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Zhao et. al. carried out an inflammatory analysis of TBI using an open head (craniotomy
required) WDI rat model (Zhao et al., 2014). Before impact, a helmet-like disc was placed on the
dura of the rat. Using a 20 g steel rod, dropped from a height of 25 cm, an impact velocity of
approximately 2.214 ms-1 with approximately 0.049 J of kinetic energy was achieved. Shamoperated rats were anesthetized and only received the right parietal craniotomy operation. The
levels of TNF-α, IL-1β, IL-6, and IL-10 were examined from six rats in each group 72 hrs after
injury. Subsequently, an additional six were euthanized on days 5 or 14 following injury for
determination of astrocyte (GFAP) and microglial (Iba-1) cell markers in the cortex and
hippocampal cornu ammonis 3 (CA3) area (Zhao et al., 2014). Results indicated in the TBI
groups, the levels of IL-1β, IL-6, and tumor necrosis factor-alpha (TNF-α) in the brain tissue
ipsilateral to impact were significantly increased 3-days after injury compared to sham. In
contrast, the level of IL-10 was significantly decreased in the brain tissue ipsilateral to injury 3days post-injury compared to sham. In congruence with these findings, the number of microglia
and astrocytes were also significantly increased in the TBI groups compared to sham (Zhao et
al., 2014). Overall, these data are evidence of the inflammatory response to low-level impacts
and their role in the initiation and progression of the secondary phase of TBI.
Singh et al. (2016) carried out an inflammatory analysis of mTBI using a closed-head
WDI rat model. Dropping a 450 g brass rod weight from a height of 25 cm, an impact velocity of
approximately 2.21 ms-1 and a KE of 1.10 J was achieved. Diffuse tensor imaging was used to
investigate morphological changes associated with inflammatory evaluation (serum cytokine
levels (TNF-α and IL-10) and astrocytic (GFAP) expressions) at 4 hrs, 1-, 3- and 5-days postimpact for sham comparison (0 hr PI) (Singh et al., 2016). A significant elevation in serum levels
of pro-inflammatory cytokine TNF-α was observed at 4 hrs and anti-inflammatory cytokine, IL37

10, at day 1 post-impact compared to sham (0 hr) (Singh et al., 2016). Additionally, GFAP
immunoreactivity in the cerebral cortex was significantly increased at day 3 and day 5 as
compared to sham (Singh et al., 2016). Notably, there was no substantial changes of GFAP
expression observed in the hippocampal or corpus collosum regions (Singh et al., 2016).
Concurrently, a significant decrease in cortical mean diffusivity (MD) was observed 3- and 5days post-impact (Singh et al., 2016). Additionally, a significant decrease in cortical radial
diffusivity was observed at 1-, 3-, and 5-days post-impact (Singh et al., 2016). However, the
hippocampus and corpus collosum did not show signs of significant alteration in diffuse tensor
imaging measurements (Singh et al., 2016). Overall, these results suggest that an mTBI can
initiate microstructural alterations and an inflammatory cascade at an acute timeline, when no
injury is visible on conventional MRI.
Collectively, these studies all provide evidence of a significant biological response to
mild TBIs. Additionally, evidence has shown this response can lead to neuroinflammatory events
that may or may not recover (Singh et al., 2016). Furthermore, while there is limited data
regarding the investigation of cytokine expressions due to low-level impacts using rodent
models, they are all open head investigated injuries (Lagraoui et al., 2012; Zhao et al., 2014). As
such, the investigation of cytokine analysis has yet to be employed in low-level, closed head,
impact studies.
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CHAPTER III
A NEW WEIGHT DROP INJURY DEVICE SUITABLE FOR MILD AND
SUBCONCUSSIVE CLOSED HEAD INJURIES
USING A RODENT MODEL
3.1

Introduction
Numerous animal models have been developed over several decades to address the

heterogeneous nature of the clinical conditions following a traumatic brain injury (TBI). Still,
most models are unable to simulate the entire spectrum of human TBI or reproduce common
mechanisms of injury due to biomechanical forces and pathophysiological complexity of the
injury process (Shultz et al., 2017). Further, as seen in extensive literature reviews, it has been
shown that all models are confounded by the variability of injury severity and neurological
outcomes due to TBI (Hoogenboom et al., 2019; Xiong et al., 2014). Thus, these limitations
make biomechanical, cellular, molecular, and translational studies challenging.
Weight drop models have been gaining attention in the field of neuroscience given their
similarities to clinical TBI (Albert-Weissenberger & Sirén, 2010) and their ability to simulate the
full spectrum of TBI, ranging from subconcussive (SC) to severe TBI (Lavender et al., 2020;
Bodnar et al., 2019; Ma et al., 2019). Other commonly employed TBI models, such as the fluid
percussion injury and controlled cortical impact induce a focal brain contusion with little axonal
injury (Johnson et al., 2015; Marklund, 2016). Conversely, weight drop injury models aim to
reproduce diffuse brain injury (Marmarou et al., 1994). The basis for a WDI model is an impact
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from a free-falling guided weight onto the head (open (with or without craniotomy) or closed) of
a lightly anesthetized animal. In WDI models, injury severity is related to gravity force, thus the
severity of impact can be controlled via modifications to the weight mass or release height.
Additionally, the nature of injury and affiliated neurological deficits are dependent upon impact
location (central or lateral), biomechanics (i.e., the weight’s geometry (Pleasant et al., 2011) and
degree of head movement (Mychasiuk et al., 2016)), and sex differences (Mychasiuk et al.,
2016).
The vast majority of experimental investigations that employ a WDI model relate to
exploring the pathophysiological consequences and functional deficits following a mild
traumatic brain injury (mTBI) (Ma et al., 2019; Bodnar et al., 2019; Bree, Stratton, et al., 2020;
B Fehily et al., 2019; Henninger et al., 2007; Hsieh et al., 2017; Kim & Han, 2017; K Singh et
al., 2016). A finite number of studies using a WDI model have focused on the sequalae of events
following a single (Bree, Mackenzie, et al., 2020; Bree & Levy, 2018) and repeated occurrence
of a SC impact (Bree, Stratton, et al., 2020; Lavender et al., 2020; Sagarkar et al., 2017).
Currently, there is a dearth of knowledge regarding a threshold of multiple SC injuries and their
frequency before permanent cerebral damage occurs (Bailes et al., 2013; King et al., 2015). As
such, given the current lack of understanding between concussive and SC impacts in clinical
cases, there is a need for the development of an in-house built, weight drop injury device suitable
for a mild and SC closed head impact (CHI) using a rodent model.
This chapter describes the development of a non-surgical rodent model for a diffuse
closed head injury (CHI) to utilize as a model of a mild and SC TBI. The in-house built weight
drop model was developed to reproduce key aspects of head injuries so that a mechanistic
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understanding of how behavioral deficits and neuroinflammation might be developed in a rodent
model.
3.2

Materials and Methods
A weight drop apparatus suitable for a CHI was designed and implemented to model a

wide range of brain injuries in rats. The CHI design intended to meet two sets of criteria for TBI:
improve the controllability of weight drop release and provide repeatability. One major goal in
the development of this in-house CHI device was to be able to achieve a range of thresholds for
brain injury, from mild to SC, to compare single versus repeated injuries.
3.2.1

System Overview
The in-house CHI model design used a polyvinyl chloride (PVC) tube to guide an

impactor to fall from a predetermined height, an impactor weight of a predetermined mass, an
electromagnetic solenoid to hold/release the impactor from a predetermined height, a 12-voltage
direct current (DC) switching power supply to power the solenoid, a switch to turn on/off the
supply power to the solenoid, a chronograph system to provide a change in time (i.e., velocity)
data as the impactor passed through the tube, and an Arduino to control the chronograph system.
A photograph of the system, seen in Figure 3.1, shows all the parts of the novel device: (1) 12Volt switching power supply, (2) Arduino, (3) hold/release switch, (4) impactor weights, (5)
chronograph system, (6) PVC tube, and (7) electromagnetic solenoid.
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Weight Drop Injury apparatus used for experimental procedures.

Illustrative image of the novel, in-house, weight drop injury apparatus. Photograph of functional
elements of the apparatus labeled as follows: 1) 12-Volt power supply, 2) Arduino, 3) release
switch, 4) projectile weights, 5) chronograph system, 6) PVC tube, 7) electromagnetic solenoid.

The controllability of the weight drop system was achieved using an electromagnetic
solenoid powered by a 12-voltage direct current (DC) power switching supply. Finally, the
following electrical hardware arrangement was used to facilitate repeatability: an Arduino and
computer to operate the system using a LabVIEW program (National Instruments).
3.2.2

Mechanical Hardware and Linkages
The framework of the system to hold the 0.654 m PVC tube (0.033 m outer diameter

(OD)) consisted of a wooden board (0.038 x 0.038 x 0.445 m) mounted to a wooden framework
base to allow for a rigid, but portable structure. The base of the framework, called the bedding,
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was also made of wood and covered with a vinyl tile (0.451 x 0.197 x 0.038 m) to serve as an
area for the anesthetized rodent to lay on. A foam bedding (mass 32.60 g, thickness 0.025 m,
density 16.30 kg/m3) was placed on top of vinyl tile (under animal) to support the head to allow
some linear anterior-posterior motion with minimal angular rotational movement at the moment
of impact. To ensure linear anterior-posterior motion of the rat head, the impactor weight was
positioned to impact the animal’s head 90 degrees from the horizontal plane (bedding). This was
ensured by the PVC tube which was also square to the bedding. The foam was chosen and tested
in the lab using a static weight equal to the maximum planned impact force with compression
less than 50% of the initial thickness of the foam.
The design used an electromagnetic solenoid (White Rodgers Part # 70-111224),
mounted on the top of the PVC tube using a 3D-printed polylactic acid (PLA) holder (see Figure
3.2A), to provide control of the hold and release of the impactor. To alter the severity of impact
by modifying the impact height, the PLA holder was specifically designed to allow the solenoid
to be moved vertically above the top of the tube. Furthermore, the use of the solenoid ensured
repeatability of the impactor’s velocity. To control the power stage of the solenoid connected to
the 12-Volt power switching supply, a toggle switch, located on the base of the wooden
framework, was added to the system (Figure 3.2B).
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A

Figure 3.2

B

Close-up view of the electromagnetic solenoid and release switch for the weight
drop injury apparatus.

(4) Picture of the ‘hold’ state of the electromagnetic solenoid in the PLA (black) holder
holding the impactor at the top of the PVC tube. (B) Photo of the toggle switch used to
control power to the solenoid using a 12-Volt power supply.
3.2.3

Electronics
To measure the velocity of impact, a chronograph system (Figure 3.3) was incorporated

to validate the impactor’s speed. The chronograph system consisted of two light gate (LG) sensor
boards, each with four infrared (IR) transmitter photodiodes (Vishay Semiconductors Part #
TSUS5400), on one side of a 3D-printed PLA holder (Figure 3.3A), and 8 IR emitter
photodiodes mounted on the opposite side to create a light-sensing area. On the inside of the
chronograph PLA holder, slits were made for each IR transmitter to direct light to its receiver
(Figure 3.3B). The distal spacing between photodiodes slits on LG sensor boards 1 and 2 was 51
mm. The LG sensors, connected directly to an Arduino, operated on transmission mode to detect
an interruption of light path (in time) between photodiodes when the impactor mass passed
through. Time (microseconds) of light path interruption for each LG sensor board was collected
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by the Arduino and used to calculate the impact velocity. This electrical enhancement of the
chronograph system gave our weight drop impact design the capability to have a high degree of
consistency measuring impact timing and velocity needed to verify the repeatability of impact.

A

B

1
4
3

2

Figure 3.3

Chronograph system.

Illustrative images of the chronograph system of the weight drop injury apparatus. (A) Outside
view of light gate sensor boards (numerically labeled 1 and 2) using photodiodes (labeled as 3)
mounted on a 3D-printed PLA holder. (B) Inside view of the chronograph system showing slits
(labeled 4) used for directing light of one light gate sensor board to the parallel light gate sensor
board.
3.2.4

Software
The main controller for the WDI system was the 12-Volt DC switching power supply.

The sequence of data calculation was automatically handled with a custom Arduino code and
data collection by a custom-designed LabVIEW program using a Windows-10 computer. The
user interface of the LabVIEW program consisted of three input parameters for the operation
including a file path for data recording into a file, a drop-down box for selecting the impactor’s
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weight, and a user note section (Figure 3.4). As part of the custom-designed LabVIEW program,
each time the toggle switch moves from the hold to release state, the user note, velocity, and
kinetic energy (KE) of impact are collected and stored to the file path. Figure 3.5 illustrates the
order of events for the weight drop injury design.

Figure 3.4

Screenshot of the custom-designed LabVIEW program for the weight drop
apparatus.

Figure 3.5

Schematic of the order of events for the in-house built weight drop injury device.
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3.2.5

Impact Data Analysis
In post-processing, the data from the chronograph (i.e., the time difference of the

impactor passing through the LG sensor boards) and data calculated in the Arduino code
(velocity and KE) were collected and stored after each impact. The velocity (ms-1) for each
impact was calculated as the distance between light gate sensors (~51 mm) divided by the time
(μs) of light path interruption between the two sensors. The formula for this calculation is shown
in Equation 3.1 where v is the velocity, d is the distance between photodiodes on LG sensor
boards 1 and 2, and t is the time of light path interruption between photodiodes LG sensor
boards. Further, the kinetic energy was calculated from velocity (v) using Equation 3.2 where 𝐸𝐾
is the kinetic energy (J) and m is the mass (kg) of the impactor.
𝑣=
𝐸𝐾 =
3.3

𝑑
𝑡

1
𝑚𝑣 2
2

(3.1)
(3.2)

Statistical Analysis
To gather the dynamics of impact for our weight drop injury device, two impactor

weights (27.17 and 67.84 g) were dropped from a height of 0.81 m upon the head of rat cadavers.
Twelve drop measurements were collected for each weight and used to represent the device’s
reproducible performance. Measurements included velocity and KE. A univariate analysis was
conducted using the PROC UNIVARIATE in SAS (SAS Institute, Cary NC) for the maximum
and minimum velocity and kinetic energy (KE) values obtained for all impacts. Although normal
distribution could be assumed due to the large sample size, the assumption of normality was
confirmed using a Shapiro-Wilk test (p>0.05). All statistical analyses were assessed at the
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α=0.05 level of significance. The null hypothesis was rejected when p<0.05. The mean ±
standard deviation (STD) obtained for each group can be found in Table 3.1.
3.4

Results
Dropping the 67.84 g weight from a height of 0.81 m yielded an average impact velocity

of 3.83 ± 0.01 ms-1 and an average KE of 0.50 ± 0.00 J. Alternatively, the lower impactor weight
(27.17 gms) yielded an average impact velocity of 3.84 ± 0.01 ms-1 with a mean KE of 0.20 ±
0.00 J. Descriptive Statistics obtained from the univariate analysis performed on the impact data
can be found in Table 3.1. The impact dynamic results for each variable from the Shapiro-Wilk
test of normality are as follows: velocity for the 27.17 g weight (p=0.0003), KE for the 27.17 g
weight (p=0.0003), velocity for the 67.84 g weight (p=0.0171), and KE for the 67.84 g weight
(p=0.0181). With an alpha level of 0.05, these results rejected normality of variables. Lastly, no
skull fractures were present during experimental testing of the impactors.
Table 3.1

Impact dynamics of in-house built weight drop device.

Projectile
Weight (gms)

Standard
Minimum Maximum
Deviation
Velocity (ms-1)
3.838
0.009
3.820
3.850
27.17
Kinetic Energy (J)
0.200
0.001
0.198
0.201
Velocity (ms-1)
3.825
0.010
3.800
3.840
67.84
Kinetic Energy (J)
0.496
0.003
0.490
0.500
The projectile weight (gms), mean, standard deviation, minimum and maximum values for
velocity (ms-1) and kinetic energy (J) calculated impact data.
3.5

Variable

Mean

Discussion
This chapter describes the construction and operation of the in-house developed weight

drop injury device which was designed to simulate any severity of TBI. Among the design’s
strengths is its high repeatability and controllability of injury dynamics including impact velocity
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and KE. These two impact parameters are essential for monitoring and recording when designing
and using a mechanical means to induce brain trauma.
There is no definable impact threshold for the spectrum of mild injury severities;
however, based on an extensive literature search, rat CHI models that employed WDI devices
ranged in investigative KE impact loads of 0.25 (Lavender et al., 2020) – 4.42 J (Fujita et al.,
2012; Hsieh et al., 2017). Our weight drop injury device is capable of inducing impact loads
within these mTBI ranges and below. Impact dynamics of the in-house built device, described in
Table 3.1, indicate high repeatability and controllability of injury mechanics. Thus, the goal to
develop a device that can range in injury metrics suitable for mTBI and SC impact loads was
achieved.
Each impactor’s tip was specifically designed according to size (12.7 mm) and shape (flat
tip). To compare, CCI impactor tips (diameters) range from 1-6 mm in size depending on the
rodent. Generally, 3 mm tips are commonly used for mice and 5-6 mm tips for rats (Osier &
Dixon, 2016). Again, most CCI designs are confined to one area of the brain (focal) due to their
tip size. When a force is applied perpendicular to the top of the rodent’s head, it exerts pressure
on the head’s surface equal to the ratio of force (F) to surface area (A). Recall the formula for
pressure (p) in Equation 3.3.

𝑝=

𝐹
𝐴

(3.3)

An interesting consequence of this ratio is that the force will not change regardless of pressure
increase or decrease. However, as surface area reduces, net pressure increases. In the tip design
for the in-house weight drop injury apparatus, a greater tip diameter was preferred to produce a
more diffuse injury rather than a focal impact injury. Tip geometry shape was influenced by
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Pleasant et. al. (2011) who used finite element modeling to demonstrate that tip geometry was a
significant determinant of cell death in cortical tissues (Pleasant et al., 2011). Using a CCI device
on a murine model, their findings report that injury with a flat tip resulted in greater acute
cortical hemorrhage and neuron loss in mice compared to a rounded tip (Pleasant et al., 2011).
The flat tip impactor showed more regional hippocampal neurodegeneration at earlier time points
in mice compared to the rounded tip impactor (Pleasant et al., 2011). Even though the CCI brain
injury with a flat tip impactor resulted in greater maximal tissue strains than impacts with a
rounded tip, behavioral responses, such as motor and cognitive functions, of brain-injured mice
were not grossly influenced by impactor tip geometry (Pleasant et al., 2011). These results
suggest that slowing the progression of cortical cell death through the use of a rounded tip did
not compromise the fidelity of the behavioral response (Pleasant et al., 2011).
3.6

Conclusion
The development and characterization of an in-house built WDI apparatus for CHIs was

achieved for producing experimental and repeatable brain injury for rodent models. The injury
model produced impact ranges of those reported in literature and below using a rat model. In
publishing the characterization and results of the in-house built design, it is hoped this device
will lay the groundwork for research investigations exploring the relationship between
concussive and SC injuries in the context of single and repeated impacts.
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CHAPTER IV
BEHAVIORAL AND HISTOLOGICAL INFLAMMATORY ANALYSIS FOLLOWING A
MILD TRAUMATIC BRAIN INJURY USING A RODENT MODEL: A PILOT STUDY
4.1

Introduction
It has been historically proven that animal models are instrumental in increasing our

understanding of the pathophysiological and behavioral consequences of traumatic brain injury.
While mTBI has been the subject of numerous clinical and preclinical research efforts, there
remains a lack of identifying the threshold for an mTBI. Several preclinical studies utilize impact
magnitudes that overlap in severity of impact (concussive and subconcussive) among different
labs. For instance, preclinical investigations aiming to model SC impacts in rat models (Bree,
Stratton, et al., 2020; Lavender et al., 2020; Sagarkar et al., 2017) are seen overlapping with
impact magnitudes reported from research modeling mTBI in rats (Christie et al., 2019;
Henninger et al., 2007; Kim & Han, 2017; Singh et al., 2016). For this reason, the present pilot
study was designed to determine the lowest impact magnitude suitable for an mTBI using the
previously discussed in-house built impact device. As previously mentioned in Chapter II (see
section 2.2), according to literature, the lowest explorative closed head impact load labeled as an
mTBI for a rat model was approximately 0.15 J. Thus, the present investigation aimed to explore
two impact magnitudes slightly higher than the lowest reported mTBI impact load. The criteria
for determining the appropriate mTBI load for a rat model included the absence of skull fracture,
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the presence of acute behavioral measures, and/or evidence of neuroinflammation following
impact.
The amount of time required for recovery from a single mTBI, or if full recovery occurs,
has been a leading focus of preclinical investigations of head trauma (Bree, Mackenzie, et al.,
2020; Fraunberger et al., 2020; Hsieh et al., 2017; Shapira et al., 1988; Singh et al., 2016). In
terms of concussion, it is fundamentally important to determine the lower limits of system
perturbation and establish the time frame of recovery. This would not only expand our
understanding of secondary brain injury but may also provide insight for identifying a threshold
for injury tolerance. The majority of preclinical investigations aiming to model a single closed
head concussive head impact in rats concentrate on acute (0-24 hours) and subacute (1-14 days)
sequalae to determine secondary injury phenomena (Brian R. Christie et al., 2019; Jamnia et al.,
2017; Kim & Han, 2017; Li et al., 2015; Yates et al., 2017; Motoki Fujita et al., 2012; Bree,
Mackenzie, et al., 2020; Dara Bree & Levy, 2018; Fraunberger et al., 2020; T.-H. Hsieh et al.,
2017; Shapira et al., 1988; Singh et al., 2016). However, literature reports peak changes in
inflammation at 3- and 7-days post-injury (Ekmark-Lewén et al., 2013; Fraunberger et al., 2020;
Hsieh et al., 2017; Lagraoui et al., 2012; Marschner et al., 2019; Singh et al., 2016; Zhao et al.,
2014). As such, we investigated evidence of secondary injury phenomena following a single
blunt impact with a kinetic energy of either 0.2 or 0.5 J at two recovery time points, 3- and 7days, following impact. Animal groups consisting of 6 animals each were labeled as follows:
High3, Low3, High7, Low7, Sham3, and Sham7.
4.2

Methods
The following sections outline the experimental design and methods utilized for each

procedure. In addition, this section provides animal number details along with impact,
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behavioral, euthanasia, cytokine multiplex, and histological procedures. Analytical and statistical
methods have been outlined as appropriate for each experimental procedure.
4.2.1

Experimental Design
An overview of the experimental elements and design for the pilot study can be seen in

Figure 4.1. All procedures for the experimental pilot study were approved by the Mississippi
State University Institutional Animal Care and Use Committee (IACUC) under protocol number
20-456 (see Appendix A).

Figure 4.1
4.2.2

An overview of the experimental elements and design for the pilot study.

Animals
Thirty-six male Sprague-Dawley rats (250-300 g; Envigo, Indianapolis, IN) were housed

three per cage in an Association for Assessment and Accreditation of Laboratory Animal Care
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(AAALAC) accredited facility on a 12-hour light/dark cycle and provided free access to food
and water in accordance with an Institutional Animal Care and Use Committee (IACUC)approved protocol. Upon arrival, rats were randomly assigned to one of four injury (impact) or
sham groups. Animal groups (n=6) were divided by assigned recovery time (3- or 7-days postimpact (DPI)) and labeled as follows: High3 (0.5 J impact load with 3-day recovery period),
Low3 (0.2 J impact load with 3-day recovery period), High7 (0.5 J impact load with 7-day
recovery period), Low7 (0.2 J impact load with 7-day recovery period), Sham3 (no impact with
3-day recovery period), and Sham7 (no impact with 7-day recovery period). To control for
environmental variation due to cage placement, rats remained in their original cage placement
after random assignment. Sham rats underwent all procedures as the impact rats (n=36)
excluding the blunt impact. All animals were sacrificed on the final day of recovery (3- or 7DPI).
Prior to the impact procedure, rats were administered ketamine (100-200 mg/kg
intraperitoneal injection (IP)) and xylazine (5-10 mg/kg IP) for analgesia. Loss of righting reflex
was used to indicate the depth of anesthesia. Upon completion of head impact, atipamezole
(0.05-0.06 mg/kg intramuscular injection (IM)) was administered to reverse the effects of
xylazine. In addition to this reversal agent, rats were administered a single dose of
Buprenorphine IR (0.05 mg/kg subcutaneous injection) for analgesia.
To control pica behavior, a common side effect of buprenorphine, rats were housed
individually on cage paper with two to three food pellets to encourage food intake for
approximately 24 hours as opposed to standard rodent bedding when returned to the colony postimpact. After 24 hours following analgesic administration, animals were returned to group
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housing and placed on standard bedding with food and water provided ad libitum. Pica behavior
was monitored for 3-days following the duration of analgesia.
4.2.3

Impact Device and Procedures
A novel, in-house-built weight drop injury device (WDI) was used to deliver a single,

closed head, blunt impact to the external head surface of each impact-assigned rat (n=24). Here,
we tested two different closed head impact paradigms, employed in separate cohorts of rats. The
first paradigm involved a single impact, using a 67.97 g weight drop. The second paradigm
employed a single 27.17 g weight drop. All head injury paradigms were conducted on animals
after the loss of tail-pinch reflex and righting reflex following anesthesia. While anesthetized, all
animals (n=36) were placed chest down directly under the weight-drop head trauma device on
the foam-covered (density 16.30 kg/m3) horizontal platform. The device consisted of a hollow
cylindrical tube (81 cm) placed vertically over the center of the rat’s head. At the end of the tube
was an attachment with a target circle cut out that marks the location where the projectile mass
would impact the head of the rat. To ensure consistency of the hit location, each rat head was
flushed against the target circle of the attachment at the end of the tube (see Figure 4.2) so that
the projectile weight struck the scalp slightly anterior to the center point between the ears. No
physical constraints were applied to the anesthetized rats.
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Figure 4.2

Weight drop injury device.

Notes: Sagittal viewpoint of a rat placed on the platform under the novel, in-house, weight drop
injury apparatus. B) Aerial perspective of a rat placed on the platform under the chronograph
system of the weigh drop injury apparatus.
After animals regained their righting reflex upon administration of the reversal agent, rats
were returned immediately to individual cages for recovery. For all paradigms, sham animals
were administered the same drugs as impact animals, but not subjected to the weight drop.
Finally, biomechanics, e.g., impact velocity (ms-1) and kinetic energy (J), of all injury paradigms
were recorded.
4.2.3.1

Statistical Analysis of Impact Data Analysis
A univariate analysis was conducted using the PROC UNIVARIATE in SAS (SAS

Institute, Cary NC) for the maximum and minimum velocity and kinetic energy (KE) values
obtained for all impacts. All statistical analyses were assessed at the α=0.05 level of significance.
The null hypothesis was rejected when p<0.05.
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4.2.4

Behavioral Analysis
Behavioral testing was performed for all animals 24 hours before impact and on the final

day of recovery post-impact (3-days and 7-days, respectively). Each experimental run included
two impact animals (a high-load and low-load impact) and one sham animal. The Open Field
Test (OFT) was conducted in a 1.02 m (length) x 1.02 m (width) x 0.36 m (height) apparatus
divided into four equal quadrants allowing three animals to be run simultaneously (a high-load
impact animal, low-load impact animal, and sham). Low illumination was achieved using redLED light strips mounted to the inner top edges of the apparatus via an adhesive backing. Light
pollution from other areas near the experimental room was minimized by blacking out the
window on the door with an impenetrable material. All open field tests were video recorded
using a Canon EOS Rebel digital camera mounted above the testing apparatus. Videos were
uploaded and scored using ANY-maze behavioral tracking software (ANY-maze, Stoelting Co.,
USA). Raw scores were collected from ANY-maze and analyzed.
The rotarod assay was conducted in an automated 4-lane rotarod unit (Dual Species
Economic Rotarod, Columbus Instruments, USA), again, allowing three animals to be run
simultaneously (a high-load impact animal, low-load impact animal, and sham). The rotarod unit
consisted of a rotating spindle (diameter 7.3025 cm) and individual compartments (‘lanes’) for
each rat. A personal Windows-10 computer using a custom-designed LabVIEW program was
connected to the rotarod unit for data collection. Recorded data included the time of fall for each
subject, the reason for fall (jump, passive rotation, or actual fall), and all experimental setup
parameters. The attained speed (rpm) and latency to fall (sec) for each subject were used for
analysis. An overview of the behavioral timeline can be seen in Figure 4.3.
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Figure 4.3
4.2.4.1

Behavioral timeline for the Open Field Test (green font) and rotarod (blue font)
assays.
Open Field Test Procedures and Data Acquisition

An acclimation period of 5-minutes was provided for each rat prior to testing. During
acclimation, rats were placed alone in the testing room (in their home cages) with the overhead
lights turned off. Following acclimation, video recording began, and three animals were
simultaneously placed into their respective quadrant of the open field. For each experimental run,
two impact animals were accompanied by one sham animal (a high-load impact, low-load
impact, and sham). The duration of the OFT assay was 30 minutes. Upon completion of the test,
the video recording was stopped, the animals were removed and returned to their colony as the
apparatus was cleaned. Each test group remained in their colony for 3 hours before beginning the
rotarod assay.
Video files were uploaded into ANY-maze for post-test tracking analysis. Using the
apparatus tools within ANY-maze, the outer and center zones were defined as represented in
Figure 4.4. The outer zone was defined as the outer-most border and extended far enough to
accommodate the width of the rats. For the software to detect entry into the defined center zone,
the animal had to completely exit the outer zone.
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Figure 4.4

Representation of the Open Field Test apparatus.

The diagram represents the top perspective of the OFT apparatus and indicates the separation of
the outer zone (blue) and center zone (green) in the bottom-right quadrant.
Locomotor activity was measured by the following eleven variables: 1) total distance
traveled (m), 2) average speed (ms-1), 3) maximum speed (m/s), 4) total time mobile overall
(mins), 5) total time immobile overall (mins), 6) total time mobile in the outer zone (mins), 7)
total time immobile in the outer zone (mins), 8) total distance traveled in the outer zone (m), 9)
total time mobile in the center zone (mins), 10) total time immobile in the center zone (mins),
and 11) total distance traveled in the center zone (m).
Metrics of anxiety-like behavior were measured by the total time spent in the outer zone
(mins), the total time in the center zone (mins), and the number of entries into the center zone.
The Thigmotaxis Index (TI) was calculated using Equation 4.1 where 𝑂𝑍 represents the time
spent in the outer zone and 𝐶𝑍 represents the time spent in the center zone.
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𝑇𝐼 =

4.2.4.2

𝑂𝑍 − 𝐶𝑍
𝑂𝑍 + 𝐶𝑍

(5.1)

Rotarod Procedures and Data Acquisition
Three hours following the completion of the OFT, rats were removed from the colony,

returned to the behavior testing room, and allowed a 5-minute acclimation period in their home
cage before testing. During acclimation, rats remained in their cages while the rotarod unit ran
from 4 to 40 rpm in 300 sec. Following acclimation, each experimental group (high-load impact,
low-load impact, and sham animal) underwent three test trials separated by 15-minute inter-trial
intervals. Before each trial began, rodents were placed in individual lanes (see Fig. 4.5) and
allowed to walk at 4 rpm. Once all animals began walking without aid, the acceleration mode of
the unit was turned on and set to begin accelerating from 4 to 40 rpm in 300 sec (5 minutes).
Upon completion of the third and final trial, the LabVIEW recording was stopped, the animals
were removed, and returned to their colony as the apparatus was cleaned for the next group.
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Figure 4.5

Image of an experimental group (includes a high-load impact, low-load impact,
and sham rat) walking on the rotating rod of rotarod assay.

The determination of maximal performance capacity and motor learning were measured
by recording the attained speed (rpm) and latency to fall (sec) of each subject.
4.2.4.3

Statistical Analysis of Behavioral Assays
Data analysis for behavioral tests were analyzed using two different statistical

computations. For the analysis of treatment groups where repeated measures occurred (baseline
vs. recovery day performance), a linear mixed model analysis with treatment, day, and their
interaction as fixed effects and animal within treatment as the random effect was performed
using PROC MIXED in SAS. Main effects and interactions were assessed at the α=0.05 level of
significance. The null hypothesis was rejected when p<0.05. The mean ± standard error of the
mean (SEM) obtained for each group was used to describe the center and spread of group data.
All plots were obtained using GraphPad Prism® 8 (GraphPad Software, Inc., La Jolla, CA,
USA).
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4.2.5

Brain Collection Process
After completion of all behavioral testing on recovery days (3- and 7-DPI), animals were

euthanized using carbon dioxide in a chamber. Subsequently, rats were decapitated using a
guillotine as a confirmation of euthanasia. Following this, the brain samples were extracted and
submerged in phosphate-buffered saline (PBS; pH 7.4, Sigma-Aldrich, St. Louis, MO) for
approximately 10 minutes. Brain tissues were then trimmed using a 1 mm coronal acrylic brain
matrix (Ted Pella, Inc., Redding, CA, USA) to improve consistency. Using a Rat Brain Atlas
(Paxinos, Watson: The Rat Brain in Stereotaxic Coordinates, 7th Edition) as a guide, the first trim
was made 2 mm directly in front of the optic chiasm (2.48 bregma; see blade 1 in Figure 4.6).
The second trim was made at the optic chiasm (0.48 bregma; see blade 2 in Figure 4.6) with each
subsequent cut made 2 mm caudal to the preceding trim for a total of five tissue sections (each
section was 2 mm thick). For the first three trims, the motor cortex was cut out from each side of
the cerebral hemisphere and immediately stored in microcentrifuge tubes placed in dry ice (−20
°C) and then stored at −80 °C until further analysis. On the fourth trimmed tissue section (-2.56
bregma; tissue between blades 4 and 5 in Figure 4.6), where both the hippocampus and motor
cortex were present in the tissue, this section was placed in a cassette and submerged in 10%
neutral buffered formalin (NBF) solution for 72 hours for the preparation of histological analysis.
The fifth and final trimmed tissue section (-3.56 bregma; tissue between blades 5 and 6 in Figure
4.6) was used to cut out the hippocampus of each cerebral hemisphere, placed in dry ice, and
then stored at −80 °C until further analysis. Brain samples were typically extracted and properly
stored within 20 minutes.
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Figure 4.6

Representative image of brain tissue trimming protocol.

Shown are the A) acrylic brain trimming matrix, B) blades used for trimming, and C) optic
chiasm (the location of the second trim). The distance between each razor was 2 mm.
4.2.6

Cytokine Analysis and Data Acquisition
To measure cytokine concentrations in brain lysates, a custom Procartaplex multiplex

immunoassay (catalog no. PPX-03; Thermo Fisher Scientific, Carlsbad, CA) was used. The
multiplex immunoassay was used to measure IL-6, TNF-α, and IL-10 concentrations in the
hippocampus and motor cortex regions of animals. Upon analysis, tissue samples of each region
(~20 mg) were thawed on ice and homogenized with a rotor-stator in 100 µL of ProcartaPlex cell
lysis buffer (catalog no. EPX-99999-000; Life Technologies, Carlsbad, CA) for 30 sec each at
4°C. Brain tissue lysates were then centrifuged at 10,000 G for 10 minutes at 4°C and lysate
supernatants were collected and prepared for analysis in a multiplex assay reader (Luminex 200).
Finally, each brain lysate and standard concentrations were determined using Bio-Plex manager
software (Bio-Rad).
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4.2.7

Histology
Using a Leica RM2255 rotary microtome (Leica Microsystems Inc., Buffalo Grove, IL),

5 µm sections were obtained from paraffin embedded tissues and prepared for hematoxylin and
eosin (H&E), ionized calcium binding adaptor molecule 1 (Iba-1), and glial fibrillary acidic
protein (GFAP) staining.
4.2.7.1

H&E
Paraffin embedded tissues were sectioned at 5 μm onto charged slides and stained with

hematoxylin and eosin (H&E). Upon analysis of the 36 H&E tissue sections, only one group
assignment, High7, showed all six tissue blocks confirmed with an appropriate tissue depth for
immunohistochemistry. The remaining group assignment blocks (High3, Low3, Sham3, Low7,
and Sham7) were cut too deep, anatomically, in the tissue for the study’s regions of interest. A
table of the original and final number of tissue blocks can be seen in Table 4.1.
Table 4.1

Initial and Final Tissue Block Numbers

Final Number of Blocks Chosen for
Immunohistochemical Staining
(High / Low / Sham)
3-Days
(n=6) / (n=6) / (n=6)
(n=4) / (n=2) / (n=4)
7-Days
(n=6) / (n=6) / (n=6)
(n=6) / (n=3) / (n=5)
Tissue block numbers within each experimental group prior to H&E staining and after visual analysis
of H&E staining under the Olympus BX60 microscope. From the 3-day recovery assigned groups, 4,
3, and 4 tissue blocks from High, Low, and Sham groups, respectively, were confirmed with an
appropriate tissue depth for immunohistochemical staining. Of the 7-day recovery group
assignments, 6, 3, and 5 tissue blocks of groups High, Low, and Sham, respectively, were approved
for immunohistochemistry staining.
Recovery
Group

4.2.7.2

Initial Number of Blocks
(High / Low / Sham)

Immunohistochemistry
In order to investigate evidence of inflammation (microgliosis and astrogliosis) due to

injury, each tissue section underwent Iba-1 and GFAP immunostaining. Paraffin embedded
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tissues were sectioned at 5 μm onto charged slides. Unstained slides were deparaffinized and
pretreated as follows: endogenous peroxidase activity was blocked with 3% hydrogen peroxide
(Biocare ipb5000) for 5 minutes. The primary antibodies were applied as follows: GFAP
(Agilent z0334, 1:2000, 30min) and IBA-1 (Biocare cp290, 1:100, 30 min). All immunostaining
was performed on an IntelliPATH autostainer. A negative control without primary was included
for each. Detection was performed using Rabbit-on-Canine HRP polymer (Biocare rc542)
according to insert directions mixed in with DaVinci green diluent (Biocare pd900). The tissues
were developed with DAB chromogen substrate (Biocare) for 5 minutes. The slides were then
counterstained with hematoxylin (Biocare) for 5 minutes. The slides were then washed,
dehydrated and coverslipped.
Due to unknown error, both GFAP and Iba-1 slides were unevenly stained. Possibilities
for unevenness could be due to inadequate fixation, air drying of tissue samples, or staining
issues. It is not likely that the error might be due to inadequate fixation because we submerged
all the cassettes in approximately half a liter of 10% NBF. It is also unlikely that the error may be
due to air drying of samples because, after extraction, tissues were immediately dropped in PBS
for ~10 minutes before being removed and placed in the acrylic matrix for slicing. Slicing of
tissue for appropriate sections took approximately 5-10 minutes. Finally, the error for uneven
staining might be due to the staining process itself. However, the positive control slides used by
the histology lab had no issues (no evidence of irregularity) and controls were run at the same
time as research slides. To attempt to get the full section stained on the slides, the stained slides
were re-run through the immunostaining protocol. The resulting GFAP and Iba-1 slides resulted
in weak/irregular staining of the same areas (see Appendix B) necessitating a criterion to be met
for determining which tissue section and hemisphere of the section was appropriately stained.
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The criteria for selecting the appropriate section and hemisphere of the cerebral tissues were
based on the stained areas that have a correctly stained internal control (cells around blood
vessels). Depending on which hemisphere of the cerebral tissue met the criteria for appropriate
GFAP and Iba-1 staining for each tissue section, either the left or right cingulum was imaged.
Whichever section and hemisphere met this criterion was marked to move forward with image
analysis. Lastly, because there were not enough slides to rerun the stain, image analysis via
threshold was no longer an appropriate method to measure immunoreactivity of astrocytes
(GFAP) and microglia (Iba-1) due to unevenness of staining through sections. Thus, positively
stained cell count was used to measure the immunoreactivity of astrocytes and microglia.
4.2.7.3

Microscopy and Image Analysis
The anatomical regions of interest selected for this study were comprised in the

hippocampal area of the cerebral tissue: cornu ammonia 1 (CA1), cornu ammonis 3 (CA3), and
the dentate gyrus (DG). It was originally planned to explore evidence of Iba-1 and GFAP
immunoreactivity within the motor cortex (MC) region of the cerebral cortex, however, because
this region encompasses a larger area of the cerebral tissue than the DG, CA1, and CA3 regions,
the Olympus BX60 (Olympus Optical Co Ltd, Tokyo Japan) microscope was unable to capture
the entire region at 20x magnification. Consequently, there was an increase in the possibility of
image overlapping caused by human error. Thus, it was decided not to move forward with the
image analysis of the MC region.
As mentioned before, due to an undetermined error, GFAP and Iba-1 slides were
unevenly stained. Thus, the tissue section chosen for image analysis of stained slides depended
on which hemisphere of the tissue met the criteria for appropriate GFAP and Iba-1 staining.
Again, the criteria for selecting the appropriate hemisphere(s) of the cerebral tissue section were
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based on the stained areas that had a correctly stained internal control (positively stained cells
around blood vessels). Whichever section and hemisphere(s) met this criterion were then marked
to move forward with the cell count image analysis. Micrographs for each hippocampal region of
interest that were appropriately stained were taken at 20x magnification using an Olympus BX60
microscope equipped with an Infinity3 Lumenera (Lumenera Corporation, ON, CA) camera and
the Infinity Analyze (Lumenera) imaging software. Representative micrographs were captured at
4x magnification for illustration only and were not analyzed. See Appendix C for selected
representative micrographs (4x and 20x magnification) of GFAP and Iba-1 immunostained tissue
sections based on sections with a measurement most representative of the mean positive cell
count for each group.
Micrographs captured at 20x magnification were analyzed in QuPath (v.0.2.0) software
(Bankhead et al., 2017). The micrograph scale bar (100μm) was used to set the scale in QuPath
to ensure accurate measurements (1.465 pixels per micron). The general processing and analysis
workflow in QuPath for each image consisted of several steps: selecting the image type and
region of interest, applying the positive pixel count, and data collection. The image type of each
image was selected as Brightfield (H-DAB). By selecting Brightfield (H-DAB), QuPath then sets
default stain vectors to characterize hematoxylin and DAB.
Following the selection of image type, the area of interest of each image was manually
outlined by use of the Rectangle tool. Once the region was defined, the positive cell detection
tool was used to detect positive pixels. During this process, QuPath detects every cell in the
selected region by using a built-in cell segmentation algorithm. Immunoreactivity in the tissues
was shown by positive DAB staining within the tissue. QuPath’s default DAB threshold for
GFAP and Iba-1 stained images was 0.1. Finally, the number of positive cell counts was
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computed, and the numbers of astrocytes (both positively and negatively stained) were
automatically counted. The resultant image from QuPath contained both blue and red pixels. The
red pixels contained the areas that the program determined as positive stains and the blue pixels
were classified as negative stains. Representative examples of a non-processed and processed
GFAP-stained cerebral section are shown in Figure 4.7. All data were extracted from QuPath and
further calculations were performed in Microsoft Excel. The density of positive astrocytes was
defined as the number of positively stained astrocytes/mm2. In excel, the density of positive
astrocytes was calculated by dividing the number of positive cells by the total number of pixels
in the defined region of interest (1 px2 = 4.66e-7 mm2). The number of positively stained
astrocytes/mm2 was then used for statistical analysis as a measure of immunoreactivity.
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Figure 4.7

Representative example of a non-processed and processed cell count analysis using
QuPath.

Representative pictures of an unanalyzed (A) and QuPath-analyzed (B) GFAP-stained section of
the dentate gyrus, the latter with coloring of the positively stained astrocyte cells (red) and
negatively stained astrocyte cells (blue).
4.2.7.4

Statistical Analysis of Immunostaining
The number of positive cell counts/mm2 of the generalized hippocampal region of interest

(DG, CA1, and CA3) was calculated from all sections obtained from all 20x microscopic images
collected. Of the slides that had appropriate staining over the left and right hemispheres, the left
and right hemisphere 20x images were not analyzed separately due to the wide surface area of
the head impact. The mean ± SEM number of positive cell counts/mm2 for each group was used
to describe the center and spread of the positive cell counts/mm2 results per group per brain
region of interest (DG, CA1, and CA3). Additionally, the difference in group mean number of
positive cells per mm2 vs. sham mean number of positive cell counts/mm2 was also calculated.
Data analysis and statistical computations were carried out using a one-way ANOVA model,
with treatment as the explanatory variable, in SAS (SAS Institute, Cary NC). Pairwise
comparisons were conducted using a post hoc LSMeans Difference test. Normality was
determined using a Shapiro-Wilk test and the homogeneity of variances was determined using
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Levene’s test. If the assumption of normality was not met, nonparametric methods were
employed. In incidences where the assumption of equal variance was not met, a Welch’s test was
used in lieu of the ANOVA p-value. All statistical analyses were conducted using SAS with a
significant level of p<0.05. Furthermore, all plots were obtained using GraphPad Prism® 8.
4.3
4.3.1

Results
Impact Data
A weight drop injury device was employed to induce a head injury from two projectile

weights (27.17 and 67.84 gms) at an impact height of 0.81 m. Animals that were impacted with
the higher projectile weight were considered “high” impact groups. Alternately, those who
received an impact with the lower weight (27.17 g) were labeled as “low” impact groups.
According to the data, high impact groups received an average impact velocity of 3.83 ± 0.01
ms-1 and average kinetic energy of 0.50 ± 0.00 J. Alternatively, low impact groups had an
average impact velocity of 3.86 ± 0.00 ms-1 and kinetic energy of 0.20 ± 0.00 J. Descriptive
Statistics obtained from the univariate analysis performed on the impact data can be found in
Table 4.2.
Impact dynamics results from the Shapiro-Wilk test of normality for each variable are as
follows: velocity for high impact groups (p=0.018), KE for high impact groups (p=0.018),
velocity for low impact groups (p=0.160), and KE for low impact groups (p<0.0001).
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Table 4.2

Impact dynamics according to projectile weights.

Projectile
Weight (gms)

Standard
Minimum Maximum
Deviation
Velocity (ms-1)
3.863
0.009
3.850
3.880
27.17
Kinetic Energy (J)
0.203
0.001
0.201
0.205
-1
Velocity (ms )
3.832
0.013
3.820
3.860
67.84
Kinetic Energy (J)
0.498
0.003
0.495
0.505
The projectile weight (gms), mean, standard deviation, minimum and maximum values for
velocity (ms-1) and kinetic energy (J) calculated impact data.
4.3.2

Variable

Mean

Behavior

4.3.2.1

Open Field Test
An Open Field Test (OFT) was employed to investigate indications of altered general

locomotor activity or anxiety-like behavior due to impact and throughout recovery (3- and 7days). In Tables 4.3-4.4, the overall significance of the effects is presented beside the variable's
name. Results from the ANOVA test for the repeated measures design indicated only two
variables, from the 3-day recovery groups, showed a significant interaction effect between
treatment and day. As such, a separate table with the specific groups and day of testing showing
significant differences was reported (Table 4.5). Plots represent the mean with error bars
representing the SEM. For all plots, significant differences (p<0.05) between group pairs are
denoted with one asterisk (*).
Table 4.3

Open Field Test ANOVA summary for the repeated measures design of the 3-day
recovery groups.

Open Field Test Variables
Total Distance Traveled (m)
Average Speed (m/s)
Maximum Speed (m/s)

ANOVA For Repeated Measures Design
of 3-Day Recovery Groups
Treatment x Day
Treatment
Day
0.054
0.277
0.001 *
0.046 *
0.291
0.675
0.269
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Table 4.3 (continued)
Total Time Mobile (mins)
Total Time Immobile (mins)

0.878
0.879

0.402
0.402

0.000 *
0.000 *

Total Time in Outer Zone (mins)

0.702

0.670

0.991

0.037 *

-

-

Time Mobile Outer Zone (mins)

0.681

0.056

0.000 *

Time Immobile Outer Zone (mins)

0.929

0.534

0.002 *

Number of Entries into Center Zone
Distance Traveled Center Zone (m)

0.113
0.562

0.553
0.806

0.022 *
0.396

Total Time in Center Zone (mins)

0.699

0.667

0.986

Time Mobile Center Zone (mins)

0.897

0.777

0.632

Time Immobile Center Zone (mins)

0.381

0.537

0.410

Thigmotaxis Index

0.699

0.668

0.986

Distance Traveled Outer Zone (m)

The p-values obtained from the mixed model ANOVA tests for each OFT variable is presented.
Significant differences of the effect are indicated by an asterisk (*).
Table 4.4

Open Field Test ANOVA summary for the repeated measures design of the 7-day
recovery groups.

Open Field Test Variables
Total Distance Traveled (m)
Average Speed (m/s)
Maximum Speed (m/s)
Total Time Mobile (mins)
Total Time Immobile (mins)

ANOVA For Repeated Measures Design
of 7-Day Recovery Groups
Treatment x Day
Treatment
Day
0.376
0.262
0.025 *
0.293
0.254
0.030 *
0.156
0.619
0.863
0.923
0.055
0.005 *
0.923
0.055
0.005 *

Total Time in Outer Zone (mins)

0.642

0.042 *

0.593

Distance Traveled Outer Zone (m)

0.467

0.412

0.008 *

Time Mobile Outer Zone (mins)

0.617

0.847

0.005 *

Time Immobile Outer Zone (mins)

0.980

0.028 *

0.008 *

Number of Entries into Center Zone

0.090

0.101

0.713

Distance Traveled Center Zone (m)

0.618

0.270

0.472

Total Time in Center Zone (mins)

0.642

0.042 *

0.599

Time Mobile Center Zone (mins)

0.505

0.029 *

0.362
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Table 4.4 (continued)
Time Immobile Center Zone (mins)

0.287

0.189

0.417

Thigmotaxis Index

0.642

0.042 *

0.598

The p-values obtained from the mixed model ANOVA tests for each OFT variable is presented.
Significant differences of the effects are indicated by an asterisk (*).
Table 4.5

Open field test result summary of Fisher's least significant difference test for day 3
recovery groups where significant differences were observed for the interaction
effect.

Open Field
Test Variables

Differences of Least Square Means for Day 3 Recovery Groups

Effect
Group
Day
Group
Day
Treatment*Day
High
BL
High
TD
ANOVA (p=0.001) *
Average Speed
(m/s)
Treatment*Day
Sham
BL
Sham
TD
ANOVA (p=0.007) *
Treatment*Day
High
BL
High
TD
ANOVA (p=0.0003) *
Distance
Treatment*Day
Traveled in
Low
TD
Sham
TD
ANOVA (p=0.021) *
Outer Zone (m)
Treatment*Day
Sham
BL
Sham
TD
ANOVA (p=0.003) *
Significant differences between group pairs by day of behavioral testing (baseline vs. recovery
day) are identified from the Fisher’s LSD test procedure next to each group’s statistic.
For the sake of brevity, the remainder of this research will focus only on the following
general locomotive activity variables: total distance traveled and total time immobile (mins).
Furthermore, the following variables associated with measuring anxious-like behavior, total time
in outer zone (mins), and total time in center zone (mins), thigmotaxis index, and number of
center zone entries, will be further discussed from this point forward.
With respect to measurements related to general locomotor activity, no significant
differences were seen between injury and sham groups, regardless of recovery (Figure 4.8A).;
however, on average, the animals traveled significantly more total distance at baseline compared
to recovery days (Table 4.3-4.4). In the context of the total time animals spent immobile during
73

the OFT, data indicated on average, regardless of recovery time, the animals spent significantly
more time immobile on the day of recovery compared to baseline (Tables 4.3-4.4) (Figure 4.8B).

Figure 4.8

Total distance traveled (m) and total time immobile (mins).

Comparison plots of the (A) total distance traveled in meters and the (B) total time immobile in
minutes among impact recovery groups High3, Low3, High7, Low7, and sham groups, Sham3
and Sham7, during the 30 minute OFT assay. The ANOVA results indicated no significant
differences among groups with respect to the total distance traveled and total time immobile of
OFT. On average, recovery groups travelled significant less distance and were immobile for a
greater amount of time than baseline groups. Plots show the mean and the standard error of the
mean (error bars).
Significant differences between injury and shams were evident between 7-day recovery
groups with respect to the total time spent in the outer zone and total time spent in the center
zone (Table 4.4). Post hoc LSMeans Difference test revealed that, on average, the High7 impact
group spent significantly less time in the center zone (Figure 4.9A) and more time in the outer
zone (Figure 4.9B) than sham (p=0.017 and p=0.017, respectively) group (Table 4.4). This
phenomenon is further reflected in the analysis of the thigmotaxis index analysis (Figure 4.9C),
which indicates, on average, the High7 impact group spent a significantly greater test duration in
the outer zone (higher thigmotaxis index) compared to Sham7 (p=0.017) (Table 4.4). Overall,
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these results support the indication that the higher-impact load injury group shows increased
anxiety-like behaviors, as indicated by a significant increase in the thigmotaxis index after 7days of recovery. Finally, post hoc LSMeans Difference test results showed no significant
differences concerning the number of center zone entries between injury and sham groups,
regardless of recovery day (Figure 4.9D). However, on average, the 3-day recovery assigned
animals did enter the center zone significantly fewer times upon recovery compared to their
baseline measurements (Table 4.3).

Figure 4.9

Plots for (a) time in center zone (mins), (b) time in outer zone (mins), (c) the index
of thigmotaxis, and (d) the number of entries into the center zone.

Comparison plots of the OFT group results for (A) time in center zone (mins), (B) time in outer
zone (mins), (C) the index of thigmotaxis, and (D) the number of entries into the center zone
among impact recovery groups High3, Low3, High7, Low7, and sham groups, Sham3 and
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Sham7, during the 30 minute OFT assay. Post hoc LSMeans Difference test results indicated, on
average, significant differences between High7 and Sham7 groups for (A) time in outer zone
(mins), (B) time in center zone (mins) and (C) the index of thigmotaxis. An asterisk (*) denotes a
significant difference (p<0.05). Plots show the mean and the standard error of the mean (error
bars).
4.3.2.2

Rotarod Test
Somewhat surprisingly, injury groups did not show impairment of motor coordination on

the rotarod compared to their sham groups, regardless of recovery day. However, when
comparing the differences of latency performance for all animals, regardless of group
assignment, by recovery groups, significant differences were present. The differences in latency
performance between 3- and 7-day recovery groups have been summarized as the mean ± SEM
in Tables 4.6 and 4.7, respectively.
When comparing the differences of latency time for all animals, regardless of group
assignment, by recovery groups, significant differences among groups were present between day
of rotarod testing (p<0.0001) and trials (p<0.0001) (Tables 4.5 and 4.6). According to Tables 4.6
and 4.7, on average, all animals, across trials and treatment, performed significantly better on the
day of recovery compared to baseline (3DPI: p<0.0001, and 7DPI: p=0.0006). Additionally, data
showed that on average, all animals, across treatment and recovery days, performed significantly
better on trials 2 and 3 compared to trial 1 (see Tables 4.6 and 4.7), most likely due to a learning
effect.
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Table 4.6

Differences in latency (s) summary for 3-day recovery groups across all animals,
regardless of group assignment.

Effect
Day
ANOVA (p<0.0001) *
Trial
ANOVA (p=0.0002) *
Trial
ANOVA (p<0.0001) *
Trial
ANOVA (p=0.2116)

Differences in Latency (s) of Day 3 Recovery Groups
Trials by Day of Testing

Mean ± SEM

Baseline

Recovery

-97.19 ± 13.75

Trial 1

Trial 2

-49.40 ± 12.16

Trial 1

Trial 3

-63.22 ± 11.89

Trial 2

Trial 3

-13.83 ± 10.93

The mean ± standard error of the mean (SEM) of latency (s) for the differences between test day
(baseline vs. recovery) and trials (1, 2, and 3) of all animals within the 3-day recovery groups,
High3 (n=6), Low3 (n=6), and sham3 (n=6), during the rotarod test. The p-values obtained from
the ANVOA suggest that on average, all animals, across trials and treatment, performed
significantly better on the day of recovery compared to baseline. Furthermore, on average, all
animals, across treatment and recovery days, performed significantly better on trials 2 and 3
compared to trial 1. Significant differences (p<0.05) between effects are denoted with one
asterisk (*).
Table 4.7

Differences in latency (s) summary for 7-day recovery groups across all animals,
regardless of group assignment.

Effect
Day
ANOVA (p=0.0006) *
Trial
ANOVA (p<0.0001) *
Trial
ANOVA (p=0.0005) *
Trial
ANOVA (p=0.3489)

Differences in Latency (s) of Day 7 Recovery Groups
Trials by Day of Testing

Mean ± SEM

Baseline

Recovery

-61.41 ± 14.30

Trial 1

Trial 2

-40.34 ± 8.59

Trial 1

Trial 3

-32.23 ± 8.69

Trial 2

Trial 3

8.12 ± 8.59

The mean ± standard error of the mean (SEM) of latency (s) for the differences between day
(baseline vs. recovery) and trials (1, 2, and 3) of all animals within the 7-day recovery groups,
High7 (n=6), Low7 (n=6), and sham7 (n=6), during the rotarod test. The p-values obtained from
the ANVOA suggest that on average, all animals, across trials and treatment, performed
significantly better on the day of recovery compared to baseline. Furthermore, on average, all
animals, across treatment and recovery days, performed significantly better on trials 2 and 3
compared to trial 1. Significant differences (p<0.05) between effects are denoted with one
asterisk (*).
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4.3.3

Histology
To investigate histological evidence of neuroinflammation, positive cell count analysis

was performed for brain tissue sections to assess microgliosis and astrogliosis using
immunohistochemical markers Iba-1 and GFAP, respectively. Histological analysis was
performed for the dentate gyrus (DG), cornu ammonis 1 (CA1), and cornu ammonis 3 (CA3)
subregions of the hippocampus. Histochemical assessment of H&E tissue sections revealed no
macroscopic lesions due to impact. Representative micrographs of GFAP and Iba-1 tissue
sections for each region of interest can be seen in Appendix C.2.1 and Appendix C.2.2,
respectively. Plots for GFAP (Figure 4.10) and Iba-1 (Figure 4.11) analysis present the mean
positive cell counts/mm2. Error bars represent the SEM. For all plots, significance is denoted
with one asterisk (*) indicative as p-value smaller than 0.05 (p<0.05).
4.3.3.1

GFAP
Glial fibrillary acidic protein (GFAP) was used as an immunohistochemical marker for

astrocytes. The number of positive cell counts/mm2 was used to analyze the proportion of GFAP
immunoreactivity within each brain region of interest (DG, CA1, and CA3) for each group as a
measure of astrogliosis. Summary statistics for the GFAP positive cell counts/mm2
measurements obtained for each region analyzed can be seen in Table 4.7. Descriptive statistics
of animal groups for each region (DG, CA1, and CA3) are displayed by region of interest in
Table 4.7.
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Table 4.8
Brain
Region

GFAP positive cell count/mm2 summary.
Group

Day of
Recovery

Mean ± SEM

95% CI
Lower
Upper

Impact vs. Sham
Mean Diff ± SEM

High
332.32 ± 93.27
-69.00
733.63
90.78 ± 111.324
Low
3
230.98 ± 8.73
120.01
341.95
-10.56 ± 115.032
DG
Sham
241.54 ± 68.52
51.30
431.78
ANOVA
High
394.67 ± 68.65 204.08
585.27
28.01 ± 92.785
(p=0.579)
Low
7
331.14 ± 93.78 -860.48 1522.77 -35.52 ± 106.951
Sham
366.66 ± 68.37 176.82
556.5
High
278.51 ± 87.48
0.11
556.91
-9.15 ± 122.915
Low
3
157.22 ± 6.2
78.45
236.00 -130.43 ± 129.573
CA1
Sham
287.65 ± 77.23
73.22
502.07
ANOVA
High
361.9 ± 87.89
117.87
605.92
21.13 ± 107.504
(p=0.760)
Low
7
324.5 ± 79.3
-683.07 1332.06 -16.27 ± 101.414
Sham
340.77 ± 67.29 153.94
527.59
High
190.75 ± 43.37
0.11
556.91
37.17 ± 80.305
Low
3
130.31 ± 22.29
78.45
236.00
-23.27 ± 87.308
CA3
Sham
153.58 ± 51.42
73.22
502.07
ANOVA
High
281.89 ± 94.62 117.87
605.92
67.75 ± 119.433
(p=0.742)
Low
7
219.54 ± 26.41 -683.07 1332.06
5.40 ± 87.3
Sham
214.14 ± 63.86 153.94
527.59
Summary of cell count of positive GFAP immunoreactivity within the DG, CA1, and CA3 for impact
recovery and sham groups. For the mean differences ± SEM between injury and sham groups,
comparisons were based on recovery time (e.g., High3 vs. Sham3, Low3 vs. Sham3, High7 vs.
Sham7, and Low7 vs. Sham7). The p-value obtained from ANOVA procedures is listed beneath each
brain region title.
Results from GFAP immunostaining indicated no significant differences between groups
with respect to the number of GFAP positive cells/mm2 (Figure 4.10). Moreover, positive cell
count analysis of GFAP immunoreactivity did not indicate any injury group, regardless of
recovery, to be statistically significant from sham (Figure 4.10). Although group Low3 visually
seems statistically different from High3 and Sham3 groups within the CA1 region, according to
our statistical analysis, they were not (p=0.411 and p=0.361, respectfully) (Figure 4.10B).
Furthermore, the trends observed for GFAP positive cells/mm2 analysis were mimicked for all
three regions of interest with respect to recovery days between animal groups (Figure 4.10A-C).
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In short, the GFAP positive cell count analysis showed no evidence of increased astrogliosis in
the hippocampus for DG, CA1, or CA3 (Figure 4.10A-C).

Figure 4.10

The number of positive GFAP cell counts/mm2 for (A) DG, (B) CA1, and (C)
CA3.

Comparison plots of the cell count of positive GFAP immunoreactivity (number of GFAP+
cells/mm2). Data are presented as mean ± SEM for impact recovery groups High3, High7, Low3,
Low7, Sham3, and Sham7 in the (A) DG, (B) CA1, and (C) CA3.
4.3.3.2

Iba-1
Ionized calcium-binding adaptor molecule-1 (Iba-1) was used as an

immunohistochemical marker for microglia. The number of positive cell counts/mm2 was used to
analyze the proportion of Iba-1 immunoreactivity within the DG, CA1, and CA3 regions for each
group as a measure of microgliosis. Summary statistics for the Iba-1 manual positive cell
counts/mm2 measurements obtained for each region can be seen in Table 4.8. Results of the oneway ANOVA analysis are displayed by region of interest in Table 4.8.
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Table 4.9
Brain
Region

Iba-1 positive cell count summary.
Group

Day of
Recovery

Mean ± SEM

95% CI
Lower
Upper

Impact vs. Sham
Mean Diff ± SEM

High
42.54 ± 4.97
21.17
63.91
-6.15 ± 8.612
Low
3
57.74 ± 30.79
-333.49 448.98
9.05 ± 19.016
DG
Sham
48.69 ± 5.86
32.43
64.96
ANOVA
High
81.82 ± 29.35
0.33
163.31
-8.24 ± 35.625
(p=0.580)
Low
7
67 ± 21.55
-25.72
159.71
-23.06 ± 18.087
Sham
90.06 ± 21.92
29.18
150.93
High
33.32 ± 3.69
17.42
49.22
-5.34 ± 9.594
Low
3
37.31 ± 13.92
-139.6
214.21
-1.35 ± 13.703
CA1
Sham
38.66 ± 6.9
19.49
57.83
ANOVA
High
44.34 ± 21.18
-14.46
103.14
-30.46 ± 37.614
(p=0.719)
Low
7
30.64 ± 7.17
-0.23
61.51
-44.16 ± 39.26
Sham
74.8 ± 34.29
-20.39
170
High
24.51 ± 3.81
8.11
40.92
-2.86 ± 5.189
Low
3
23.38 ± 8.75
-87.75
134.52
-3.99 ± 7.183
CA3
Sham
27.37 ± 3.28
18.25
36.49
ANOVA
High
97.52 ± 37.02
-5.27
200.31
42.82 ± 38.301
(p=0.096)
Low
7
41.26 ± 7.5
17.41
65.11
-13.44 ± 12.446
Sham
54.7 ± 9.31
28.84
80.56
Summary of positive cells (number of positive cell counts/mm2) of Iba-1immunoreactivity within the
DG, CA1, and CA3 for impact recovery and sham groups. For the mean differences ± SEM between
impact groups and sham, comparisons were based on recovery time (e.g., High3 vs. Sham3, Low3
vs. Sham3, High7 vs. Sham7, and Low7 vs. Sham7). The p-value obtained from ANOVA procedures
is listed beneath each brain region title.
Similar to the positive cell counts/mm2 for GFAP, analysis of the Iba-1 positive cell
counts/mm2 revealed no significant differences between injury and sham groups, regardless of
recovery, within the DG, CA1, and CA3 regions (Figure 4.11A-C). Although not significant, on
average, the low impact group exhibited the highest hippocampal expression of Iba-1
immunoreactivity after a 3-day recovery in the DG region (Figure 4.11A). However, in the CA1
and CA3 regions, on average, the sham group exhibited the highest hippocampal Iba-1 positive
cell count/mm2 expression after a 3-day recovery (Figure 4.11B-C). For the 7-day recovery
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groups, although insignificant, the sham group exhibited the highest hippocampal expression,
apart from the CA3 region, which was most apparent within DG (Figure 4.11A).
Mean positive cells/mm2 of Iba-1 immunoreactivity for the low impact group showed the
greatest deviation from sham with a larger mean positive cells/mm2 at 3-DPI within the DG
region (9.05 ± 19.016) compared to the higher impact group (-6.15 ± 8.612) (Table 4.8).
Alternatively, the high impact group expressed a greater mean deviation of Iba-1 positive
cells/mm2 from sham within the CA3 region after 7-day of recovery (42.82 ± 38.301) (Table
4.8).

Figure 4.11

The number of positive Iba-1 cell counts/mm2 for (a) DG, (b) CA1, and (c) CA3.

Comparison plots of the cell count of positive Iba-1 immunoreactivity (Number of Iba-1 +
cells/mm2). Data are presented as mean ± SEM for impact recovery groups High3, High7, Low3,
Low7, sham3, and sham7 in the (a) DG, (b) CA1, and (c) CA3. Within the CA1 hippocampal
region (B), pairwise comparison results indicated a significant decrease in the number of positive
Iba-1 cell counts/mm2 for each experimental group after 7-days of recovery compared to 3-days
of recovery.
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4.3.4

Cytokines
In the 36 brain sections that were used to detect the presence of IL-6, TNF-α, and IL-10,

in the motor cortex and hippocampus regions, levels were below the threshold of detection. To
review plate setup and the detection signal of each analyte for each region of interest see Tables
D.1 and D.2 in Appendix D.
4.4

Discussion
Using a novel weight drop injury device capable of producing repeatable, closed head

impact loads, the present study first aimed to develop a rodent model of a single, surgery-free,
blunt impact to determine the appropriate impact magnitude suitable for an mTBI. Secondly, this
study was designed to establish the foundation for the subsequent analysis thereby addressing the
absence of knowledge surrounding the comparative effects between a single concussive impact
and repeated SC impacts.
4.4.1

Behavioral Alterations Due to Impact
A substantial amount of evidence has classified mTBI as a functional disruptive injury

(Bodnar et al., 2019; Eme, 2017; Emery et al., 2016; Hartlage et al., 2001). However, a fair
number of preclinical observations have reported subtle behavioral deficits resulting from a
concussion (Bodnar et al., 2019; Henninger et al., 2007; T. H. Hsieh et al., 2017). In the present
study, we explored evidence of altered behavioral function in groups High3, Low3, High7, and
Low7 using commonly utilized behavioral tests of general locomotor activity (OFT), anxiety-like
behavior (OFT), and motor coordination (rotarod).
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4.4.1.1

General Locomotor Activity
Here we utilized an Open Field Test (OFT) to assess changes in general locomotor

activity throughout a 30-minute test (Figure 4.7). Results showed that, following a 3- and 7-day
recovery period from impact, the general locomotor activities of injury groups did not
significantly differ from shams, pointing to the possibility of the low form of mTBI. Similarly,
several other rodent models of mTBI have also reported unaffected general locomotor activity in
an open field assay (D Bree, Mackenzie, et al., 2020; Dara Bree & Levy, 2018; Broussard et al.,
2018; Taib et al., 2017; Tweedie et al., 2016; Wirth et al., 2017; Wilson, 2019) Thus, our
discovery of an absence of alteration due to a lower range magnitude of mTBI severity in
locomotor activity was consequently expected.
4.4.1.2

Anxiety-like Behavior
A commonly affected behavior due to mild traumatic brain injury includes elevated

anxiety and is frequently investigated in other models of mTBI (Bodnar et al., 2019; Malkesman
et al., 2013) and clinical concussion (Armstrong & Morrow, 2019; Wood et al., 2014). As a
measurement of anxiety-related behavior in rodents, activity in the center region of an open field
apparatus is commonly focused upon. In the context of an OFT, wall-hugging behavior, or
thigmotaxis, is observed in rodents and is linked to anxiety-like behavior (Gould et al., 2009;
Seibenhener & Wooten, 2015). Thigmotaxis is determined as a ratio of the difference in the time
spent in the outer and center zone relative to the total time spent in both zones (Equation 4.1).
Increased thigmotaxis is interpreted as elevated anxiety and is commonly reported in rodent
models of head trauma (Bodnar et al., 2019; Bree, Stratton, et al., 2020; Jamnia et al., 2017).
Animals that are considered less anxious are viewed as more willing to explore the open and
brightly lit center zone of the arena (Prut & Belzung, 2003).
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In the present study, after 7-days of recovery, the high impact recovery group displayed a
significant increase in anxious-like behavior as seen in the thigmotaxis index analysis (Figure
4.9C). These findings align with other previous studies exploring anxiogenic-like behavior in
OFT which identify elevated thigmotaxis in rodents following a single concussion. A murine
mTBI study conducted by Tucker et al. (2017) observed an increase in thigmotaxis following a
1- and 10-day recovery from a controlled cortical impact (CCI) with an impact velocity of 5 ms-1
(KE = 0.09 J). Another study performed by Namjoshi et al. (2017) observed an increase in
thigmotactic behavior of mice in mTBI groups (0.6 and 0.7 J) compared to sham at 1- and 7-days
post-TBI using a Closed Head Impact Model of Engineered Rotational Acceleration
(CHIMERA) piston design. Furthermore, according to a widely cited review article by Bodnar et
al. (2019), the majority of preclinical mTBI investigations identify an elevation of the
thigmotaxic index in rodents following head impact. Thus, our finding of anxiety-like behavior
due to a concussion, albeit a low-grade concussion, was consequently expected.
Furthermore, a previous study exploring center zone entries using an OFT, after a 5-day
recovery period, also reports an insignificant decrease in the number of center zone entries after a
single mTBI, using a controlled cortical impact model, compared to shams (Broussard et al.,
2018). Additionally, to the best of the investigator’s knowledge, only one other study has also
reported an insignificant difference, after 7-days of recovery, in rats exposed to a single
concussive impact using a fluid percussion impact model (2.19 atm) (Beitchman et al., 2020).
In summary, results from the present behavioral investigation revealed no significant
changes in general locomotor activity from a low-level mTBI. However, we observed that the
higher mTBI impact load led to a significant increase in thigmotaxis, after 7-days of recovery,
compared to shams, suggesting anxiogenic-like behavior due to the 0.5 J mTBI impact load.
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4.4.1.3

Motor Coordination
In order to explore alterations in motor coordination due to impact, we utilized a rotarod

test. Results showed that while the performance of rats improved over time, there were no
differences found between injury and sham groups for the latency to fall, suggesting that our
investigative impact magnitudes of mTBI do not affect gross motor function. These results agree
with one other study that employed a WDI apparatus to model a blunt, closed-scalp head injury
(0.5 J) in rats to measure neurologic functions using a rotarod test (Kim & Han, 2017). Results
indicated that there were no significant differences in latency to fall for injured rats compared to
sham (Kim & Han, 2017).
In contrast to these findings, a murine study conducted by Namjoshi et al. (2017) reported
the minimum injury level required with a single impact, using the CHIMERA platform (a pistonbased model), to result in rotarod deficits up to 14-days following injury was observed at impact
energies of 0.6 and 0.7 J. Interestingly, in another previously investigative murine study using a
modified version of the CHIMERA model, no motor impairments on the rotarod was found after
1-, 3-, or 5-days following a single impact with energies of 1.7 J or 2.1 J (Sauerbeck et al., 2018).
Furthermore, several studies that report significant differences of motor deficits between mTBI
and sham groups typically employ a murine model with an impact magnitude range
distinguishably lower (0.00075 – 0.06 J) than the present study’s investigative range (Y. C. Chen
et al., 2014; G Onyszchuk et al., 2007; S. H. Yang et al., 2013). Thus, it has been noted that data
and conclusions regarding the effects of mTBI on motor coordination in rodents are inconsistent
and that additional research is warranted.
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4.4.2

Neuroinflammation Due to Impact
In the present study, we evaluated the response of reactive astrocytes between the two

investigative injury groups through the analysis of the positive cell counts of GFAP
immunoreactivity. Similarly, we performed a positive cell count analysis of Iba -1
immunoreactivity to assess the microglial response. Both positive cell counts of Iba-1 and GFAP
immunoreactivity were assessed within the DG, CA1, and CA3 subregions of the hippocampus.
Results indicated that the number GFAP and Iba-1 positive cells/mm2 for both injury
groups, High and Low, following a 3- and 7-day recovery, was approximately equal to sham for
all three brain regions indicating no evidence of astrogliosis or microgliosis (Figure 4.10-4.11).
However, although insignificant, on average, high impact groups exhibited the highest
hippocampal expression of GFAP immunoreactivity in all three hippocampal regions of interest,
regardless of recovery time, except within the CA1 region after 3-DPI (Figure 4.10), which was
most apparent within the DG (Figure 4.10A). Moreover, although insignificant, GFAP
immunoreactivity appeared to be consistently upregulated for all experimental groups as
recovery time increased within all three regions of interest (Figure 4.10).
Overall, these results indicate that again, although insignificant from shams, the high
impact load groups exhibited slightly more GFAP positive cells/mm2 signaling a potential
increase in astrocytic reactivity. Therefore, our results suggest a minimal presence of
neuroinflammation within the hippocampus after 3-days of recovery, apart from the CA1 region,
which increases 7-days after injury for injury groups who received the higher impact load. More
conservatively, these results signal a degree of cellular perturbation due to the higher impact load
injury compared to low impact and sham groups. These results were expected as nearly all
preclinical models and clinical observations of head injury report an increase in GFAP
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expression (Abdelhak et al., 2022; Bogoslovsky et al., 2017; Fehily et al., 2019; Fraunberger et
al., 2020; Kim & Han, 2017; Marschner et al., 2019; Singh et al., 2016).
As with the GFAP analysis results, injury groups, regardless of recovery assignments, did
not reveal a significant difference from sham with respect to Iba-1 immunoreactivity indicating
no evidence of microgliosis (Figure 4.11A-C). Overall, although insignificant, Iba-1
immunoreactivity appeared to be consistently upregulated for all experimental groups as
recovery time increased, except for the lower impact group in the CA1 region (Figure 4.11B).
This subtle reduction in GFAP immunoreactivity over time within the CA1 region is most likely
because of the low number of samples available for groups Low3 (n=2) and Low7 (n=3)
compared to the other experimental groups (High3 (n=4), Sham3 (n=5), High7 (n=6), and Sham7
(n=5)). As such, our results suggest that a minimal presence of microgliosis was seen for all
groups within each hippocampal region as recovery time increased. From a conservative point of
view, the histological findings signal a subtle degree of cellular perturbation due to injury.
4.4.3

Cytokine Expression Due to Impact
An unexpected limitation of this work is the lack of cytokine detection in experimental

rats. Surprisingly, the procarta multiplex assay for IL-6, TNF-α, and IL-10 cytokines was not
successful using the brain tissues from this study. Possible reasons for low signal levels or
negligible expression of cytokines could be due to targets falling below detection limits of the
assay or a human error (i.e., the appropriate detection timeline of these specific cytokines was
missed, not enough detector antibody used, or the standards may not have been reconstituted or
diluted correctly).
Several rodent models investigating cytokines produced following low-level mTBIs
report an increase in IL-6 and TNF-𝛼 levels as well as a decrease in IL-10 concentrations in
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brain tissue within the acute and subacute phases of secondary injury (Lee et al., 2012; Wang et
al., 2011; Xia et al., 2012; Lagraoui et al., 2012; Dalgard et al., 2012; Zhao et al., 2014). Thus,
these data are evidence of the inflammatory response of TBI at low-level impacts. It is important
to note that compared to our investigative model of an mTBI, these are more severe models
requiring the generation of craniotomies, with the subsequent disruption of the blood brain
barrier, which has been shown to influence the pathology of inflammation (Cole et al., 2011).
Works of others in the field of TBI have shown that with more severe levels of head
injuries the greater are the inflammatory markers of pathology. This has been shown in injury
models including FPI (Mukherjee et al., 2011), CCI (Harting et al., 2008), and WDI (Holmin et
al., 1997; Sarkaki et al., 2013). In the present study, it is not possible to say to what extent the
evidence of cytokine expression is due to the absence of results. However, according to literature
and with the present study’s histological findings, it is conjectured that a minimal elevation of
pro-inflammatory cytokine (TNF-𝛼 and IL-6) concentration levels in animal groups would be
present as recovery increased as seen in the subtle increase of microgliosis in the histological
findings. It is widely accepted that microglia are potent producers of TNF-𝛼 and IL-6 when they
assume a pro-inflammatory phenotype (Bell-Temin et al., 2015; Madathil et al., 2018). However,
because Iba-1 does not differentiate between pro- and anti-inflammatory microglial phenotypes,
it is not possible to confirm the above hypothesis unless future analysis exploring this avenue is
performed.
4.5

Conclusion
In brief, our data showed no evidence of disruption of motor coordination in injured

animals compared to shams. There was, however, evidence of elevated anxiety-like behavior in
the high impact group compared to sham. Additionally, there was minimal evidence of
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neuroinflammation between the high impact and sham groups. Notably, although not significant,
overall, animals who received the higher impact load expressed the highest (50%) number of
GFAP and Iba-1 positive cells/mm2 followed by low impact (42%) and sham groups (8%).
Therefore, our pilot study exploring the comparative pathophysiology between single low-level
impacts (0.2 J vs. 0.5 J) showed that animals receiving the higher impact load led to a significant
increase in anxiety-like behavior compared to sham.
The present work has laid the foundation for a biomechanically informed model of the
lower end ranges of mTBI, according to literature, that manifests pathology unlike that currently
seen in models of concussion. Despite the insignificant results of alterations in motor
coordination and inflammatory analysis, it revealed important aspects of lower-level impact
loads. First, this work provides evidence in support of the notion that not every closed head
impact has the capacity to result in system perturbations. Although a theoretical injury threshold
may not exist for rats using a WDI model, based on the present study’s findings, we hypothesize
a biomechanical threshold level of impact associated with a lack of functional impairment and
neuroinflammation due to a single closed head injury is likely around an energy level of 0.2 J.
However, targeted investigations would be necessary to explore this hypothesis. Investigations
may include expanding the recovery timeline between 12 hours and 2 weeks post-injury,
involving additional behavior tests to test cognitive impairment, and/or analyzing brain tissues
for the presence of cytokines, just to name a few. Not only could this data inform investigators of
injury relief strategies, but it would directly affect treatment targets and the development of
therapeutic interventions.
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CHAPTER V
BEHAVIORAL AND HISTOLOGICAL INFLAMMATORY ANALYSIS FOLLOWING A
SINGLE MILD TRAUMATIC BRAIN INJURY AND REPEATED SUBCONCUSSIVE
INJURY USING A RODENT MODEL
5.1

Introduction
Previous work aimed to explore two impact magnitudes slightly higher than the lowest

reported mTBI for a closed head impact found in literature. However, since the results did not
present significant evidence of neuroinflammation due to a single impact of 0.2 or 0.5 J, it was
decided to use the energy intensity of 0.5 J as the impact load for the repetitive SC impact group
in the present study. Using a rodent model, the present study aimed to investigate the
pathophysiological differences between the two injury paradigms, a single mTBI, with a kinetic
energy (KE) of 1.5 J, and repeated subconcussive (RSC) impacts, KE = 0.5 J, with subdivided
cumulative KEs equal to the single mTBI impact (i.e., 0.5 J x 3 = 1.5 J). However, upon the first
day of impacts for rodents receiving a single mTBI impact (1.5 J), two of the four rodents died
within 5 minutes following head trauma. After necropsy was performed on the two rodents, the
final diagnosis concluded both rats sustained subdural hemorrhage with one rat showing
evidence of a fractured parietal bone. As such, it was decided to decrease the severity of impact
load for mTBI from 1.5 to 1.0 J. Subsequently, the impact load for the RSC impacts was also
decreased to a kinetic energy of 0.33 J. The following criteria were used to determine the
appropriate mTBI impact load for a rat model: 0% mortality due to impact, the absence of skull
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fracture, the presence of behavioral measures, and/or neuroinflammation via
immunohistochemistry.
To understand the analysis of the sequelae following the two injury paradigms, impact
animals were divided into four groups and subjected to either a single mTBI load of 1 J or three
SC impact loads of 0.33 J with an assigned recovery time of either 3- or 7-days post-final impact
and compared to sham. Similar to the previous study’s design (see Chapter 4), the present study
evaluated evidence of behavioral alterations, inflammation, and cerebral vulnerability using
behavioral assays and immunohistochemistry. Measurement outcomes were assessed at two
recovery time points, 3- and 7-days, following the final closed head injury (CHI).
5.2

Methods
The following sections outline the experimental design and methods utilized for each

procedure. In addition, this section provides animal number details along with impact,
behavioral, euthanasia, and histological procedures for the full study. Analytical and statistical
methods have been outlined as appropriate for each experimental procedure.
5.2.1

Experimental Design
An overview of the experimental elements and design for the full study can be viewed in

Figure 5.1. All procedures for the experimental full study have been approved by the Mississippi
State University Institutional Animal Care and Use Committee (IACUC) under protocol number
20-456 (see Appendix A).
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Figure 5.1
5.2.2

An overview of the experimental elements and design for the full study.

Animals
Ninety-six male Sprague-Dawley rats (250-300 g; Envigo, Indianapolis, IN) were housed

in a 12-hour light/dark cycle facility accredited by the Association for Assessment and
Accreditation of Laboratory Animal Care (AAALAC). Upon arrival, animals were kept in
quarantine for 3-days before experimentation to ensure the quality of health and adequate
acclimation to the environment. Rats were housed in groups of two in transparent cages on
standard bedding with unlimited access to food pellets and water ad libitum prior to testing and
again after 24 hours following the final administration of analgesia.
Rats were randomly assigned to one of 4 injury groups (n=48) or sham groups (n=48).
Groups were then divided by assigned recovery time (3- or 7-days post-impact (DPI)). Each
impact-recovery group (n=4) consisted of twelve rats and was accompanied by twelve sham rats.
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Sham rats underwent all procedures as the impact rats excluding the blunt impact. For each cage,
one rat was assigned as an impact rat while the other was assigned as a sham.
Prior to each impact procedure, rats were administered ketamine (100-200 mg/kg IP) and
xylazine (5-10 mg/kg IP). Loss of righting reflex was used to indicate the depth of anesthesia.
Upon completion of head impact, atipamezole (5-10 mg/ml IM) was administered to reverse the
effects of xylazine. In addition to this reversal agent, rats were administered a single dose of
Buprenorphine SR (1 mg/ml SC) for analgesia. Following the impact procedure (or post-final
impact for repeated SC recovery groups), each rat begins their assigned recovery time (3- or 7days). On the final day of recovery, animals were sacrificed.
To control pica behavior, a common side effect of buprenorphine, rats were housed
individually on cage paper for approximately 24 hours as opposed to standard rodent bedding
when returned to the colony post-impact. After 24 hours following analgesic administration,
animals were returned to group housing and placed on standard bedding with food and water
provided ad libitum. Pica behavior was monitored throughout the 3-day effective duration of
analgesia.
Eleven animals died before the completion of the study due to an adverse reaction to
anesthesia. According to the veterinary doctor on staff, the rats most likely aspirated saliva due
to hypersalivation from ketamine. Using all the precautionary extra rodents on hand, only six of
the eleven animals were replaced. A table of original animal numbers and final animal numbers
can be seen in Table 5.1.
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Table 5.1

Initial and Final Animal Numbers

Recovery Group

Starting Number of Rats
Final Number of Rats
(mTBI / RSC / Sham / RSham)
(mTBI / RSC / Sham / RSham)
3-Days
(n=12) / (n=12) / (n=12) / (n= 12)
(n=12) / (n=10) / (n=12) / (n= 9)
7-Days
(n=12) / (n=12) / (n=12) / (n= 12)
(n=12) / (n=12) / (n=12) / (n= 12)
Animal numbers within each experimental group at the beginning and end of the study reflecting
animals lost. From the 3-day recovery assigned groups, two rats within the repeated SC impact
group and three rats from the repeated sham group died shortly after impact due to anesthesia.
Note: mTBI=mild Traumatic Brain Injury; RSC = repeated subconcussive injury; RSham =
repeated Sham.
5.2.3

Impact Device and Procedures
The impact device, procedures, and statistical analysis of the impact data used in the

present study have been previously described (see Chapters 4.2.3). The only modifications made to

the present study’s impact device were the projectile weights. Animals assigned to receive a
single mTBI impact (n=24) were hit to the top side of the head with a 136.03 g weight. Those
assigned to receive a repeated SC impact within an inter-injury interval of 24 hours for 3
consecutive days (n=24) were impacted with a 44.72 g weight.
5.2.4

Behavioral Analysis
All behavior and statistical analysis used in the present study have been previously

described (see Chapters 4.2.4). The only modification made to the present study’s setup was for
each experimental run of the open field and rotarod tests a total of four rodents were employed,
two injury (a single mTBI and RSC) and two sham animals (a sham and repeated sham).
5.2.5

Brain Collection Process
After completion of all behavioral testing on recovery days (3- and 7-DPI), animals were

euthanized using carbon dioxide in a chamber. Subsequently, rats were decapitated using a
guillotine as a confirmation of euthanasia. Following this, the brain samples were dissected and
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hemisected by a midline sagittal cut. One-half of each brain was placed in dry ice and stored at
−80 °C until further analysis. The other half was trimmed using a 1 mm coronal acrylic brain
matrix (Ted Pella, Inc., Redding, CA, USA). Using a Rat Brain Atlas (Paxinos, Watson: The Rat
Brain in Stereotaxic Coordinates, 7th Edition) as a guide, the first trim was made 2 mm directly
in front of the optic chiasm (2.48 bregma; see blade 1 in Figure 5.2) with each subsequent cut
made 2 mm caudal to the preceding trim for a total of three 2 mm tissue sections. Trimmed
sections were placed in cassettes (2-3 trims from the same brain per cassette) and submerged in
10% neutral buffered formalin (NBF) solution for at least 3 weeks in preparation for processing
and paraffin embedding.

Figure 5.2

Representative image of left cerebral hemisphere tissue trimming protocol.

Shown are the A) acrylic brain trimming matrix, B) optic chiasm (the location of the first trim),
and C) blades used for trimming. The distance between each razor was 2 mm.
5.2.6

Histology
All histological and statistical analyses used in the present study have been previously

described (see Chapters 4.2.7). The only modification made to the present study’s
immunohistochemical investigation was adding an immunohistochemical stain for the
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assessment of neuronal loss due to injury. To investigate evidence of neuronal loss, each tissue
section underwent NeuN (neuronal nuclei) immunostaining.
Prior to NeuN staining, paraffin-embedded tissues were sectioned at 5 μm onto charged
slides. Unstained slides were deparaffinized and pretreated with Reveal Decloaker (Biocare
rv1000m) in a Decloaking Chamber (Biocare) for 15 minutes at 110°C. Immunostaining was
performed on an IntelliPATH autostainer. Endogenous peroxidase activity was blocked with 3%
hydrogen peroxide (Biocare ipb5000) for 5 minutes. The primary antibody for NeuN (Abcam
ab177487, 1:800, 1hr) was then applied. A negative control without primary was included.
Detection was performed using Rabbit-on-Canine HRP polymer (Biocare rc542) according to
insert directions mixed in with DaVinci green diluent (Biocare pd900). The tissues were then
developed with DAB chromogen substrate (Biocare) for 5 minutes. Following that, slides were
counterstained with hematoxylin (Biocare) for 5 minutes. Finally, slides were washed,
dehydrated and coverslipped.
5.3
5.3.1

Results
Impact Data
A weight drop injury device was employed to induce either mTBI or subconcussive

injury using two projectile weights (136.03 and 44.72 g) at an impact height of 0.81 m. Animals
that were impacted with the greater projectile weight were considered mTBI impact groups.
Alternately, those who received an impact with the lower weight (44.72 g) were labeled as RSC
impact groups. Descriptive Statistics obtained from the univariate analysis performed on the
impact data can be found in Table 5.2. According to the data, mTBI impact groups received an
average impact velocity of 3.87 ± 0.01 ms-1 and average kinetic energy of 1.02 ± 0.00 J.
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Alternatively, RSC impact groups had an average impact velocity of 3.89 ± 0.14 ms-1 and kinetic
energy of 0.34 ± 0.03 J.
Impact dynamics results from the Shapiro-Wilk test of normality for each variable are as
follows: velocity for mTBI impact groups (p<0.001), KE for mTBI impact groups (p=0.0002),
velocity for RSC impact groups (p<0.001), and KE for RSC impact groups (p<0.0001).
Table 5.2

Impact dynamics according to projectile weight.

Projectile
Weight (gms)

Standard
Minimum Maximum
Deviation
Velocity (ms-1)
3.891
0.140
3.190
4.680
44.72
Kinetic Energy (J)
0.339
0.025
0.228
0.490
-1
Velocity (ms )
3.866
0.006
3.860
3.880
136.03
Kinetic Energy (J)
1.016
0.003
1.013
1.024
The projectile weight (gms), mean, standard deviation, minimum and maximum values for
velocity (ms-1) and kinetic energy (J) calculated impact data.
5.3.2
5.3.2.1

Variable

Mean

Behavior
Open Field Test
An Open Field Test (OFT) was employed to investigate indications of altered general

locomotor activity or anxiety-like behavior due to impact and throughout recovery (3- and 7days). In Tables 5.3-5.4, overall significance of three main effects are presented beside the
variable's name. Results from the ANOVA test for the repeated measures design did indicate
four variables showing a significant interaction effect between treatment and day, but only
following 3 days of recovery (Table 5.3). As such, a separate table with the specific groups and
day of testing showing significant differences was reported for the 3-day recovery groups (Table
5.5). Moreover, there were several variables, within both recovery groups, that showed a
significant effect for either treatment, day of testing, or both (Tables 5.3-5.4). Plots represent the
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mean with error bars representing the SEM. For all plots, significant differences (p<0.05)
between group pairs are denoted with one asterisk (*).
Table 5.3

Open Field Test ANOVA summary for the repeated measures design of the 3-day
recovery groups.

Open Field Test Variables
Total Distance Traveled (m)
Average Speed (m/s)
Maximum Speed (m/s)
Total Time Mobile (mins)
Total Time Immobile (mins)
Total Time in Outer Zone (mins)

ANOVA For Repeated Measures Design
of 3-Day Recovery Groups
Treatment x Day
Treatment
Day
0.176
0.262
0.001 *
0.801
0.145
<0.0001 *
0.179
0.373
0.418
0.016 *
0.562
0.633
<0.0001 *
0.019 *

-

-

0.262

0.036 *

0.002 *

0.039 *

-

-

Time Immobile Outer Zone (mins)

0.745

0.752

<0.0001 *

Number of Entries into Center Zone

0.106

0.047 *

0.033 *

Distance Traveled Center Zone (m)

0.1501

0.878

0.006 *

Total Time in Center Zone (mins)

0.0443 *

-

-

Time Mobile Center Zone (mins)

0.0836

0.002 *

0.000 *

Time Immobile Center Zone (mins)

0.0986

0.137

0.203

Thigmotaxis Index

0.1961

0.006 *

<0.0001 *

Distance Traveled Outer Zone (m)
Time Mobile Outer Zone (mins)

The p-values obtained from the mixed model ANOVA tests for each OFT variable is presented.
Significant differences of the effect are indicated by an asterisk (*).
Table 5.4

Open Field Test ANOVA summary for the repeated measures design of the 7-day
recovery groups.

Open Field Test Variables
Total Distance Traveled (m)
Average Speed (m/s)
Maximum Speed (m/s)
Total Time Mobile (mins)

ANOVA For Repeated Measures Design
of 7-Day Recovery Groups
Treatment x Day
Treatment
Day
0.523
0.051
0.053
0.711
0.195
0.300
0.688
0.401
0.265
0.208
0.000 *
0.005 *
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Table 5.4 (continued)
Total Time Immobile (mins)

0.870

0.110

0.275

Total Time in Outer Zone (mins)

0.064

0.006 *

0.001 *

Distance Traveled Outer Zone (m)

0.459

0.064

0.176

Time Mobile Outer Zone (mins)

0.192

0.003 *

0.007 *

Time Immobile Outer Zone (mins)

0.854

0.135 *

0.283

Number of Entries into Center Zone

0.989

0.037 *

0.003 *

Distance Traveled Center Zone (m)

0.912

0.248

0.002 *

Total Time in Center Zone (mins)

0.816

0.504

0.248

Time Mobile Center Zone (mins)

0.893

0.249

0.232

Time Immobile Center Zone (mins)

0.839

0.382

0.869

Thigmotaxis Index
0.810
0.767
0.750
The p-values obtained from the mixed model ANOVA tests for each OFT variable is presented.
Significant differences of the effects are indicated by an asterisk (*).
Table 5.5

Open field test result summary of Fisher's least significant difference test for day 3
recovery groups where significant differences were observed for the interaction
effect.

Open Field Test
Variables

Differences of Least Square Means for Day 3 Recovery Groups

Effect
Group Day Group
Day
Total Time
Treatment*Day
mTBI
BL
mTBI
TD
Mobile (mins)
ANOVA (p=0.008) *
Treatment*Day
RSC
BL
RSC
TD
ANOVA
(p=0.005) *
Total Time in
Outer Zone (mins)
Treatment*Day
RSham
BL
RSham
TD
ANOVA (p=0.002) *
Time Mobile
Treatment*Day
Sham
BL
Sham
TD
Outer Zone (mins)
ANOVA (p=0.003) *
Total Time in
Treatment*Day
mTBI
BL
mTBI
TD
Center Zone (mins)
ANOVA (p<0.0001) *
Significant differences between group pairs by day of behavioral testing (baseline vs. recovery
day) are identified from the Fisher’s LSD test procedure next to each group’s statistic.
As previously mentioned in section 4.3.2, the following variables will be further
discussed in detail: total distance traveled and total time mobile (mins), total time in outer zone
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(mins), and total time in center zone (mins), thigmotaxis index, and number of center zone
entries.
With respect to measurements related to general locomotor activity, no significant
differences were seen between injury and sham groups, regardless of recovery (Figure 5.3A);
however, on average, the 3-day recovery group animals traveled significantly more total distance
at baseline compared to recovery days (Table 5.3). In the context of the total time animals spent
mobile during the OFT, data indicated, group mTBI3 spent a significantly reduced amount of
time mobile following 3-days of recovery compared to baseline measurements (p=0.008) (Table
5.3) (Figure 5.3B). Furthermore, on average, the 7-day recovery group animals spent
significantly more time mobile on the day of recovery compared to baseline (Tables 5.4).

Figure 5.3

Total distance traveled (m) and total time immobile (sec).

Comparison plots of the (A) total distance traveled in meters and the (B) total time immobile in
minutes among impact recovery groups mTBI3 (n=12) and RSC3 (n=10), mTBI7 (n=11), and
RSC7 (n=11), and control groups, Sham3 (n=12), RSham3 (n=9), Sham7 (n=12), RSham7 (n=12),
during the 30 minute OFT assay. Fisher's LSD method indicated that group mTBI3 spent a
significantly reduced amount of time mobile following 3-days of recovery compared to baseline
measurements (p=0.008) (B). The asterisk located above the bracket indicates significance
(p<0.05) between groups. Plots show the mean and the standard error of the mean (error bars).
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In terms of time spent in the outer zone, data revealed that RSham3 (p=0.0002) and RSC3
(p=0.005) injury groups spent a significantly greater amount of time in the outer zone upon
recovery time compared to baseline measurements (Table 5.5) (Figure 5.4A). Moreover, on
average, the 7-day recovery group animals spent significantly more time in the outer zone upon
recovery compared to baseline (Table 5.4). Additionally, on average, RSC7 animals spent
significantly more time in the outer zone compared to mTBI7 animals (Table 5.4). Alternatively,
Fisher's LSD method test results revealed that group mTBI3 spent a significantly reduced amount
of time in the center zone upon recovery time compared to baseline (p<0.0001) (Figure 5.4B).
According to the thigmotaxis index analysis, no differences were seen between injury and sham
groups, regardless of recovery (Figure 5.4C); however, on average, the 3-day recovery group
animals traveled significantly more total distance upon recovery compared to baseline (Table
5.3). Furthermore, on average, groups RSC3 and Sham3 showed significantly greater thigmotaxis
indexes compared to group mTBI3 (0.007 and 0.003, respectively) (Table 5.3). Overall, these
results further support the indication that injury groups showed no evidence of anxiety-like
behaviors, as indicated by similarity in the thigmotaxis index measurements with their associated
shams upon recovery days.
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Figure 5.4

Plots for (A) time in the outer zone (mins), (B) time in the center zone (mins), (C)
the index of thigmotaxis, and (D) the number of center zone entries.

Comparison plots of the OFT group results for (A) time in outer zone (mins), (B) time in center
zone (mins), (C) the index of thigmotaxis, and (D) the number of center zone entries among
impact recovery groups mTBI3 (n=12) and RSC3 (n=10), mTBI7 (n=11), and RSC7 (n=11), and
control groups, Sham3 (n=12), RSham3 (n=9), Sham7 (n=12), RSham7 (n=12) was used to assess
anxiety-like behavior. Fisher's LSD method indicated groups RSham3 and RSC3 spending a
significantly greater amount of time in the outer zone upon recovery time compared to baseline
measurements. Alternatively, group mTBI3 spent a significantly reduced amount of time in the
center zone upon recovery time compared to baseline. No differences were seen between injury
and sham groups with respect to thigmotaxis index and number of center zone entries. An
asterisk (*) denotes a significant difference (p<0.05). Plots show the mean (symbols) and the
standard error of the mean (error bars).

Lastly, no significant differences were observed between injury and their associated sham
groups, regardless of recovery time, with respect to the number of center zone entries (Figure
5.4D). However, within the 3-day recovery animal groups, on average, group mTBI3 entered the
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center zone a significantly greater amount of time than Sham3 rats (p=0.042) (Table 5.3).
Moreover, on average, group mTBI7 entered the center zone a significantly greater amount of
time than RSC7 injury rats (p=0.030) (Table 5.4). Fisher's LSD test also indicated, on average,
the 3-day recovery group animals entered the center zone a significantly greater amount at
baseline compared to their 3-day recovery day (p=0.025) (Table 5.3). Alternatively, the 7-day
recovery animal groups, on average, transversed the center zone a significantly greater number
of times upon their recovery test day compared to their baseline test day (p=0.004) (Table 5.4).
Overall, these open field test results indicate that impact animals, regardless of recovery, were
not significantly different from sham in terms of general locomotive activity. Additionally, these
data indicate that injury groups result in negligible expression of anxiety-like behavior,
regardless of recovery time, as indicated by similarities in the thigmotaxis index and the number
of center zone entries when compared to shams.
5.3.2.2

Rotarod Test
A rotarod test was employed to investigate indications of altered sensory/locomotive

coordination due to injury and throughout recovery (3- and 7-days). According to the ANOVA
model, when comparing the differences in latency performance between animal groups, none
showed a significant interaction effect between treatment and day (Table 5.6). Interestingly,
when comparing the differences in latency time between treatment groups within the 3-day
recovery assigned animals, significant differences were present (Table 5.6). However, because
the two treatment groups showing significant differences in latency performance (mTBI3 vs
RSham3) were not between appropriate injury and sham groups, this finding was not discussed
further.
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When comparing the differences in latency time for all animals, regardless of group
assignment, by recovery groups, data showed a significant effect on the day of testing
(p<0.0001) and of trials (p<0.0001) (Table 5.6). The differences in latency performance between
3- and 7- day recovery groups have been summarized as the mean ± the standard error of the
mean in Tables 5.7 and 5.8, respectively.
Table 5.6

Rotarod ANOVA summary for the repeated measures design of all recovery
groups.

Recovery Animal
Groups

ANOVA For Repeated Measures Design

Trial
Treatment x Day
Treatment
Day
3-Day Groups
0.316
0.041 *
<.0001 *
<.0001 *
7-Day Groups
0.328
0.431
<.0001 *
<.0001 *
The p-values obtained from the mixed model ANOVA tests is presented. Significant differences
of the effect are indicated by an asterisk (*).
Table 5.7

Differences in latency (s) summary for 3-day recovery groups across all animals,
regardless of group assignment.

Effect

Differences in Latency (s) of Day 3 Recovery Groups
Trials by Day of Testing
Mean ± SEM

Day
Baseline
Recovery
-39.88 ± 6.16
ANOVA (p<0.0001) *
Trial
Trial 1
Trial 2
-23.60 ± 6.79
ANOVA (p=0.0007) *
Trial
Trial 1
Trial 3
-31.18 ± 6.79
ANOVA (p<0.0001) *
Trial
Trial 2
Trial 3
-7.58 ± 6.66
ANOVA (p=0.2565)
The mean ± standard error of the mean (SEM) of latency (s) for the differences between day
(baseline vs. recovery) and trials (1, 2, and 3) of all animals within the 3-day recovery groups,
mTBI3 (n=12), RSC3 (n=10), Sham3 (n=12), and RSham3 (n=9), during the rotarod test. The pvalue obtained from the ANVOA performed on each day of testing is presented. Significant
differences (p<0.05) between effects are denoted with one asterisk (*).
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Table 5.8

Differences in latency (s) summary for 7-day recovery groups across all animals,
regardless of group assignment.
Differences in Latency (s) of Day 7 Recovery Groups
Trials by Day of Testing
Mean ± SEM

Effect
Day
Baseline
Recovery
-44.51 ± 6.12
ANOVA (p<0.0001) *
Trial
Trial 1
Trial 2
-26.63 ± 5.39
ANOVA (p<0.0001) *
Trial
Trial 1
Trial 3
-36.76 ± 5.45
ANOVA (p<0.0001) *
Trial
Trial 2
Trial 3
-10.13 ± 5.41
ANOVA (p=0.0627)
The mean ± standard error of the mean (SEM) of latency (s) for the differences between day
(baseline vs. recovery) and trials (1, 2, and 3) of all animals within the 7-day recovery groups,
mTBI7 (n=11), RSC7 (n=11), Sham7 (n=12), and RSham7 (n=12), during the rotarod test. The pvalue obtained from the ANVOA performed on each day of testing is presented. Significant
differences (p<0.05) between effects are denoted with one asterisk (*).
According to Tables 5.7 and 5.8, on average, all animals, across trials and treatment,
performed significantly better on the day of recovery compared to baseline. Additionally, data
showed that on average, all rats, across treatment and recovery days, performed significantly
better on trials 2 and 3 compared to trial 1 (see Tables 5.7 and 5.8).
5.3.3

Histology
To investigate histological evidence of neuronal loss and neuroinflammation, positive

cell count analysis was performed for brain tissue sections to assess mature neurons, microglia,
and astrocytes using immunohistochemical markers NeuN, Iba-1, and GFAP, respectively.
Histological analysis was performed for the dentate gyrus (DG), cornu ammonis 1 (CA1), and
cornu ammonis 3 (CA3) subregions of the hippocampus. Histochemical assessment of H&E
tissue sections revealed no macroscopic lesions due to impact. Representative micrographs of
NeuN, GFAP, and Iba-1 tissue sections can be seen in Appendix E.2.1, E.2.2, and E.2.3,
respectively. Plots for NeuN (Figure 5.6), GFAP (Figure 5.7), and Iba-1 (Figure 5.8) analysis
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present the mean positive cell counts/mm2. Error bars represent the SEM. For all plots,
significance is denoted with one asterisk (*) indicative of a p-value smaller than 0.05 (p<0.05).
5.3.3.1

NeuN
Neuronal Nuclei (NeuN) was used as an immunohistochemical marker for mature

neurons. The number of positive cell counts/mm2 was used to analyze the proportion of mature
neuronal immunoreactivity within each brain hippocampal region of interest (DG, CA1, and
CA3) for each group as a measure of neuronal loss due to injury. Summary statistics for the
NeuN positive cell counts/mm2 measurements obtained for each region analyzed can be seen in
Table 5.7. Descriptive statistics of animal groups for each hippocampal region are displayed by
region of interest in Table 5.7. Representative micrographs for each region can be found in
Appendix E.2.1.
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Table 5.9
Brain Region

DG
ANOVA
(p=0.690)

CA1
ANOVA
(p=0.831)

CA3
ANOVA
(p=0.810)

NeuN positive cell count/mm2 summary.
Group

mTBI
RSC
Sham
RSham
mTBI
RSC
Sham
RSham
mTBI
RSC
Sham
RSham
mTBI
RSC
Sham
RSham
mTBI
RSC
Sham
RSham
mTBI
RSC
Sham
RSham

Day of
Recovery

3

7

3

7

3

7

Mean ± SEM

420.38 ± 8.33
423.63 ± 11.47
422.86 ± 10.35
431.67 ± 5.02
426.70 ± 5.76
421.18 ± 10.54
444.37 ± 13.95
419.21 ± 12.16
135.73 ± 5.91
130.63 ± 5.79
136.52 ± 2.28
130.29 ± 4.28
135.8 ± 3.95
136.02 ± 3.74
131.67 ± 3.51
142.87 ± 11.36
301.67 ± 10.44
282.62 ± 16
295.36 ± 9.85
281.83 ± 10.09
285.81 ± 11.97
310.3 ± 16.32
292.8 ± 12.98
285.34 ± 19.89

95% CI

Lower
401.82
397.67
400.08
420.09
414.02
397.98
413.68
392.11
122.72
117.52
131.50
120.43
127.11
127.79
123.94
117.56
278.69
246.42
273.69
258.57
259.47
274.39
264.24
241.03

Upper
438.95
449.58
445.63
443.25
439.39
444.37
475.06
446.30
148.74
143.73
141.54
140.15
144.49
144.26
139.41
168.17
324.65
318.81
317.04
305.09
312.14
346.21
321.36
329.65

Impact vs. Control
Mean Diff ± SEM

-2.48 ± 13.07
-8.04 ± 13.03

-17.67 ± 15.09
1.97 ± 16.02

-0.79 ± 6.33
0.34 ± 7.34

4.13 ± 5.29
-6.85 ± 11.53

6.31 ± 14.35
0.79 ± 19.42

-6.99 ± 17.65
24.96 ± 25.55

Summary of cell count of positive NeuN immunoreactivity within the DG, CA1, and CA3 for
impact recovery and their associated sham groups. For the mean differences ± SEM between
injury and their associated sham groups, comparisons were based on recovery time (e.g., mTBI3
vs. Sham3, RSC3 vs. RSham3, mTBI7 vs. Sham7, and RSC7 vs. RSham7). The p-value obtained
from ANOVA procedures is listed beneath each brain region title
Results from NeuN immunostaining indicated no significant differences between groups,
regardless of recovery time and region of interest, with respect to the number of NeuN positive
cells/mm2 (Figure 5.6). As a result, the NeuN positive cell count analysis showed no evidence of
neuronal loss in the hippocampus for DG, CA1, or CA3 (Figure 5.6A-C). Interestingly, though,
mean NeuN positive cells/mm2 analysis for the three hippocampal regions of interest yielded
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lower levels of positive NeuN immunoreactivity in the CA1 region (Figure 5.6B) than in the DG
(Figure 5.6A) and CA3 (Figure 5.6C) regions.
Finally, the number of NeuN positive cells/mm2 of NeuN immunoreactivity for the mTBI
group shows the greatest deviation from Sham with a larger mean number of NeuN positive
cells/mm2 with respect to the CA3 region at 3-DPI (Table 5.7). In that same region of interest,
the repeated SC injury group also shows a greater mean count of NeuN positive cells/mm2 than
RSham after 7-DPI (Table 5.7).

Figure 5.5

The number of positive NeuN cell counts/mm2 for(A) DG, (B) CA1, and (C) CA3.

Comparison plots of the cell count of positive NeuN immunoreactivity (number of NeuN+
cells/mm2). Data are presented as mean ± SEM for recovery groups Sham3, RSham3, mTBI3,
RSC3, Sham7, RSham7, mTBI7, and RSC7 in the (A) DG, (B) CA1, and (C) CA3.
5.3.3.2

GFAP
Glial fibrillary acidic protein (GFAP) was used as an immunohistochemical marker for

astrocytes. The number of positive cell counts/mm2 was used to analyze the proportion of GFAP
immunoreactivity within each brain region of interest for each group as a measure of astrogliosis.
Summary statistics for the GFAP positive cell counts/mm2 measurements obtained for each
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region of interest by animal groups were analyzed and can be seen in Table 5.8. Representative
micrographs for each region can be found in Appendix E.2.2.
Table 5.10
Brain Region

DG
ANOVA
(p=0.343)

CA1
ANOVA
(p=0.292)

CA3
ANOVA
(p=0.734)

GFAP positive cell count/mm2 summary.
Group

mTBI
RSC
Sham
RSham
mTBI
RSC
Sham
RSham
mTBI
RSC
Sham
RSham
mTBI
RSC
Sham
RSham
mTBI
RSC
Sham
RSham
mTBI
RSC
Sham
RSham

Day of
Recovery

3

7

3

7

3

7

Mean ± SEM

109.91 ± 10.81
107.91 ± 11.88
92.42 ± 12.08
127.91 ± 15.99
85.27 ± 11.00
88.34 ± 15.4
102.84 ± 11.15
113.46 ± 15.58
116.36 ± 13.32
101.12 ± 17.11
85.45 ± 13.62
124.52 ± 21.07
78.86 ± 11.83
87.32 ± 15.81
87.32 ± 15.81
119.92 ± 16.5
81.91 ± 10.97
88.2 ± 18.72
66.44 ± 10.79
84.98 ± 13.88
65.34 ± 11.53
70.05 ± 14.61
61.02 ± 9.02
79.99 ± 12.87

95% CI

Lower
86.11
81.02
65.83
91.03
61.05
54.44
78.30
78.75
87.04
62.41
55.47
75.94
52.83
52.52
72.55
83.16
57.76
45.02
42.69
52.97
39.97
37.89
41.17
51.30

Upper
133.71
134.79
119.00
164.78
109.48
122.23
127.38
148.16
145.68
139.83
115.42
173.10
104.90
122.12
139.92
156.68
106.06
131.37
90.20
116.99
90.71
102.20
80.88
108.68

Impact vs. Control
Mean Diff ± SEM

17.49 ± 16.21
-20.00 ± 19.66

-17.57 ± 15.66
-25.12 ± 21.93

30.91 ± 19.05
-23.40 ± 26.91

-27.37 ± 19.34
-32.60 ± 22.85

15.47 ± 15.39
3.22 ± 22.91

4.32 ± 14.64
-9.94 ± 19.62

Summary of cell count of positive GFAP immunoreactivity within the DG, CA1, and CA3 for
impact recovery and their associated sham groups. For the mean differences ± SEM between
injury and their associated sham groups, comparisons were based on recovery time (e.g., mTBI3
vs. Sham3, RSC3 vs. RSham3, mTBI7 vs. Sham7, and RSC7 vs. RSham7). The p-value obtained
from ANOVA procedures is listed beneath each brain region title.
Results from GFAP immunostaining also indicated no significant differences between
groups with respect to the number of GFAP positive cells/mm2 (Figure 5.7). Moreover, positive
cell count analysis of GFAP immunoreactivity did not indicate any injury group, regardless of
recovery, to be statistically significant from sham (Figure 5.7). Therefore, the GFAP positive cell
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count analysis showed no evidence of increased astrogliosis in the hippocampus for DG, CA1, or
CA3 (Figure 5.7A-C).
The trends observed for GFAP positive cells/mm2 analysis in CA1 were mimicked in
results obtained for the DG and CA1 region with respect to recovery days between animal
groups (Figure 5.7A-B). In the CA3 region, all 7-day recovery groups showed a decreasing trend
in GFAP immunoreactivity compared to 3-day recovery groups (Figure 5.7C). Overall, the post
hoc LSMeans Difference test indicated that, although insignificant, injury groups did not
consistently show increased expression of astrogliosis compared to their associated shams (Table
5.8 and Figure 5.7).

Figure 5.6

The number of positive GFAP cell counts/mm2 for (A) DG, (B) CA1, and (C)
CA3.

Comparison plots of the cell count of positive GFAP immunoreactivity (number of GFAP+
cells/mm2). Data are presented as mean ± SEM for recovery groups Sham3, RSham3, mTBI3,
RSC3, Sham7, RSham7, mTBI7, and RSC7 in the (A) DG, (B) CA1, and (C) CA3.
Notably, the mean positive cells/mm2 of GFAP immunoreactivity for mTBI groups show
the greatest deviation from sham with a larger mean positive cells/mm2 with respect to the CA1
and CA3 hippocampal regions after 3-days of recovery (Table 5.8). Conversely, RSC injury
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groups show the greatest deviation from RSham with a smaller mean GFAP positive cells/mm2
for the DG regions after a 3-day recovery and all hippocampal regions analyzed after 7-days of
recovery (Table 5.8). Finally, mean GFAP positive cells/mm2 analysis for the three hippocampal
regions of interest yielded lower levels of positive GFAP immunoreactivity in the CA3 region
(Figure 5.7C) than in the DG (Figure 5.7A) and CA1 (Figure 5.7B) regions.
Lastly, the trends observed for the GFAP positive cells/mm2 analysis in all three
hippocampal regions of interest were in agreeance with respect to recovery days between injury
and sham, except within the CA3 region where Sham7 showed a subtle decrease in GFAP
immunoreactivity but not within the DG and CA1 regions(Figure 5.7A-C).
5.3.3.3

Iba-1
Ionized calcium-binding adaptor molecule-1 (Iba-1) was used as an

immunohistochemical marker for microglia. The number of positive cell counts/mm2 was used to
analyze the proportion of Iba-1 immunoreactivity within the DG, CA1, and CA3 regions for each
group as a measure of microgliosis. Summary statistics for the Iba-1 positive cell counts/mm2
measurements obtained for each region can be seen in Table 5.9. Representative micrographs for
each region can be found in Appendix E.2.3.
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Table 5.11
Brain Region

DG
ANOVA
(p=0.151)

CA1
Welch’s
ANOVA
(p=0.022)

CA3
ANOVA
(p=0.351)

Iba-1 positive cell count/mm2 summary.
Group

mTBI
RSC
Sham
RSham
mTBI
RSC
Sham
RSham
mTBI
RSC
Sham
RSham
mTBI
RSC
Sham
RSham
mTBI
RSC
Sham
RSham
mTBI
RSC
Sham
RSham

Day of
Recovery

3

7

3

7

3

7

Mean ± SEM

186.66 ± 26.77
194.60 ± 32.18
118.76 ± 28.23
140.38 ± 34.29
145.43 ± 26.85
96.60 ± 13.24
160.48 ± 28.46
163.55 ± 17.92
164.83 ± 25.6
187.2 ± 29.35
78.99 ± 13.75
114.40 ± 11.37
115.75 ± 22.5
100.79 ± 14.99
133.87 ± 25.71
148.99 ± 18.24
162.42 ± 22.36
160.59 ± 25.94
94.37 ± 22.52
130.42 ± 30.64
108.70 ± 25.44
114.59 ± 27.09
152.13 ± 33.67
163.46 ± 19.35

95% CI

Lower
127.74
121.81
56.63
61.30
86.34
67.46
97.84
123.63
108.48
120.80
48.72
88.17
66.22
67.80
77.27
108.34
113.21
101.91
44.80
59.78
52.70
54.96
78.02
120.34

Upper
245.57
267.39
180.88
219.45
204.53
125.73
223.13
203.48
221.17
253.59
109.26
140.63
165.28
133.79
190.46
189.64
211.62
219.26
143.94
201.07
164.71
174.23
226.24
206.58

Impact vs. Control
Mean Diff ± SEM

67.90 ± 38.90
54.22 ± 46.99

-15.05 ± 39.13
-66.95 ± 22.02

85.84 ± 29.06
72.80 ± 32.84

-18.12 ± 34.17
-48.20 ± 23.45

68.05 ± 31.73
30.17 ± 39.89

-43.43 ± 42.203
-48.87 ± 33.852

Summary of cell count of positive Iba-1 immunoreactivity within the DG, CA1, and CA3 for
impact recovery and their associated sham groups. For the mean differences ± SEM between
injury and their associated sham groups, comparisons were based on recovery time (e.g., mTBI3
vs. Sham3, RSC3 vs. RSham3, mTBI7 vs. Sham7, and RSC7 vs. RSham7). The p-value obtained
from ANOVA procedures is listed beneath each brain region title.
In contrast to the positive cell counts/mm2 for GFAP (Table 5.8), analysis of the Iba-1
positive cell counts/mm2 showed significant differences between recovery day groups for the DG
and CA1 brain regions (Figure 5.8A-B) but not CA3 region (Figure 5.8C). Within the CA1
hippocampal regions, Fisher’s LSD test results indicated a significant reduction in the number of
Iba-1 positive cell counts/mm2 for the repeated subconcussive injury group after 7-days of
recovery compared to 3-days of recovery (p=0.006) (Figure 5.8B). Although insignificant,
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similar trends are expressed for the RSC group after 7-DPI within the DG and CA3 regions
(Figure 5.8A,C). Furthermore, results within the CA1 region also showed both injury groups
expressing significantly more positive Iba-1 cell counts/mm2 compared to their associated sham
groups (mTBI3 vs Sham3: p=0.004; RSC3 vs RSham3: p=0.0294) (Figure 5.8B). However, it
should be noted that the two injury groups were not statistically different from each other
(p=0.467).
Results indicated that after 3-days of recovery, peak expression of positive Iba-1 cell
counts/mm2 was achieved for both injury groups in all three hippocampal regions of interest
(Figure 5.8A-C). These results were unsurprising and agreed with other reports of increased
inflammation of microglial marker expression 3-DPI (Sandhir et al., 2008; G. Wang et al., 2013).
Within the 3-day recovery groups, the repeated SC impact group showed the highest
hippocampal expression of positive Iba-1 cells/mm2 within the DG (194.6 ± 32.18) and CA1
(187.2 ± 29.35) brain regions. Alternatively, the mTBI group displayed the greatest number of
positive Iba-1 cells/mm2 within the CA3 (162.42 ± 22.36) region after 3-DPI (Table 5.11). Mean
positive cells/mm2 of Iba-1 immunoreactivity at 7-DPI showed that the RSham group exhibited
the highest hippocampal expression that was most apparent within DG (163.55 ± 17.92, Table
5.11).
Mean positive cells/mm2 of Iba-1 immunoreactivity for the mTBI group showed the
greatest deviation from Sham, with a larger mean positive cells/mm2 with respect to all
hippocampal regions after 3-days of recovery (Table 5.11). Alternatively, the RSC injury group
shows the greatest deviation from RSham with a smaller mean Iba-1 positive cells/mm2 for all
hippocampal regions analyzed after 7-days of recovery (Table 5.11).
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Figure 5.7

The number of positive Iba-1 cell counts/mm2 for (A) DG, (B) CA1, and (C) CA3.

Comparison plots of the cell count of positive Iba-1 immunoreactivity (number of Iba-1+
cells/mm2). Data are presented as mean ± SEM for recovery groups Sham3, RSham3, mTBI3,
RSC3, Sham7, RSham7, mTBI7, and RSC7 in the (A) DG, (B) CA1, and (C) CA3.
Finally, the trends observed for the Iba-1 positive cells/mm2 analysis in all three
hippocampal regions of interest were in agreeance with respect to recovery days between
experimental groups (Figure 5.8).
5.4

Discussion
A large body of literature, including several in-depth review articles, suggests that RSC

head impacts over an extended period may cumulatively induce significant structural and
functional changes to the brain (Bailes et al., 2013; Koerte et al., 2015; Mainwaring et al., 2018;
Moore et al., 2017). Although there has been recent interest in the cumulative effects of
subconcussive impacts (Rawlings et al., 2020), limited discovery has been performed to
determine the pathophysiological consequences (Bree, Stratton, et al., 2020; Gangolli et al.,
2019; Hiles-Murison et al., 2021; Lavender et al., 2020; Long, 2017; Sagarkar et al., 2017;
Wilson, 2019). As such, the present study utilized, for the first time, a rat model to investigate
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the comparative pathodynamics between a single concussive impact and RSC head impacts with
subdivided cumulative energy of the single concussive impact extending over multiple time
points.
5.4.1

Behavioral Alterations Due to Impact
In order to explore potential behavioral deficits following a single concussive and

repeated SC impact, the open field (general locomotor activity and anxiety-like behavior) and
rotarod (motor function) tests were utilized.
5.4.1.1

General Locomotor Activity
In general, animals with head trauma will be less active and have lower ambulatory

activity (Bree, Stratton, Levy 2020; Beitchman et al., 2020; Budde et al., 2013; Schwerin et al.,
2017; L. Y. Yang et al., 2016). This is typically associated with decreased total distance traveled
and movement time measurements assessed in the open field test. In the present study, injured
rats were no different than shams at 3- and 7-days after injury on measures of locomotive activity
in the open field (Figure 5.3). However, we did see a decrease in mobility upon recovery among
the mTBI3 animal group compared to baseline (Figure 5.3). This decrease in mobility could an
indication of memory loss due to injury whereas group Sham3 showed no signs of change in
mobility following recovery. Future analysis exploring this hypothesis would be needed to
confirm the previous statement.
In previous studies, deficits in locomotive activity following a single mTBI have been
reported in rodent models up to 14-DPI (Bodnar et al., 2019; Bree & Levy, 2018; Fromm et al.,
2004; Mychasiuk et al., 2014, 2015, 2016; Sharma et al., 2014). Alternatively, other rodent
models of head trauma reported unaffected general locomotor activity utilizing the open field test
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(Bodnar et al., 2019; Ritter et al., 2021; Washington et al., 2012; Shultz et al., 2011; Taib et al.,
2017; Almeida-Suhett et al., 2014). Additionally, a finite number of studies have been done for
repeated subconcussive injury models and their role in locomotor activity deficits (D Bree,
Stratton, et al., 2020; Wilson, 2019; Gangolli et al., 2019).
5.4.1.2

Anxiety-Like Behavior
Similarly seen with measurements of locomotive activity, evaluation of anxiety states by

using the open field test did not show distinct differences in anxiety-like behavior between sham
and injured rats. Interestingly, though, our results did show group mTBI3 spending significantly
less time in the center zone following impact compared to baseline measurements (Figure 5.4).
Outside of individual variations within the mTBI3 animal group’s measurements at baseline, we
are unsure of this change in behavior over time. Furthermore, even though the injury groups
were not statistically significant from their associated sham groups, our data does indicate injury
groups, on average, to be statistically different from each other with respect to time spent in the
outer zone of the open field test (Tables 5.3-5.4). Thus, this is the study’s first evidence of
pathodynamic differences resulting from a single impact of an mTBI and repeated SC impacts
with subdivided cumulative kinetic energies (KEs) equal to the single mTBI impact.
Although our results following the single concussive group do not replicate the majority
of literature (D Bree, Mackenzie, et al., 2020; Sagarkar et al., 2017; Beitchman et al., 2020;
Almeida-Suhett et al., 2014; Namjoshi et al., 2017; Kosari-Nasab et al., 2019; Meyer et al.,
2012), they do agree with other reports of insignificant evidence of anxious-like behavior
compared to sham observed up to 7-days following a single mTBI (Taib et al., 2017; Beitchman
et al., 2020; Nichols et al., 2016). Furthermore, a limited number of studies have investigated
evidence of anxious-like behavior due to repeated subconcussive injury models (Sagarkar et al,
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2017; Gangolli et al., 2019; Wilson, 2019). Among these, two experiments report no differences
in anxiety-related behavior in rats receiving repetitive subconcussive injuries compared to shams
(Gangolli et al., 2019; Wilson, 2019). Thus, our results in the RSC group do replicate the
majority of those reported in the literature.
5.4.1.3

Motor Coordination
Our study employed the rotarod test as a proxy of motor function and coordination. We

observed that neither injury groups led to significant motor deficits. As previously examined in
Chapter IV’s discussion (see 4.4.1.3), the effects of mild TBI on neuromotor function in rodents
are inconsistent in terms of impact intensity (Namjoshi et al., 2017; Sauerbeck et al., 2018).
Alternatively, our findings agree with the majority of preclinical models of repeated SC injuries
reveal a lack of neuromotor impairment (Hiles-Murison et al., 2021; Wilson, 2019).
Our present and previous (see Chapter IV) models of a mild TBI could be too benign to
show deficits in the less-sensitive task used to assess motor coordination which is typically used
in mild head injury models. It is also possible that the rotarod test is not a completely effective
means of studying motor coordination post-concussion. There are separate motor coordination
tasks such as the foot fault test and balance beam task that could be used in future studies to try
to better assess motor coordination following a single mild head injury. Overall, this study’s
investigative model of a single concussion and repeated subconcussive injuries was insufficient
to produce short-term behavioral deficits at 3- and 7-DPI.
5.4.2

Role of Neuroinflammation
As seen in many cases of an mTBI, the injury may result in damaged neurons, neuronal

death, axonal injury, disruption to the blood-brain barrier, and other changes in the extracellular
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space, such as ionic fluctuations, that are detected by, and activate, microglia (Eyolfson et al.,
2020; Sofroniew & Vinters, 2010; Wofford et al., 2019; Yi & Hazell, 2006). Upon activation,
microglia undergo a morphological change, taking on an amoeboid shape, and scavenge the
central nervous system producing and releasing pro-inflammatory cytokines, chemokines, and
free radicals (Kumar & Brain, 2012; Chiu et al., 2016; Aihara et al., 2009). As activated
microglia congregate to the injury sites, clearance of cellular debris (i.e., broken myelin or
cellular membranes) and toxic substances become the main role of these cells, known as
phagocytosis (Chiu et al., 2016). Similarly, astrocytes are also involved in neuroinflammation,
undergoing a morphological change known as reactive astrogliosis that involves cellular
hypertrophy, lengthened processes, increased expression of GFAP, and the production/release of
pro-inflammatory mediators (Sofroniew & Vinters, 2010; Zhang et al., 2010).
In the present study, we evaluated evidence of neuronal loss and neuroinflammation up to
7-days following a single mTBI and repeated SC impacts. To assess evidence of neuronal loss
and neuroinflammation occurring at an early stage following trauma, a marker of mature neurons
(NeuN), reactive astrocytes (GFAP), and microglia (Iba-1) was employed. All three
immunohistochemical tissue stains (NeuN, GFAP, and Iba-1) were quantitatively assessed
through the analysis of the positive cell counts of immunoreactivity within the DG, CA1, and
CA3 subregions of the hippocampus.
Results indicated that the number of NeuN positive cells/mm2 for both injury groups,
mTBI and RSC, following a 3- and 7-day recovery period, was approximately equal to their
associated sham groups for all three investigated brain regions indicating no evidence of
neuronal loss (Figure 5.6). Thus, these findings suggest that the investigative impact loads do not
lead to neuronal loss within the hippocampus at a subacute timeframe. Moreover, because the
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mTBI load magnitude investigated in the present study is within the lower end range found in
literature for rat CHI models that employed WDI devices (see Chapter 3’s Discussion Section),
our discovery of the absence of neuronal loss was somewhat expected. Likewise, previous work
from DeFord et al. (2002) showed similarly following a single episode of an mTBI (0.589 J),
repeated mild injury (cumulative input energy of 2.35 J) was associated with impairments in
spatial learning and cognition (Morris water maze) in mice despite the absence of observed cell
death in the cortex and hippocampus.
Our histological results also indicated that the number of GFAP positive cells/mm2 for
both injury groups, mTBI and RSC, following a 3- and 7-day recovery, was approximately equal
to that of their sham groups for all three brain regions indicating no evidence of astrogliosis
(Figure 5.7). This finding is paralleled by the work of Singh et al. (2016), who showed that
following a single mTBI (1.1 J) using a WDI device, GFAP+ cells were significantly increased
at 3- and 5-days following impact in the cortical gray matter but not in the hippocampus or
corpus callosum regions as compared to shams. It is hypothesized that the reason the injury
groups do not show a significant difference in GFAP immunoreactivity compared to their
associated shams is perhaps that the significant influx of reactive astrocytes, often recruited by
microglial cells (Liu et al., 2011; Jha et al., 2019), occurs at an alternative or later recovery time
point as similarly seen in Y. C. Chen et al. (2014). Using a controlled cortical impact (CCI) to
induce an mTBI on a murine model, a significant increase in GFAP expression occurred 8-days
following injury in the hippocampus & cortex brain regions compared to sham (Y. C. Chen et al.,
2014). Furthermore, it has been suggested by Eyolfson et al. (2020) that microglial are thought to
be the first responders to injury, followed by astrocytes, thereafter.
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As with the GFAP analysis results, neither injury group, regardless of recovery day,
revealed a significant difference from their associated sham group with respect to Iba-1
immunoreactivity within the DG and CA3 brain regions (Figure 5.8A, C). However, our data
indicated that following a 3-day recovery period, both mTBI and RSC injury groups revealed a
significant increase in microgliosis in tandem with minimal evidence of astrogliosis. After 7days of recovery, histological findings showed a significant decrease in microgliosis from the
RSC group compared to its 3-day recovery group within CA1 region (Figure 5.8B). It is
speculated that following this reducing shift in activated microglia cells, at a recovery time point
not investigated in the present study, astrocytes may subsequently become reactive and assemble
at the site of injury to aid in neurogenesis, synaptogenesis, and glial scar formation following
neurotrauma (Zhou et al., 2020).
5.5

Conclusion
We aimed to investigate the pathodynamic differences between a single mTBI and

repeated subconcussive impacts with subdivided cumulative KEs equal to the single mTBI
impact using a rat model. For this investigation, a weight drop injury platform was employed to
model a surgery-free, closed-head injury in rats. We utilized two impact magnitudes for
investigation, 1.0 J for the single, mild TBI group and 0.33 J for the repeated subconcussive
injury group for a total of 3 impacts with an inter-injury of 24 hrs (3 x 0.33 J ≈ 1.0 J). According
to literature, a single head impact around this magnitude (1.0 J) can induce subacute behavior
alterations (Bree, Mackenzie, et al., 2020) and neuroinflammation (Fraunberger et al., 2020;
Singh et al., 2016) in a rodent model. Thus, we anticipated our mTBI model would result in
transient evidence of behavioral dysfunction and neuroinflammation. Alternatively, for the
repeated SC injury model, since this is the first report of its kind using a rat model, the
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behavioral and histological outcomes were predicted to subtlety echo that of the mTBI
pathodynamics.
To this end, although there was no significant difference between injury and sham groups
with respect to behavioral disturbances, we identified one significant difference between the
injury groups with respect to behavioral outcomes. On average, a significant increase in anxiouslike behavior was seen in the RSC animal group compared to the single mTBI group after 7-days
of recovery. Thus, directed investigations into the specifics of this unique phenomenon would
greatly add to our understanding of functional disturbances resulting from the two injury groups.
Alternatively, from an neuroinflammatory perspective, both mTBI and RSC injury groups led to
extensive microgliosis in the gray matter following 3-days post-impact.
Overall, the present study revealed important aspects of the cumulative effects of SC
injuries. This work does not provide evidence in support of the notion that, upon recovery,
repeated subconcussive impacts do result in behavioral disturbances, that do not manifest
following a single mTBI of the same energy input. Therefore, as demonstrated, the repetitive
occurrence of low-level impacts, with a 0.33 J impact load and an inter-injury interval of 24 hrs
for a total of 3 impacts, do not lead to deleterious behavioral deficits following a 3- and 7- day
recovery period. However, RSC impacts do lead to neuroinflammation as early as 3-days postfinal impact, as similarly seen in the mTBI impact group.
Although a cumulative injury threshold for subconcussive impacts was not evident in the
current investigation, there still may be a threshold at which no pathodynamic shift occurs.
Future investigations would be necessary to explore evidence of a cumulative threshold. The
importance of this cannot be understated. Not only could this data inform low-level injury
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mitigation strategies, but it would directly affect treatment targets and the development of
therapeutic interventions.
One limitation of this study was the inability to histologically assess the corpus callosum
pathology, part of the white matter structure within the cerebral tissue, due to inconsistent
hemisphere cutting following extraction of the tissue. This limitation prevented analysis of a
white matter damage due to injury and restricted analysis to deeper gray matter parenchymal
structures. Because there was limited evidence of inflammatory markers within the gray matter
hippocampal regions of the cerebral tissue, it would be beneficial to analyze a commonly
explored white matter region, such as the corpus callosum, where tracts of myelinated axons
reside.
Another constraint of this study was the limited recovery times explored. Due to financial
reasons, only two subacute recovery times were explored to investigate behavioral dysfunction
and inflammatory analysis. This may explain why there was no evidence of a significant increase
in positive GFAP cells/mm2 within the hippocampal regions. Understanding these limitations
will allow researchers to advance basic experimental properties, in an effort to produce findings
that have greater clinical relevance.
Future investigations would aim to address the current limitations and improve or expand
our current findings. For example, although 3- and 7-days recovery times are typically associated
with systematic perturbations following head injury (Bree, Stratton, et al., 2020; Ekmark-Lewén
et al., 2013; Fraunberger et al., 2020; Hsieh et al., 2017; Marschner et al., 2019; Singh et al.,
2016), we did not see evidence of increased astrogliosis following our injury profiles. One
hypothesis is that the significant influx of reactive astrocytes might occur at a recovery time
point not currently investigated. Perhaps an increase in astrogliosis for a single mTBI impact,
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with a 1.0 J impact load, and repeated SC impacts, with a 0.33 J impact load with an inter-injury
interval of 24 hrs for a total of 3 impacts, occurs at an alternative recovery time point, e.g. 0.5-,
1-, 10-, 14-, 21-, or 30-days. Adding acute (0-24 hours), subacute (1-14 days), and long-term (>
14 days) recovery time points would provide further insight into understanding the
neuropathological response following concussive and subconcussive injuries of the same
cumulative impact magnitude. Alternatively, it could be because the total impact magnitude
(~1.0 J) was too benign to cause an increase in reactive astrocytes. Targeted investigations would
need to be explored to confirm these hypotheses. Additionally, the inclusion of cytokine and
chemokine analysis would also expand our understanding of neuroinflammatory signaling
dynamics.
Moreover, including neuronal degeneration analysis would shed light on our current
findings. Our histological results showed no evidence of neuronal loss due to injury. However,
there was evidence of increased microgliosis within the gray matter, namely the CA1
hippocampal region, following a single mTBI and repeated SC injury. This increased number of
Iba-1 cells/mm2 observed in both injury groups may imply disruption of neurons. Thus, it may be
interesting to include histological analysis of neuronal degeneration to further complement our
inflammatory findings.
Furthermore, the addition of behavioral assays traditionally associated with motor
coordination such as the balance beam test and foot fault test would be beneficial in growing our
understanding of the current behavioral findings. These would provide additional assays that
might be more sensitive to a single mild TBI impact.
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Figure A.1

IACUC approval letter for experimental studies.
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APPENDIX B
PILOT STUDY: IRREGULAR STAINING OF GFAP AND IBA-1 SLIDES

153

B.1

Methods
Each GFAP and Iba-1 immunostained tissue section on a slide was scanned using a

PathScan Enabler 5 (Meyer Instruments, Houston, TX, USA) whole slide scanner and then
processed in HistoView software, (Pacific Image Electronics Inc., CA USA). Representative
images for GFAP and Iba-1 immunostained tissue sections were selected based on tissue sections
with uneven staining across the tissue. The scans were not used for analytical purposes but
allowed spatial context for visualization of unevenness in staining.
B.2

Results
Figures B.1 and B.2 show representative GFAP and Iba-1 immunostained tissue images

from each experimental group of the pilot study. As seen in each representative image (Figure
B.1 and B.2), there is noticeable unevenness in staining. Visually, the proportion of GFAP+
(brown colored stain) often varied between cerebral hemispheres (Figure B.1a, b, and f), while
other sections showed disproportion of staining at an angle (Figure B.1c, d, and e). Similarly, the
proportion of Iba-1+ also showed inconsistencies at an angle (Figure B.2).
As a result, a criterion was set to determine the appropriate tissue section and hemisphere
of the cerebral tissue for properly stained regions of interest (DG, CA1, and CA3). The criteria
for selecting the appropriate section and hemisphere of the cingulum were based on the stained
areas that had evidence of correctly stained internal control (cells around blood vessels).
Whichever section and hemisphere met this criterion, was marked for moving forward with cell
count image analysis.
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Figure B.1

Representative GFAP micrographs (4x) of each group according to recovery days
that show disproportion in GFAP+ staining.

Micrographs (4x) of GFAP expression at 3- (a, c, and e) and 7-DPI (b, d, and f) for sham, high
(0.5J), and low (0.2J) impact recovery groups.

155

Figure B.2

Representative Iba-1 micrographs (4x) of each group according to recovery days
depicting the irregularity of Iba-1+ staining.

Micrographs (4x) of Iba-1 expression at 3- (a, c, and e) and 7-DPI (b, d, and f) for sham, high
(0.5J), and low (0.2J) impact recovery groups.
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APPENDIX C
PILOT STUDY: REPRESENTATIVE MICROGRAPHS FOR GFAP AND IBA-1
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C.1

Methods
Representative micrographs (20x magnification) for GFAP and Iba-1 immunostained

tissue sections were selected based on tissue sections with a positive cell count measurement
most representative of the mean positive cell count for each group. Selected representative 20x
magnification micrographs are presented for injury (High3, Low3, High7, and Low7) and sham
groups (Sham3 and Sham7) for each hippocampal region of interest (DG, CA1, and CA3) for
both Iba-1 and GFAP in conjunction with a representative 4x magnification image for reference.
For this section, animal groups are labeled as follows: High-load impact groups (0.5 J mTBI),
Low-load impact groups (0.2 J mTBI), and Sham recovery groups (Sham). Lastly, the 4x
magnification micrograph was not used for analytical purposes but allows spatial context for
higher magnification micrographs.
C.2
C.2.1

Results
GFAP Micrographs
Representative GFAP micrographs at 4x magnification are presented for DG (Figure

C.1a), CA1 (Figure C.2a), and CA3 (Figure C.3a) with a representative imaging location for
each indicated with a black box. The average number of positive GFAP cells for all sample
images of the hippocampal regions of interest were referred to in selecting representative 20x
magnification micrographs. For each representative GFAP 20x magnification micrograph, a
representative astrocyte expressing positive GFAP immunoreactivity is indicated by a black
arrow.
Despite the unevenness in staining (Appendix B), the representative GFAP micrographs
(20x magnification) of each region of interest illustrate that the sections were able to undergo
158

image analysis of immunoreactivity of astrocytes via cell count. As seen in the number of
positive cells plot for DG (Figure 4.10a), the representative micrographs (20x magnification)
shown in Figure E.1b-g do not show observable differences between groups by or between
recovery days. Furthermore, this is confirmed visually, as the proportion of GFAP+ (brown
colored stain) is not different between recovery groups (Figure C.1d-g) or sham (Figure C.1b-c),
regardless of recovery day.
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Figure C.1

Representative GFAP micrographs of DG.

Rats were subjected to sham or closed-head mTBI impact (either 0.5 or 0.2 J) and euthanized at
3- or 7-DPI. The (a) location of the DG representative images is presented using 4x
magnification with a 500μm scale bar. Micrographs (20x) of GFAP expression in dentate gyrus
region at 3- (b, d, and f) and 7-DPI (c, e, and g) for sham, high (0.5J), and low (0.2J) impact
recovery groups with a 100μm scale bar. A representative astrocyte expressing positive GFAP
immunoreactivity is indicated for each 20x magnification micrograph by a black arrowhead.
Figure C.2 shows a representative GFAP micrograph of the hippocampus at 4x
magnification with a representative CA1 imaging location indicated by a black box. While the
representative 20x magnification micrographs of CA1 visually reflect significant variations of
the intensity/darkness of the DAB stain in injury groups (see Figures C.2e,f), the reader must
understand that the measurements were based off positive cell counts of GFAP rather than
staining intensity. As such, data indicated no significant variations of GFAP positive cell count
analysis within the CA1 region between all experimental groups, regardless of recovery day.
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Figure C.2

Representative GFAP micrographs of CA1.

Rats were subjected to sham or closed-head mTBI impact (either 0.5 or 0.2 J) and euthanized at
3- or 7-DPI. The (a) location of the representative images is presented using 4x magnification
with a 500μm scale bar. Micrographs (20x) of GFAP expression in CA1 region at 3- (b, d, and f)
and 7-DPI (c, e, and g) for sham, high (0.5J), and low (0.2J) impact recovery groups with a
100μm scale bar. A representative astrocyte expressing positive GFAP immunoreactivity is
indicated for each 20x magnification micrograph by a black arrowhead.
Figure C.3 shows a representative GFAP micrograph of the hippocampus at 4x
magnification with a representative CA3 imaging location indicated by a black box. Again, the
representative 20x magnification micrographs of CA3 visually reflect the insignificant variations
seen in the GFAP positive cell count analysis of CA3 (Figure 4.10c) when comparing injury
(Figure C.3d-g) and sham (Figure C.3b-c) groups, regardless of recovery day.
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Figure C.3

Representative GFAP micrographs of CA3

Rats were subjected to sham or closed-head mTBI impact (either 0.5 or 0.2 J) and euthanized at
3- or 7-DPI. The (a) location of the representative images is presented using 4x magnification
with a 500μm scale bar. Micrographs (20x) of GFAP expression in CA3 region at 3- (b, d, and f)
and 7-DPI (c, e, and g) for sham, high (0.5J), and low (0.2J) impact recovery groups with a
100μm scale bar. A representative astrocyte expressing positive GFAP immunoreactivity is
indicated for each 20x magnification micrograph by a black arrowhead.
C.2.2

Iba-1 Micrographs
Similarly seen in GFAP immunostained tissue images immunostained tissue

images(Figure B.1), Iba-1 immunostained tissue images also showed evidence of disproportional
staining (Figure B.2). Still, representative Iba-1 micrographs (20x magnification) of the three
regions of interest illustrated that the sections were able to undergo image analysis of
immunoreactivity of microglia via positive cell count. Representative Iba-1 micrographs at 4x
magnification are presented for DG (Figure C.4a), CA1 (Figure C.5a), and CA3 (Figure C.6a)
with a representative imaging location for each indicated with a black box. A representative
astrocyte expressing positive Iba-1 immunoreactivity is indicated for each 20x magnification
micrograph by a black arrow.
The proportion of positive Iba-1 immunoreactivity (brown color) within the DG tissue
section did not show significant differences between groups within recovery groups as well as

165

between recovery day groups (Figure 4.11a).

166

167

Figure C.4

Representative Iba-1 micrographs of DG.

Rats were subjected to sham or closed-head mTBI impact (either 0.5 or 0.2 J) and euthanized at
3- or 7-DPI. The (a) location of the representative images is presented using 4x magnification
with a 500μm scale bar. Micrographs (20x) of Iba-1 expression in dentate dyrus region at 3- (b,
d, and f) and 7-DPI (c, e, and g) for sham, high (0.5J), and low (0.2J) impact recovery groups
with a 100μm scale bar. A representative microglial cell expressing positive Iba-1
immunoreactivity is indicated for each 20x magnification micrograph by a black arrowhead.
Figure C.5 shows a representative Iba-1 micrograph of the hippocampus at 4x
magnification with a representative CA1 imaging location indicated by a black box. As seen in
the number of positive cells plot for CA1 (Figure 4.11b), the representative micrographs (20x
magnification) shown in Figure C.5b-g do not show observable differences between groups by or
between recovery days. Furthermore, this is confirmed visually, as the proportion of Iba-1+ cells
(brown colored stain) are not different between recovery groups (Figure C.5d-g) or sham (Figure
C.5b-c), regardless of recovery day.
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Figure C.5

Representative Iba-1 micrographs of CA1.

Rats were subjected to sham or closed-head mTBI impact (either 0.5 or 0.2 J) and euthanized at
3- or 7-DPI. The (a) location of the representative images is presented using 4x magnification
with a 500μm scale bar. Micrographs (20x) of Iba-1 expression in CA1 region at 3- (b, d, and f)
and 7-DPI (c, e, and g) for sham, high (0.5J), and low (0.2J) impact recovery groups with a
100μm scale bar. A representative microglial cell expressing positive Iba-1 immunoreactivity is
indicated for each 20x magnification micrograph by a black arrowhead.
Although not easily appreciated by the representative Iba-1 micrographs (20x
magnification) for CA3, on average the proportion of positive Iba-1 immunoreactivity for the 7day recovery high impact group (Figure C.6e) was notably greater than the 3-day recovery high
impact group (Figure C.6d). Notably, with respect to the proportion of Iba-1 immunoreactivity
(brown colored stain, not intensity/darkness of stain), the representative CA1 micrographs of the
high-load impact recovery groups are not easily reflected visually. This difficulty in visual
observation might be due to the low intensity/staining of positive cells for Iba-1
immunoreactivity, and thus does not adequately reflect the results obtained for cell count
analysis of CA3 (Figure 4.11c).
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Figure C.6

Representative Iba-1 micrographs of CA3.

Rats were subjected to sham or closed-head mTBI impact (either 0.5 or 0.2 J) and euthanized at
3- or 7-DPI. The (a) location of the representative images is presented using 4x magnification
with a 500μm scale bar. Micrographs (20x) of Iba-1 expression in CA3 region at 3- (b, d, and f)
and 7-DPI (c, e, and g) for sham, high (0.5J), and low (0.2J) impact recovery groups with a
100μm scale bar. A representative microglial cell expressing positive Iba-1 immunoreactivity is
indicated for each 20x magnification micrograph by a black arrowhead.
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APPENDIX D
PILOT STUDY: MULTIPLEX ASSAY PLATE SET UP AND RESULTS

173

D.1

Methods

Table D.1

Procartaplex Plate Setup.
1
Std1

3
4
5
6
7
8
9
A
H3_1
H3_3
L3_3
S3_3
H7_2 L7_2 S7_2
HPC
MC
HPC
HPC
MC
HPC HPC
B
Std2
Std2
H3_1
L3_1
L3_3
S3_3
H7_3 L7_2 S7_2
HPC
HPC
MC
HPC
HPC
MC
MC
C
Std3
Std3
H3_1
L3_1
S3_1
S3_3
H7_3 L7_3 S7_3
MC
HPC
HPC
MC
HPC
HPC HPC
D
Std4
Std4
H3_2
L3_1
S3_1
H7_1
H7_3 L7_3 S7_3
HPC
MC
MC
HPC
MC
HPC HPC
E
Std5
Std5
H3_2
L3_2
S3_1
H7_1
H7_3 L7_3 S7_3
HPC
HPC
MC
HPC
MC
MC
MC
F
Std6
Std6
H3_2
L3_2
S3_2
H7_1
L7_1 S7_1
MC
HPC
HPC
MC
HPC
HPC
G
Std7
Std7
H3_3
L3_2
S3_2
H7_2
L7_1 S7_1
HPC
MC
HPC
HPC
HPC
HPC
H
Std8
Std8
H3_3
L3_3
S3_2
H7_2
L7_1 S7_2
HPC
HPC
MC
MC
MC
HPC
Note, H3, L3, S3, H7, L7, and S7 represents High3, Low3, Sham3, High7, Low7, and Sham7
group animals, respectively. Furthermore, HPC and MC represent tissue from the hippocampus
and motor cortex regions, respectively.
D.2

2
Std1

Results

Table D.2
Plate Location
A1 & A2
B1 & B2
C1 & C2
D1 & D2
E1 & E2
F1 & F2
G1 & G2z
A3
B3
C3
D3
E3
F3
G3
H3
A4
B4
C4

Level of detection for analytes, IL-6, TNF-α, and IL-10 from pilot study.
Well/Animal Information
Avg Standard 1
Avg Standard 2
Avg Standard 3
Avg Standard 4
Avg Standard 5
Avg Standard 6
Avg Standard 7
H3_1 HPC
H3_1 HPC
H3_1 MC
H3_2 HPC
H3_2 HPC
H3_2 MC
H3_3 HPC
H3_3 HPC
H3_3 MC
L3_1 HPC
L3_1 HPC

IL-6 (pg/ml)
NA
NA
513.989
173.958
NA
14.917
64.266
<0
12.681
<0
<0
NaN
<0
<0
<0
<0
3.035
8.405
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TNFα (pg/ml)
NA
NA
2899.686
291.984
68.025
13.503
5.288
<0
<0
NaN
NaN
0.852
<0
0.727
<0
0.52
<0
NaN

IL-10 (pg/ml)
Invalid curve fit
Invalid curve fit
Invalid curve fit
Invalid curve fit
Invalid curve fit
Invalid curve fit
Invalid curve fit
NA
NA
NaN
NaN
NA
NA
NA
NA
NA
NA
NaN

Table E.2 (continued)
D4
E4
F4
G4
H4
A5
B5
C5
D5
E5
F5
G5
H5
A6
B6
C6
D6
E6
F6
G6
H6
A7
B7
C7
D7
E7
F7
G7
H7
A8
B8
C8
D8
E8
F8
G8
H8
A9
B9
C9
D9
E9

L3_1 MC
L3_2 HPC
L3_2 HPC
L3_2 MC
L3_3 HPC
L3_3 HPC
L3_3 MC
S3_1 HPC
S3_1 MC
S3_1 MC
S3_2 HPC
S3_2 HPC
S3_2 MC
S3_3 HPC
S3_3 HPC
S3_3 MC
H7_1 HPC
H7_1 HPC
H7_1 MC
H7_2 HPC
H7_2 MC
H7_2 MC
H7_3 HPC
H7_3 HPC
H7_3 MC
H7_3 MC
L7_1 HPC
L7_1 HPC
L7_1 MC
L7_2 HPC
L7_2 MC
L7_3 HPC
L7_3 HPC
L7_3 MC
S7_1 HPC
S7_1 HPC
S7_2 HPC
S7_2 HPC
S7_2 MC
S7_3 HPC
S7_3 HPC
S7_3 MC

<0
<0
NaN
<0
<0
<0
55.287
NaN
<0
0.63
32.516
32.516
<0
<0
201.899
NaN
NaN
<0
<0
<0
<0
<0
1.792
<0
<0
11.238
<0
<0
14.14
<0
<0
<0
NaN
NaN
56.952
<0
<0
27.799
<0
<0
8.405
53.625

<0
NaN
NaN
1.743
<0
<0
0.267
1.402
<0
<0
<0
<0
<0
<0
<0
<0
NaN
<0
<0
<0
<0
<0
1.193
<0
<0
<0
<0
<0
0.157
NaN
<0
NaN
NaN
NaN
<0
<0
<0
<0
<0
<0
<0
<0

NA
NaN
NaN
NA
NA
NA
NA
NaN
NaN
NaN
NA
NA
NA
NA
NA
NA
NaN
NA
NaN
NA
NA
NA
NaN
NA
NA
NA
NA
NA
NA
NaN
NA
NA
NaN
NaN
NA
NA
NA
NaN
NA
NA
NA
NA

Under “Well/Animal Information,” H3, L3, S3, H7, L7, and S7 represents High3, Low3, Sham3,
High7, Low7, and Sham7 group animals, respectively. Furthermore, HPC and MC represent
tissue from the hippocampus and motor cortex regions, respectively.
All IL-1, IL-10, and Tumour necrosis factor alpha values for injury and sham groups
were below threshold for detection for each recovery time in the study.
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APPENDIX E
FULL STUDY: REPRESENTATIVE MICROGRAPHS FOR NEUN, GFAP, AND IBA-1
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E.1

Methods
Representative micrographs (20x magnification) for NeuN, GFAP and Iba-1

immunostained tissue sections were selected based on tissue sections with a positive cell count
measurement most representative of the mean positive cell count for each group. Selected
representative 20x magnification micrographs are presented for injury (mTBI3, RSC3, mTBI7,
and RSC7) and sham groups (Sham3, RSham3, Sham7, and RSham 7) for each hippocampal
region of interest (DG, CA1, and CA3) for all three stains in conjunction with a representative 4x
magnification image for reference. The 4x magnification micrograph was not used for analytical
purposes but allows spatial context for higher magnification micrographs.
E.2
E.2.1

Results
NeuN Micrographs
Representative NeuN micrographs at 4x magnification are presented for DG (Figure

E.1a), CA1 (Figure E.2a), and CA3 (Figure E.3a) with a representative imaging location for each
indicated with a black box. The average number of positive NeuN cells for all sample images of
the hippocampal regions of interest were referred to in selecting representative 20x magnification
micrographs. For each representative NeuN 20x magnification micrograph, a representative
neuron expressing positive NeuN immunoreactivity is indicated by a black arrow.
As seen in the number of positive cells plot for the DG, CA1, and CA3 regions (Figure
5.6A-C), the representative micrographs (20x magnification) shown in Figures E.1-3b-i do not
show observable differences between groups by or between recovery days. Furthermore, this is
confirmed visually, as the proportion of NeuN+ (brown colored stain) is not different between
injury (Figure E.1-3f-i) or sham (Figure E.1-3b-e) groups, regardless of recovery day.
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Figure E.1

Representative NeuN micrographs of DG.

Rats were subjected to sham or closed-head impact(s) and euthanized at either 3- or 7-DPI. The
(a) location of the DG representative images is presented using 4x magnification with a 500μm
scale bar. Micrographs (20x) of NeuN expression in dentate gyrus region at 3- (b, d, f, and h) and
7-DPI (c, e, g, and i) for Sham, RSham, mTBI, and RSC impact recovery groups with a 100μm
scale bar. A representative neuron expressing positive NeuN immunoreactivity is indicated for
each 20x magnification micrograph by a black arrowhead.
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Figure E.2

Representative NeuN micrographs of CA1.

Rats were subjected to sham or closed-head impact(s) and euthanized at either 3- or 7-DPI. The
(a) location of the CA1 representative images is presented using 4x magnification with a 500μm
scale bar. Micrographs (20x) of NeuN expression in CA1 region at 3- (b, d, f, and h) and 7-DPI
(c, e, g, and i) for Sham, RSham, mTBI, and RSC impact recovery groups with a 100μm scale
bar. A representative neuron expressing positive NeuN immunoreactivity is indicated for each
20x magnification micrograph by a black arrowhead.
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Figure E.3

Representative NeuN micrographs of CA3.

Rats were subjected to sham or closed-head impact(s) and euthanized at either 3- or 7-days postinjury. The (a) location of the CA3 representative images is presented using 4x magnification
with a 500μm scale bar. Micrographs (20x) of NeuN expression in CA3 region at 3- (b, d, f, and
h) and 7-days (c, e, g, and i) post-injury for Sham, RSham, mTBI, and RSC impact recovery
groups with a 100μm scale bar. A representative neuron expressing positive NeuN
immunoreactivity is indicated for each 20x magnification micrograph by a black arrowhead.
E.2.2

GFAP Micrographs
Representative GFAP micrographs at 4x magnification are presented for DG (Figure

E.4a), CA1 (Figure E.5a), and CA3 (Figure E.6a) with a representative imaging location for each
indicated with a black box. The average number of positive GFAP cells for all sample images of
the hippocampal regions of interest were referred to in selecting representative 20x magnification
micrographs. For each representative GFAP 20x magnification micrograph, a representative
neuron expressing positive GFAP immunoreactivity is indicated by a black arrow.
As seen in the number of positive cells plot for the DG, CA1, and CA3 regions (Figure
5.7A-C), the representative micrographs (20x magnification) shown in Figures E.4-6b-i do not
show observable differences between groups by or between recovery days. Furthermore, this is
confirmed visually, as the proportion of GFAP + (brown colored stain) is not different between
injury (Figure E.4-6f-i) or sham (Figure E.4-6b-e) groups, regardless of recovery day.
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Figure E.4

Representative GFAP micrographs of DG.

Rats were subjected to sham or closed-head impact(s) and euthanized at either 3- or 7-days postinjury. The (a) location of the DG representative images is presented using 4x magnification with
a 500μm scale bar. Micrographs (20x) of GFAP expression in dentate gyrus region at 3- (b, d, f,
and h) and 7-days (c, e, g, and i) post-injury for Sham, RSham, mTBI, and RSC impact recovery
groups with a 100μm scale bar. A representative neuron expressing positive GFAP
immunoreactivity is indicated for each 20x magnification micrograph by a black arrowhead.
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Figure E.5

Representative GFAP micrographs of CA1.

Rats were subjected to sham or closed-head impact(s) and euthanized at either 3- or 7-days postinjury. The (a) location of the CA1 representative images is presented using 4x magnification
with a 500μm scale bar. Micrographs (20x) of GFAP expression in CA1 region at 3- (b, d, f, and
h) and 7-days (c, e, g, and i) post-injury for Sham, RSham, mTBI, and RSC impact recovery
groups with a 100μm scale bar. A representative neuron expressing positive GFAP
immunoreactivity is indicated for each 20x magnification micrograph by a black arrowhead.
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Figure E.6

Representative GFAP micrographs of CA3.

Rats were subjected to sham or closed-head impact(s) and euthanized at either 3- or 7-days postinjury. The (a) location of the CA3 representative images is presented using 4x magnification
with a 500μm scale bar. Micrographs (20x) of GFAP expression in CA3 region at 3- (b, d, f, and
h) and 7-days (c, e, g, and i) post-injury for Sham, RSham, mTBI, and RSC impact recovery
groups with a 100μm scale bar. A representative neuron expressing positive GFAP
immunoreactivity is indicated for each 20x magnification micrograph by a black arrowhead.
E.2.3

Iba-1 Micrographs
Representative Iba-1 micrographs at 4x magnification are presented for DG (Figure

E.7a), CA1 (Figure E.8a), and CA3 (Figure E.9a) with a representative imaging location for each
indicated with a black box. The average number of positive Iba-1 cells for all sample images of
the hippocampal regions of interest were referred to in selecting representative 20x magnification
micrographs. For each representative Iba-1 20x magnification micrograph, a representative
neuron expressing positive Iba-1 immunoreactivity is indicated by a black arrow.
Figure E.7a shows a representative Iba-1 micrograph of the hippocampus at 4x
magnification with a representative DG imaging location indicated by a black box. Figure E.8a
shows a representative Iba-1 micrograph of the hippocampus at 4x magnification with a
representative CA1 imaging location indicated by a black box. Histological results shown
previously in Figure 5.8A reveal that the proportion of positive Iba-1 immunoreactivity (brown
color) within the DG tissue section showed significant differences between RSC injury groups
with respect to recovery. This is visually seen as the positively stained microglia evident in the
representative micrograph for the RSC3 (Figure E.7h) injury group is slightly more than that of
the RSC7 (Figure E.7i) injury group. Notably, although the representative micrographs for
groups mTBI3 and RSham3 look visibly weaker in positive Iba-1 immunoreactivity, this
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irregularity in staining intensity does not hinder the positive cell count analysis, as seen in Figure
E.8A.
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Figure E.7

Representative Iba-1 micrographs of DG.

Rats were subjected to sham or closed-head impact(s) and euthanized at either 3- or 7-days postinjury. The (a) location of the DG representative images is presented using 4x magnification with
a 500μm scale bar. Micrographs (20x) of Iba-1 expression in dentate gyrus region at 3- (b, d, f,
and h) and 7-days (c, e, g, and i) post-injury for Sham, RSham, mTBI, and RSC impact recovery
groups with a 100μm scale bar. A representative neuron expressing positive Iba-1
immunoreactivity is indicated for each 20x magnification micrograph by a black arrowhead.
Figure E.8a shows a representative Iba-1 micrograph of the hippocampus at 4x
magnification with a representative CA1 imaging location indicated by a black box. According
to the histological analysis of the positive cell counts for Iba-1, data revealed statistical
differences between injury and sham groups following 3-days of recovery (Figure 5.8B).
However, the represented micrographs for the Iba-1 stain do not visually demonstrate this trend;
the number of positively stained microglia evident in the representative micrographs for injury
groups mTBI3 and RSham3 (Figure E.8f,h, respectively) are not greater than their associated
sham (Sham and RSham, respectively) groups (Figure E.8b,d). Furthermore, again, although not
easily seen visibly from the representative micrographs, according to the histological analysis,
the repeated SC injury group showed a greater number of positive Iba-1 cells after 3-days of
recovery compared to 7-days of recovery (Figure E.8h-i).
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Figure E.8

Representative Iba-1 micrographs of CA1.

Rats were subjected to sham or closed-head impact(s) and euthanized at either 3- or 7-days postinjury. The (a) location of the CA1 representative images is presented using 4x magnification
with a 500μm scale bar. Micrographs (20x) of Iba-1 expression in CA1 region at 3- (b, d, f, and
h) and 7-days (c, e, g, and i) post-injury for Sham, RSham, mTBI, and RSC impact recovery
groups with a 100μm scale bar. A representative neuron expressing positive Iba-1
immunoreactivity is indicated for each 20x magnification micrograph by a black arrowhead.
Similarly seen within the CA3 regions of the NeuN and GFAP positive cell count
analysis, the number of positive cells plot for the CA3 region (Figure 5.8B) does not show
differences between groups by or between recovery days. This is confirmed visually, as the
proportion of Iba-1+ (brown colored stain) is not different between injury (Figure E.9f-i) or sham
(Figure E.9b-e) groups, regardless of recovery day.
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Figure E.9

Representative Iba-1 micrographs of CA3.

Rats were subjected to sham or closed-head impact(s) and euthanized at either 3- or 7-days postinjury. The (a) location of the CA3 representative images is presented using 4x magnification
with a 500μm scale bar. Micrographs (20x) of Iba-1 expression in CA3 region at 3- (b, d, f, and
h) and 7-days (c, e, g, and i) post-injury for Sham, RSham, mTBI, and RSC impact recovery
groups with a 100μm scale bar. A representative neuron expressing positive Iba-1
immunoreactivity is indicated for each 20x magnification micrograph by a black arrowhead.
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